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  ▏i 
Abstract 
Globally, cardiovascular disease (CVD) is a major cause for morbidity and mortality. 
Exaggerated postprandial lipaemia has been implicated in the development of 
atherosclerosis, and by lowering postprandial triacylglycerol (TAG) concentrations, 
atherogenic progression may be delayed. Many studies have revealed that exercise, in 
particular acute exercise, can attenuate postprandial TAG concentration. Most of this 
evidence relates to studies conducted in Western participants. South Asians are a 
population predisposed to CVD, and their adverse lipid profiles and physical inactivity may 
be among the underlying reasons. Hence, the studies described in this thesis examined the 
potential of acute bouts of exercise to favourably modify postprandial lipaemia and other 
CVD risk markers in young, healthy, South Asian men.   
 
The first experimental study described in this thesis compared the effect of 60 minutes of 
brisk walking on postprandial TAG concentration in 15 South Asian and 14 White 
European men. Trials were conducted over two days with exercise (or rest) taking place on 
day 1 and postprandial testing on day 2. A key finding from this study was that 
postprandial TAG, glucose and interleuklin-6 (IL-6) concentrations were elevated in South 
Asian compared with White European participants after consumption of high fat meals. 
This study also revealed a non-significant trend for brisk walking to reduce postprandial 
TAG concentrations in response to high fat meals in both groups. 
 
The second experimental study reported here examined the effect of 60 minutes of 
treadmill running at 70% of 2OV  max on postprandial lipaemia and other CVD risk 
makers on the next day in 10 South Asian and 10 White European men. A significant main 
effect of trial was shown for postprandial TAG, IL-6 and soluble intercellular adhesion 
molecule-1 (sICAM-1), showing that TAG and IL-6 concentrations were lower on the 
exercise trial while sICAM-1 concentrations were higher on the exercise trial. In addition, 
ethnic group differences were observed for postprandial TAG, glucose and insulin 
concentrations indicating higher values in South Asians than White Europeans. A 
significant trial by group interaction effect was also observed for TAG, indicating a greater 
decrease after exercise in the South Asian men than the European men.   
  ▏ii 
In the third experimental study in this thesis the effect of 30 minutes of treadmill running 
on one day was compared with running for 30 minutes on three consecutive days in 11 
South Asian men with regards to postprandial lipaemia. Neither a single bout of running 
nor three consecutive days of running influenced postprandial TAG in response to high fat 
meals when compared with the response on a control trial. It is not clear why exercise was 
ineffective in reducing postprandial lipaemia in this study but possibly the energy 
expenditure of exercise was insufficient to elicit change.  
  
The final experimental chapter described in this thesis combined the data from the first 
three studies. The objective of this chapter was to enhance the sample size in an effort to 
clarify the effects of acute exercise and to clarify the effects of ethnic group with respect to 
several fasting and postprandial CVD risk markers. The key findings were: 1) fasting and 
postprandial TAG and postprandial glucose concentrations were significantly reduced by 
exercise; 2) There were significant main effects of ethnic group for fasting high density 
lipoprotein cholesterol (HDL-C), total cholesterol/ HDL-C, IL-6 and systolic blood 
pressure (SBP), indicating lower values of HDL-C and SBP and higher values of total 
cholesterol/HDL-C and IL-6 in South Asian participants. Additionally, there were 
significant main effects of ethnic group for postprandial TAG and IL-6 indicating higher 
values in South Asian participants. 
 
Taken together, these data indicate that South Asians have an adverse CVD risk factor 
profile in comparison with White Europeans and this may explain, at least in part, their 
elevated risk of CVD. Importantly, the data produced within this thesis show for the first 
time that acute bouts of exercise can be effective for lowering postprandial plasma TAG 
concentrations in South Asians, at least transiently. Thus, exercise has the potential to serve 
as a ‘non-pharmacological’ medicine in South Asians. 
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1 Introduction 
Cardiovascular disease (CVD) encompasses a range of diseases that include coronary heart 
disease (CHD) and stroke and it is the major cause of morbidity and mortality globally 
(WHO, 2011). CVD accounted for 17.3 million deaths in 2008, representing 30% of all 
global deaths. Of these deaths, an estimated 7.3 million were due to CHD and 6.2 million 
were due to stroke (WHO, 2011). By 2030, it is predicted that around 24 million people 
will die each year from CVD, mainly from CHD and stroke. These are projected to remain 
the leading causes of death (WHO, 2011).  
 
In congruence, CVD is also responsible for more deaths in the United Kingdom (UK) than 
any other single cause according to the British Heart Foundation (BHF, 2009). The ethnic 
group most affected by CVD are South Asians (BHF, 2009) who come from the Indian 
sub-continent. Geographically, the Indian subcontinent is a region critically affected by 
CVD and it makes up one quarter of the world’s population (Ramaraj & Chellappa, 2008). 
Those who have their origin from the Indian sub-continent are collectively known as South 
Asians and this includes people from India, Pakistan, Bangladesh, Nepal, Sri Lanka and 
Bhutan (Joshi et al, 2007). South Asians comprise the largest ethnic minority group (4.1%) 
living in the UK (Wild & McKeigue, 1997) and they have a higher risk of CVD than 
Europeans (Wild et al, 2007; BHF, 2009) although the reasons for this are uncertain.  
 
Among people living in the UK, the earlier onset of CHD among South Asian migrants and 
the higher incidence of CHD is most marked in those younger than 40 years of age (about a 
3 fold difference), whereas it is less marked in those older than 60 years of age (about a 1.5 
fold difference) based on the analysis of UK mortality data (Balarajan, 1991). The 
increased risk of CVD is further evident from a recent cardiovascular risk assessment study 
conducted in the UK which identified that 92% of male and female South Asians had at 
least one modifiable CVD risk factor (Rao et al, 2012). Of these, 52% were hypertensive, 
40% were obese, 75% had central obesity and 10% had a total cholesterol/high density 
lipoprotein cholesterol (HDL-C) ratio greater than six (Rao et al, 2012). 
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Since the 1950s, there has been an increased awareness that people with ancestral origins in 
the Indian subcontinent are highly susceptible to CHD (Patel and Bhopal, 2004). Danaraj 
and colleagues (1959) were possibly the first to highlight this issue. They observed a seven 
fold higher prevalence of CHD among Indians than Chinese living in Singapore. Another 
study in Singapore revealed that Indians are more prone than Malays and Chinese to 
developing central obesity with insulin resistance, hyperinsulinaemia and glucose 
intolerance (Hughes et al, 1997). In 1963, Adelstein identified this phenomenon in South 
Africa where mortality rates for CVD/CHD in mainly Indian men and women were much 
higher than in white men and women (Adelstein, 1963). These findings have since been 
confirmed in the USA (Palaniappan et al, 2004) and Canada (Sheth et al, 1999). 
 
It is important to recognise that the term “South Asian” refers to a heterogeneous 
population with important differences in diet, culture, religion and lifestyle among different 
South Asian populations. Studies have identified a three to five fold increase in the risk of 
myocardial infarction and cardiovascular death in South Asians as compared with other 
ethnic groups (McKeigue et al, 1989; Eapen et al, 2009). With respect to the prevalence of 
vascular risk factors, Bangladeshis fare the worst, followed by Pakistanis and then Indians 
(Bhopal et al, 1999). Data from the 2001 Census of England and Wales showed that people 
born in Bangladesh had the highest rates of death due to CVD, followed by those born in 
Pakistan (Wild et al, 2007). However, a review paper reported that among South Asians 
blood pressure is highest in Indians, slightly lower in Pakistanis and much lower in 
Bangladeshis (Agyemang and Bhopal, 2002). 
 
Various factors are associated with the lifestyle of populations across the world that has 
changed dramatically in the 20th century. These epidemiological transitions have been 
brought about by many developments in science and technology that now affect every facet 
of human existence (Prabhakaran and Yusuf, 2010). Most human societies have moved 
from agrarian diets and active lives to fast foods and sedentary behaviour. These changes 
have fuelled the epidemic of obesity, diabetes, hypertension and dyslipidaemia which are 
risk factors for CVD/CHD (Prabhakaran and Yusuf, 2010). The prevalence of traditional 
risk factors has been on the rise in South Asians and may contribute to their high CHD 
prevalence. The INTERHEART study identified nine traditional risk factors that contribute 
to the high CHD burden in the South Asian population. These factors are obesity, alcohol 
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consumption, physical inactivity, diabetes, hypertension, diet, psychosocial factors, 
dyslipidaemia and smoking (Joshi et al, 2007). The INTERHEART study also reported that 
South Asians have their first acute myocardial infarction five years earlier than those from 
other countries (Joshi et al, 2007). In patients with acute myocardial infarction, the high 
prevalence of conventional risk factors among South Asians largely explained their 
younger age at presentation compared with Europeans (Joshi et al, 2007). Other emerging 
risk factors (e.g.: interleukin-6 (IL-6) and soluble intercellular adhesion molecule-1 
(sICAM-1)) may also contribute, predisposing South Asians to heart disease along with 
conventional cardiac, metabolic and environmental factors (Kolluri et al, 2009). 
Environmental changes that come from adopting the habits of other cultures can further 
increase these risks. Thus, the prevalence of CHD in South Asians globally is significantly 
higher than any other ethnic group in the past forty years. (Kolluri et al, 2009). 
 
South Asians have higher plasma triacylglycerol (TAG), lower HDL-C concentrations, 
higher low density lipoprotein cholesterol (LDL-C) concentrations, and a higher prevalence 
of hypertension, type 2 diabetes, impaired glucose tolerance, increased fasting glucose, 
insulin resistance and the metabolic syndrome than other populations (Tziomalos et al, 
2008). This may be due to genetic factors predisposing to high levels of metabolic CVD 
risk factors. Alternatively/additionally, environmental influences may contribute to the 
adverse CVD risk profiles in South Asians (Reddy & Yusuf, 1998).  
 
One environmental factor which may contribute to the excessive CVD risk in South Asians 
is physical inactivity. In their review of physical activity levels among South Asians living 
in the UK Fischbacher and colleagues (2004) identified 12 studies in adults and five in 
children all of which reported lower levels of physical activity among UK South Asians 
than the general population. These findings have since been confirmed by data from a 
diabetes screening programme in Leicester, UK (Yates et al, 2010). This study was the first 
to comprehensively investigate ethnic-specific differences in both levels of physical 
activity and associations between physical activity and markers of metabolic and vascular 
health (Yates et al, 2010). According to the Health Survey for England regardless of sex, 
age and type of physical activity, South Asians are 60% less active than White Europeans 
(Williams et al, 2011). Many studies have confirmed this (Kamath et al, 1999; Owen et al, 
2009; Misra et al, 2012). The INTERHEART study also found that South Asian patients 
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with myocardial infarction and healthy South Asian controls were both less physically 
active than other ethnic groups and that the population attributable risk for physical 
inactivity in South Asian people is comparable to that for other major CHD risk factors 
(Joshi et al, 2007). 
 
It can be postulated that there are possible barriers to physical activity among South Asians. 
Physical activity is a foreign concept to the cultural identity of South Asian communities 
(Caperchione et al, 2009). Lifestyle factors, such as physical activity are therefore 
perceived as irrelevant to the disease process (Lawton et al, 2006). Moreover, the 
physiological response to physical activity may even be viewed as unhealthy and likely to 
exacerbate illness (Caperchione et al, 2009; Lawton et al, 2006). Cultural taboos against 
South Asian females and the view of physical activity beyond daily work as selfish may 
also be determinants of physical inactivity (Caperchione et al, 2009). Language barriers, 
being unfamiliar with the wider community, fear of racism, crime and social deprivation 
have all been cited as barriers to physical activity among South Asians (Caperchione et al, 
2009). 
 
Although, such barriers exist, it is critical to understand that physical inactivity is a well-
established risk factor for CVD/CHD (Wannamethee & Shaper, 2001; Yusuf et al, 2004; 
Rastogi et al, 2004; Mohan et al, 2005; Rao et al, 2012). Regular physical activity acts 
through numerous pathways to reduce the risk of CVD. These mechanisms include reduced 
adiposity, improved lipid and glucose profiles, reduced blood pressure and improved 
endothelial and immune function (Warburton et al, 2006). Regular moderate intensity 
physical activity is associated with a 30% to 50% reduction in the risk of CHD, obesity, 
diabetes and stroke (Wannamethee et al, 2000; Batty, 2002). Despite higher rates of earlier 
CHD in South Asians and a tendency for low levels of physical activity, no studies have 
addressed the acute effects of exercise in this population although observational evidence 
suggests a cardio-protective role of physical activity in South Asians (Rastogi et al, 2004; 
Mohan et al, 2005; Rao et al, 2012).  
 
One particular CVD risk factor which is positively influenced by exercise is postprandial 
lipaemia. Zilversmit (1979) presented evidence that the postprandial period may aggravate 
the atherosclerotic process. Thereafter, many investigations have suggested that exercise 
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attenuates postprandial lipaemia by reducing hepatic very low density lipoprotein-TAG 
secretion and by increasing TAG uptake within skeletal muscle (Tsetsonis et al, 1996; 
1997; Hardman, 1998; Petit and Cureton, 2003, Katsanos, 2006; Malkova and Gill, 2006; 
Miyashita et al, 2006; 2008; MacEneaney et al, 2009, Hurren et al, 2011). Postprandial 
lipaemia is more predictive of future CVD than fasting TAG alone (Bansal et al, 2007; 
Nordestgaard et al, 2007) and exercise has a tendency to decrease the risk of developing 
CVD/CHD in part through a reduction in atherosclerotic plaque formation (Gill and 
Malkova, 2006; Warburton et al, 2006). 
 
Though acute bouts of aerobic exercise performed the day prior to meal ingestion have 
been found to attenuate postprandial lipaemia these studies have been conducted 
predominantly in Western populations (Miyashita et al, 2008; MacEneaney et al, 2009; 
Hurren et al, 2011). To date, there are no data on the effect of prior exercise on 
postprandial lipaemia and other CVD risk markers in South Asians. This represents an 
important void in understanding the extent to which exercise may ameliorate CVD risk in 
South Asians.  
 
Despite the high prevalence of CHD and low levels of physical activity among South 
Asians few studies have examined the effects of exercise/physical activity on CVD/CHD or 
on risk factors for CVD/CHD in this population. Whether exercise/physical activity has any 
cardio-protective effects in South Asians remains to be determined. Thus, the primary 
purpose of the studies contained within this thesis was to investigate the influence of acute 
bouts of exercise on postprandial lipaemia and other CVD risk markers in South Asians 
compared with White Europeans.  
 
The first study in this thesis (Chapter four) examined the effect of prior walking on 
postprandial lipaemia and resting blood pressure in South Asian versus White European 
men. Study two (Chapter five) investigated the effects of an acute bout of running on 
postprandial lipaemia and on several other CVD risk markers including insulin, glucose, 
IL-6 and sICAM-1 in South Asian and White European men. Study three (Chapter six) 
examined the effects of a single bout of running versus three consecutive days of running 
on postprandial lipaemia in men of South Asian descent. The final study in this thesis 
(Chapter seven) involved a cross-sectional comparison of several fasting and postprandial 
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CVD risk markers in South Asians and White Europeans. Collectively, the studies 
presented in this thesis begin to address the very limited attention to date on the potential of 
exercise to modify CVD risk markers in South Asians.   
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2 Literature review 
2.1 Introduction 
This review will begin by briefly defining heart disease and discussing its aetiology. Recent 
heart disease statistics will then be presented for the UK, for other countries and then 
specifically for South Asians. After this there is a review of traditional and emerging risk 
factors for heart disease before these risk factors are specifically discussed in South Asians. 
Following this there is a discussion of some of the key literature examining the relationship 
between physical activity/exercise and heart disease/all-cause mortality risk and then a 
review of some key studies examining physical fitness and heart disease/all-cause mortality 
risk. Very few of these studies involve South Asian participants. Towards the end of the 
review there is a discussion of the acute and then the chronic effects of exercise on heart 
disease risk factors. The final section of the review focuses specifically on studies which 
have examined physical activity/physical fitness levels and their relationship with CVD 
risk in South Asians.   
2.2 Heart disease definition and aetiology 
Heart disease is a term used for a variety of disorders that affect the heart or make it less 
efficient by reducing its supply of oxygen or by reducing its ability to pump effectively 
(World Health Organization - WHO 2009). The term heart disease is used interchangeably 
with cardiovascular disease (CVD) which refers to anything that is related to the heart 
(cardio) and blood vessels (vascular). Congenital heart disease, angina (chest pain), 
arrhythmia (defects in the rhythm of the heart), arteriosclerosis, coronary artery disease, 
pulmonary heart disease, and myocarditis (inflammation of the heart muscle) all come 
under the ‘umbrella’ of heart disease. 
 
The main components of CVD are coronary heart disease (CHD), stroke and hypertension 
which are leading causes of death in both developed and developing nations (WHO, 2009). 
In CHD the artery progressively narrows due to the build-up of plaque, a condition called 
atherosclerosis. Atherosclerosis is a process that is the principal contributor to the 
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pathogenesis of myocardial infarction, cerebral infarction, gangrene and loss of function in 
the extremities (Ross, 1993). In normal circumstances a protective response to insults to the 
endothelium and smooth muscle cells of the wall of the artery, consists of the formation of 
fibrofatty and fibrous lesions preceded and accompanied by inflammation. The advanced 
lesions of atherosclerosis, which may occlude the artery concerned, result from an 
excessive inflammatory fibro proliferative response to numerous different forms of insult 
(Ross, 1993). 
 
This results in insufficient blood flow, called ischaemia, to the heart and eventually leads to 
a heart attack. Stroke, is a brain ischaemia due to a thrombosis (formation of a blood clot) 
or a haemorrhage (profuse bleeding from a ruptured blood vessel) of a blood vessel within 
the brain. These conditions hamper the functionality of the brain. Hypertension or high 
blood pressure is where the pressure of the blood being pumped out from the heart strains 
the artery walls. The Joint National Committee on Prevention, Detection, Evaluation and 
Treatment defined hypertension as an elevated systolic blood pressure of 140 mm Hg and 
above and/or a diastolic blood pressure of 90 mm Hg and above which then becomes a 
contributor to all major heart diseases (Chobanian et al, 2003). If blood pressure levels are 
consistently elevated this increases the risk of stroke, CHD and kidney failure.  
 
In Greek, athero refers to gruel or paste and sclerosis to hardness. Atherosclerosis entails 
deposits of waste products like fatty substances, cholesterol and cellular waste products in 
the lining of the artery (Mallika et al, 2007). This results in the formation of plaque which 
comprises of low density lipoprotein cholesterol (LDL-C), smooth muscle cells, fibrous 
tissue and calcium. The artery is segmented into three layers, intima, media and adventitia. 
The intima is the inner most layer where it is most intimate with the blood and this layer is 
also known as the endothelium. It is believed that atherosclerosis is initiated by damage to 
the endothelium. Plaque formation within the endothelium creates rough areas which 
stimulate blood clots and impair blood flow and hence oxygen transport to organs such as 
the heart, kidney and intestines (Mallika et al, 2007). This may result in the death of the 
organ cells or severe damage (American Heart Association - AHA, 2009). Atherosclerotic 
lesions start to develop early in life independently of race, sex or geographical origin. The 
rate of fatty streak development is higher between 15 and 25 years of age, while raised 
lesions begin developing slowly during the second decade of life, progressing steadily 
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during the third and more rapidly during the fourth (Sternby et al, 1999). Thus, 
cardiovascular disease is a slow and progressive disease that begins in childhood hence 
preventive measures must begin early (McGill et al, 2000).  
2.3 Heart disease statistics 
According to the World Health Organisation (WHO, 2011) CVD causes 17.3 million 
deaths in the world each year and by 2030 almost 24 million people will die from CVD. 
Some forms of CVD are more common among certain racial and ethnic groups. For 
example, African Americans are more likely to suffer from hypertension and are at a 
greater risk of heart disease than whites (AHA, 2012). Risk factors for CVD in other 
minority groups have also been studied as in the case of the South Asians. Related studies 
generally have used the white population as a comparison. 
 
2.3.1 United Kingdom 
Cardiovascular disease is responsible for more deaths in the UK than any other single cause 
according to the British Heart Foundation (BHF 2009). Cardiovascular disease caused 
190,000 deaths in 2007 and it was also a major catalyst for premature death before the age 
of 75 (29% of men and 21% of women) in the UK (BHF 2009). 2.6 million people in the 
UK are living with CHD. Half of all CVD cases are due to CHD and one-third are due to 
stroke. Coronary heart disease was responsible for 91,000 deaths in 2007 accounting for 
19% of deaths in men and 13% of deaths in women (BHF 2009). Coronary heart disease is 
also the most common cause of premature death in the UK (18% in men and 10% in 
women). Nearly all deaths from CHD are from a heart attack. Approximately 1.4 million 
people over the age of 35 years have had a heart attack and 2 million have suffered from 
angina (BHF 2009). In 2007 alone, heart attack affected 141, 000 people and 720, 000 
people had a definite heart failure. The mortality rate from CHD has been decreasing since 
the 1970s, but CHD incidence has been on the rise from the 1980s, particularly in men 
aged 75 and older.  
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2.3.2 Other countries 
In comparison with Western Europe, Australia and Japan, levels of CHD in the UK are 
moderately high (BHF 2009). The main cause of mortality in almost all European Union 
countries in 2008 (OECD, 2010) was related to ischaemic heart disease (IHD) and stroke. 
Together, they comprised 60% of all cardiovascular deaths in European Union countries for 
that year. The highest mortality rates were reported in central and eastern European 
countries for both males and females (OECD, 2010). 
 
According to AHA (2012), cardiovascular disease is the leading cause of death in the 
United States killing on average 2200 people per day, an average of one person every 39 
seconds. One or more types of CVD affect an estimated 82.6 million American adults and 
out of these an estimated 40 400 000 are ≥60 years of age. The breakdown of CVD by type 
is as follows, hypertension (74.5 million), CHD (16.3 million), myocardial infarction (7.9 
million), angina pectoris (9 million), heart failure (5.7 million), stroke (7 million) and 
congenital cardiovascular defects (650 000 to 1.3 million) (AHA, 2012). Cardiovascular 
disease is responsible for half of all deaths in the United States. Cancer, the second largest 
killer, accounts for only half as many deaths. The AHA 2012 estimates that 68% of patients 
with diabetes die of some form of CVD. 
 
Cardiovascular disease is on the rise in India affecting Indians prematurely or 5 to 6 years 
earlier than their western counterparts (Xavier et al, 2008). The presence of CHD in the 
urban population is estimated to be from 7% to 13% and in the rural population from 2% to 
7% (Prabhakaran & Yusuf, 2010). Increasing rates of urbanisation and major economic 
changes  (such as improved transportation) have led to changes in lifestyle patterns for a 
large proportion of individuals in India resulting in decreased physical activity levels for 
many Indians. Availability of energy saving devices have been responsible for increasing 
weight in the urban population leading to diabetes, hypertension and dyslipidaemia (Reddy, 
1999). A reversal of socio-economic gradients for CHD risk factors has emerged in the 
Indian population (Reddy et al, 2007; Ajay et al, 2008). These culminating with lack of 
support mechanisms for evidence based treatments and follow-up for acute myocardial 
infarction, mean that there is almost 50% higher mortality among the poor compared with 
the rich in India (Xavier et al, 2008). 
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Thirty-two per cent of all mortality resulted from this chronic disease according to a study 
administered in 45 villages in a southern state of India (Joshi et al, 2006). In India, the 
prevalence of diabetes (a major risk factor for CVD and CHD) is projected to increase from 
32 million in 2000 to 69.8 million in 2025. Similarly, the prevalence of hypertension is 
projected to increase from 118 million in 2000 to 214 million in 2025 (Kearney et al, 
2005). These projections suggest that more people will suffer from CHD in India in the 
future. The productive years of life lost in those aged 35 to 64 years is also on the rise. In 
2000, it was 9.2 million and this is expected to increase to 17.9 million by 2030 (Leeder et 
al, 2005). Once thought to be a disease of the ‘rich’, CVD is now fast affecting the poor in 
rural and urban settings. Lack of awareness of the risk factors for CVD contributes to the 
morbidity and mortality of South Asians within and outside of India (Rastogi et al, 2004). 
  
According to a Canadian study, South Asians were represented as a strong and independent 
determinant for CVD in Canada (Anand et al, 2000). Interestingly, South Asians had less 
atherosclerosis than Europeans, yet they had higher cardiovascular disease rates suggesting 
a paradox. This prevalence of CVD was highest in South Asians followed by Europeans 
and then Chinese. Anand and colleagues (2000) also found a higher prevalence of plasma 
lipid and glucose abnormalities in South Asians than in other ethnic groups (Anand et al, 
2000).  Another, study also identified that Canadians of South Asian origin have an 
increased prevalence of CVD compared with Canadians of European and Chinese origin 
(Sheth et al, 1999). Major causes of CVD were IHD and cerebral vascular disease. 
Canadian men of South Asian origin had a higher mortality rate for IHD than the men of 
European origin while men of Chinese origin had the lowest mortality rate among these 
men (Sheth et al, 1999). 
 
Furthermore, similar findings have been identified in Singapore by Danaraj and colleagues 
in 1959. Postmortem autopsies of 9,568 bodies revealed that Indians had a high rate of 
severe premature heart disease (Danaraj et al, 1959). It also revealed a rate of coronary 
atherosclerosis seven times higher in Indians than in Chinese (Danaraj et al, 1959). Hence, 
this was the first study to conclusively report the predicament of CVD in South Asians. 
Following this, Hughes and colleagues (1990) reported that diabetes was more common in 
South Asians (Indians) which may account for their higher risk of IHD than the Malays and 
Chinese in Singapore. One other study also reiterated this in Singapore showing South 
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Asians to have more than a three times higher risk of developing CHD than Chinese and 
Malays (Lee et al 2001). This phenomenon was also seen in South Africa where a higher 
mortality rate from CVD/CHD was found in Indian men and women than in white men and 
women (Adelstein, 1963).  
 
2.3.3 South Asians living in the UK 
The South Asian population who are born or have their origins from the Indian 
subcontinent (comprising of India, Pakistan, Bangladesh, Nepal, and Sri Lanka) are highly 
susceptible to CVD (Ramaraj & Chellappa, 2008). Since the 1950s and 1960s gradual 
awareness took place of this susceptibility (Patel & Bhopal, 2004). Censuses have shown a 
greater excess in mortality rates in Indian subcontinent born South Asians than the general 
population of England and Wales. This has been evident from the studies of Balarajan 
(1991) and Wild and McKeigue (1997). 
 
South Asians make up 4.1 % of the UK population and they are the largest ethnic minority 
group (Wild and Mckeigue, 1997). South Asians living in the UK are more likely to suffer 
from CVD than the general population (BHF 2009). They also experience a higher 
prevalence of non-insulin dependent diabetes mellitus, lower plasma high density 
lipoprotein cholesterol (HDL-C) concentrations and higher plasma triglyceride 
concentrations (Hughes et al, 1989; Knight et al, 1992; McKeigue et al, 1991). The 
incidence rate of myocardial infarction has been reported to be higher in South Asians 
compared with other ethnic groups. (Wild et al, 2007). Asian survivors of first myocardial 
infarction have also been identified to have a higher prevalence of hyperinsulinaemia and 
they tend to be generally younger than whites (Hughes et al, 1989).  The description South 
Asians give of their symptoms is often atypical and this makes it difficult for medical staff 
in the initial diagnosis and interpretation to take immediate action. Hence, the process of 
treatment in South Asians is delayed (Barakat et al, 2003; Teoh et al, 2007). In addition, 
impaired glucose tolerance, and central obesity exacerbate coronary artery disease in South 
Asians. On the whole, mortality ratios of CVD, CHD and stroke are also higher in South 
Asians in UK than the local population (Wild et al, 2007). This is further evident from a 
recent cardiovascular risk assessment study conducted in the UK which screened almost 
equal numbers of male and female South Asians. It identified that 92% of them had at least 
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one modifiable CVD risk factor placing them in a high CVD risk population (Rao et al, 
2012). With respect to the most prevalent CVD risk factors 52% were hypertensive, 40% 
were obese, 75% had central obesity and 10% had total cholesterol/HDL-C ratio values 
greater than six (Rao et al, 2012). Estimates suggest a three to five fold increased risk of 
myocardial infarction and cardiovascular death among migrant South Asians than other 
ethnic groups (Eapen et al, 2009). 
 
South Asians, innately have been known to have higher plasma triacylglycerol (TAG), 
lower HDL-C and higher low density lipoprotein cholesterol (LDL-C) concentrations than 
other groups. South Asians also appear to be more susceptible to hypertension, type 2 
diabetes, impaired glucose tolerance, increased fasting glucose concentration, insulin 
resistance and the metabolic syndrome than other ethnic groups (Tziomalos et al, 2008). 
This may be due to genetic factors predisposing them to high levels of metabolic 
cardiovascular risk factors. Alternatively, environmental influences may be responsible 
(Reddy & Yusuf, 1998). 
 
Although South Asians in general suffer from a higher risk of CHD than other groups in 
the UK there is also a variation in risk of CHD within the South Asian population. 
Pakistani and Bangladeshi men born in the sub-continent of India but living in the UK now 
are more than two times more likely to die from CHD than the national average. Pakistani 
women are two and half times more prone to CHD than the national average (BHF 2009). 
In terms of prevalence among them, Bangladeshis are worst affected followed by 
Pakistanis and then Indians (Bhopal et al 1999). This is the same for CVD (Wild et al, 
2007). However, for blood pressure, Indians have a higher prevalence of hypertension 
followed by Pakistanis and lastly Bangladeshis (Agyemang et al, 2002). South Asians 
resemble more of a heterogeneous than a homogeneous group. There is conflicting 
evidence over whether hypertension is more common in South Asian groups. One study 
found diastolic blood pressure among South Asian (mainly Punjabi) men in Glasgow was 
higher than in the general population but this was not so for South Asian women or for 
systolic blood pressure (Williams et al, 1994). South Asian groups in Newcastle, 
particularly Bangladeshis, were found to have lower blood pressure than Europeans 
(Bhopal et al, 1999).  
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2.4 Risk factors for heart disease 
Risk factors are conditions that elevate the danger of contracting heart disease. They can be 
categorised into modifiable and non-modifiable risk factors. Examples of modifiable risk 
factors are smoking, physical inactivity, obesity, high blood pressure and high blood 
cholesterol. Age, sex, hereditary and ethnicity are examples of non-modifiable risk factors. 
These may be categorised as traditional risk markers. In addition are the emerging risk 
markers. The following are a few examples: C-reactive protein (CRP), interleukin-6 (IL-6), 
soluble intercellular adhesion molecules (sICAM-1), soluble vascular cellular adhesion 
molecule-1 (sVCAM-1). 
 
2.4.1 Traditional risk factors 
2.4.1.1 Modifiable risk factors 
Hypertension or high blood pressure may be related to a variety of factors including  age, 
ethnicity, family history, overweight, low physical activity, high sodium intake, excessive 
alcohol consumption and psychosocial stress (AHA, 2012). Hypertension substantially 
contributes to high death rates from IHD, cerebrovascular disease and renal failure (Joshi et 
al, 2006).  There is a change with age in the relative importance of SBP and DBP as risk 
indicators. Below 50 years of age, DBP is the major predictor of IHD risk, whereas above 
60 years of age, SBP is more critical (Franklin et al, 2001). Each 20 mm Hg increase in 
SBP or 10 mm Hg increase in DBP doubles the risk of a fatal coronary event (Lewington et 
al, 2002). In the Chicago Heart Association Detection Project in Industry, men 18 to 39 
years of age at baseline with a blood pressure of 130 to 139/85 to 89 mm Hg or with stage 
1 hypertension (140 to 159/90 to 99 mm Hg) accounted for nearly 60% of all excess IHD, 
overall CVD, or all-cause mortality (Miura et al, 2001). In addition, resting heart rate and 
blood pressure, even within the normal ranges, proportionately raise the risk for developing 
diabetes mellitus in middle-aged men and women. The adverse effects of heart rate and 
blood pressure are independent of each other as well as the influences of age, body mass 
index, smoking, drinking, exercise and education. Resting heart rate and blood pressure 
may affect glucose tolerance and lead to the development of diabetes mellitus (Nagaya et 
al, 2010).  
 
   Chapter 2 
 
  ▏15 
Moreover, there is a strong correlation between time of the day and cardiovascular events 
which often coincide with the early morning surge in blood pressure (Kario et al, 2003). 
The risk as a result of the morning surge has also been noted after rising from afternoon 
siesta (Bursztyn et al, 1999). The sudden activation of the sympathetic nervous system may 
be the main mediator of the morning surge (Panza et al, 1991). Arousal from sleep is 
associated with increases in both epinephrine and norepinephrine which could be the 
mechanism responsible (Dodt et al, 1997). It is estimated that over seven million people 
worldwide die each year as a result of raised blood pressure (WHO, 2005).  
 
Hypercholesterolaemia is another risk factor for heart disease. Cholesterol is a fat-like 
substance produced by the liver that travels in the blood. It is found in all body cells and is 
the raw material for the manufacture of steroid hormones and bile acids. Its insolubility in 
water, a property that makes it useful in cell membranes also makes it hazardous. 
Accumulation of this errant cholesterol in the artery wall can lead to plaque formation, 
eventually leading to atherosclerosis and CHD. Low density lipoprotein is the carrier for 
the most cholesterol in human plasma (Brown and Goldstein, 1986). The idea that 
cholesterol plays a causal role in atherogenesis is supported by a large body of 
experimental, epidemiological and clinical evidence (Lind, 2002; Stamler et al. 1986). 
Accordingly, hypercholesterolemia has been implicated in atherosclerosis appearance and 
progression by starting a cascade of cellular and molecular events leading to endothelial 
dysfunction, plaque instability and cardiovascular events (Ross, 1993). It is estimated that 
approximately 4.4 million people worldwide die each year as a result of raised total 
cholesterol levels (WHO, 2005).  
 
Diabetes is a chronic disease that occurs when the pancreas does not produce enough 
insulin, or when the body cannot effectively use the insulin it produces (WHO, 2011). It is 
categorised into type 1 which is the inability to produce insulin and type 2 or adult onset 
which is also known as non-insulin dependent diabetes (i.e. the pancreas produces insulin 
but the tissues are unresponsive to it). Apart from these there is gestational diabetes which 
relates to elevated blood glucose concentrations induced during pregnancy. This can 
actually pave the way to the development of type 2 diabetes. Of the two main forms of 
diabetes type 2 is the most prevalent (WHO, 2011). Certain ethnic groups have a greater 
risk of developing diabetes. It is evident that people suffering from diabetes have a high 
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risk of developing CVD. Diabetes can also lead to complications such as blindness, 
amputation and kidney failure. Oxidative stress mediated by reactive oxygen species is also 
promoted by the diabetic state (Baynes et al, 1999). Diabetes affected over 220 million 
people around the world in 2005 and 1.1 million people died of diabetes in 2005 (WHO, 
2009a). Atherosclerosis, the main cause of CHD, occurs with higher than normal frequency 
in patients with diabetes and pre-diabetes and is the major cause of morbidity and mortality 
in diabetic patients (Nathan et al, 1997; Meigs et al, 1997). However, the mechanism 
responsible for the increased risk for atherosclerosis in diabetes is still controversial 
(Kuusisto et al, 1994). The response to injury hypothesis of atherosclerosis states that the 
injurious response initially occurs to the endothelium of the artery, leading to endothelial 
dysfunction (Ross, 1993). Indeed, endothelial dysfunction has been shown to occur in 
patients with diabetes (Ross, 1993; Calver et al, 1992) and chronic hyperglycaemia is 
implicated as a cause for endothelial dysfunction (Kuusisto et al, 1994; Ting et al, 1996). 
However, Type 2 diabetes and impaired glucose tolerance (IGT) are often associated with 
other risk factors such as hypertension, dyslipidaemia and obesity, each of which may 
cause endothelial dysfunction (Nathan et al, 1997; Meigs et al, 1997;  Kuusisto et al, 1994).    
 
Obesity and overweight arise as people expend fewer calories than they consume so that 
energy intake exceeds energy expenditure. This can lead to elevations in cholesterol 
concentrations, blood pressure and several other disease risk factors increasing the risk of 
coronary artery disease and diabetes and a variety of other diseases/conditions (Poirier et 
al, 2006). Being overweight is defined as having a body mass index (BMI) over 25 kg·m2 
(weight in kilogrammes divided by height in metres squared) and those with a BMI above 
30 kg·m2 are considered obese in accordance with the National Heart, Lung, and Blood 
Institute (NHLBI, 2010). Obesity increases the risk of insulin resistance and diabetes in 
particular and these in turn are related to atherogenic dyslipidaemia (Yudkin et al, 1999). 
Obesity may affect the heart through its influence on risk factors such as dyslipidaemia, 
hypertension, glucose intolerance, inflammatory markers, sleep apnoea/hypoventilation and 
the prothrombotic state (Poirier et al, 2006). Overweight and obesity predispose to or are 
associated with numerous cardiac complications such as CHD, heart failure and sudden 
death because of their impact on the cardiovascular system (Poirier et al, 2006). It is 
estimated that approximately 2.6 million people die each year as a result of being 
overweight or obese according to the WHO (2005). 
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As discussed below, a sedentary lifestyle is another major risk factor for CHD which is 
well established and is associated with a 2-fold increase in risk for CHD (Wannamethee & 
Shaper, 2001). According to the WHO, an estimated 1.9 million deaths are caused globally 
by chronic diseases resulting from inadequate physical activity. The American College of 
Sports Medicine and the American Heart Association  recommend that adults perform at 
least 30 minutes of moderate intensity physical activity on most days of the week or 
alternatively, vigorous intensity physical activity for at least 20 minutes on three days of 
the week or a combination of both (Haskell et al, 2007). The Global Recommendations on 
Physical Activity for Health suggest 150 minutes of moderate intensity aerobic physical 
activity throughout the week or at least 75 minutes of vigorous intensity aerobic physical 
activity throughout the week or an equivalent combination of moderate and vigorous 
intensity activity (WHO, 2010). Physical activity helps to decrease the risk of morbidity 
and mortality that may arise through CVD, stroke, type 2 diabetes, colon cancer and breast 
cancer. In addition, physical activity also helps to burn calories, control cholesterol, 
manage bodyweight, lower blood pressure, strengthen heart muscle, manage osteoporosis 
and manage musculoskeletal conditions (WHO, 2009b). As a result, a lower heart rate is 
achieved, stroke volume increases and this leads to an increased cardiac output. These 
enable the heart to function more effectively and efficiently. Furthermore, physical activity 
helps to raise the level of HDL-C and possibly lowers LDL-C (Hardman, 2007). Physical 
inactivity or sedentary activity may be related to obesity and the risk for chronic disease 
through an increase in energy intake and not just because of a lower energy expenditure 
(Rastogi et al, 2004). Physical inactivity may also give rise to biological setbacks such as 
increases in blood pressure, low HDL-C, decreased insulin sensitivity, poor endothelial 
function and increased atherogenic cytokine production (Pate et al, 1995; DHHS, 1996). 
Physical inactivity also leads to lower energy expenditure and reductions in lean body mass 
(Rastogi et al, 2004).  
 
Smoking has a widespread effect on heart disease. The nicotine, tar and carbon monoxide 
components cause fatty plaque to build up in the arteries eventually causing insufficient 
blood supply to the heart. Smoking raises blood cholesterol and it also impairs fibrinolysis 
raising the risk of a blood clot and hence a heart attack. Many are well informed that 
smoking causes lung cancer but many are unaware of its adverse effects on the heart. 
Smoking increases the heart rate, tightens the arteries and creates irregularities in the 
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heartbeat. Cigarette smoking triples the risk of dying of CHD. On average, adults who 
smoke cigarettes die 13 to 14 years earlier than non-smokers (AHA, 2009). Smoking 
results in impaired endothelial function, increased intima media thickness, decreased nitric 
oxide bioavailability and increased atherosclerotic plaque formation (Antoniades et al, 
2008). Children exposed to passive smoking have been found to have increased oxidative 
stress. This suggests that the generation of free radicals in the vascular wall has been 
stimulated by the inhaled smoke. This implies that passive smoking affects the non-smoker 
in the same way as a smoker (Kosecik et al, 2005). In 2001, tobacco-related mortality was 
4.9 million globally and this figure is estimated to reach 10 million by 2020 if appropriate 
action is not taken (WHO, 2002). 
 
Excessive alcohol consumption is another element that impairs the function of the heart 
which brings about high blood pressure, stroke, irregular heartbeats, and cardiomyopathy 
(disease of the heart muscle) (BHF 2010). Drinking alcohol also increases caloric intake 
facilitating weight gain and hence overweight. In addition, binge drinking results in adverse 
effects such as hypercoagulability or tissue damage (U.S.DHHS, 2005). Evidence from 
observational studies has shown that moderate alcohol consumption (one to two drinks per 
day) is associated with a lower risk of cardiovascular disease. Moderate alcohol 
consumption also is associated with reduced risk of all-cause mortality among middle-aged 
and older adults and may help to keep cognitive function intact with age (U.S.DHHS, 
2005). 
 
In addition, psychosocial factors including stress may also elevate the risk of CVD. This 
possibly relates to different personalities differently in terms of their mental and emotional 
state. According to Williams and colleagues (2009), psychosocial factors may contribute to 
CHD in both males and females. Psychosocial factors have been shown to influence CHD 
risk (Rozanski et al, 2005). Factors such as depression and chronic work stress are 
independently associated with increased risk of heart disease whereas social networks and 
support appear to be protective (Nicholson et al, 2006; Bosma & Marmot, 1997; Rosengren 
et al, 2004). A recent study examined the stress hormone - cortisol. Cortisol is produced in 
order to help the body recover from stress and regain its physiological stability. High levels 
of cortisol are associated with death from CVD. In a six year study, Vogelzangs and 
colleagues (2010) investigated 861 participants aged over 65 years measuring their urinary 
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cortisol concentration and its association with all-cause and cardiovascular mortality. This 
study found that those with the highest levels of urinary cortisol had a five-fold higher risk 
of death form CVD (Vogelzangs et al, 2010). However, no relation was found between 
high urinary cortisol and other causes of death. 
2.4.1.2 Non-modifiable risk factors 
Generally, men have a higher tendency to suffer a heart attack than women. Women have 
an innate protection against CVD due to the hormone oestrogen (Stork et al, 2004). As a 
regulator of inflammation, oestrogen exerts several anti-inflammatory effects. Oestrogen 
plays a critical anti-inflammatory role through endothelial generation of nitric oxide (NO). 
Nitric oxide is an important vasoprotector. Oestrogen helps to attenuate oxidative stress and 
inflammation through its antioxidant properties (Chakrabarti et al, 2008). With menopause 
the concentration of this hormone decreases placing postmenopausal women at a higher 
risk of CVD (Stork et al, 2008). By the age of 65 the chances of heart attack are similar 
between men and women.  
 
The risk of developing CVD increases with age. This may be due to the thickening of the 
heart’s walls together with stiffening and hardening of the arteries. This in turn affects the 
stroke volume, cardiac output and heart rate. Higher levels of inflammation have been 
observed in older adults (Najib et al, 2012). In addition, calcification and plaque necrosis 
are more common in plaque from older adults which reflects the chronic level of the 
disease (Najib et al, 2012).  
 
The risk of having heart disease is also linked to hereditary. This is a case when a parent 
has a heart condition and this can be passed down the family tree. Congenital 
cardiovascular defects or congenital heart defects may arise from abnormal formation of 
the heart or major blood vessels (AHA, 2009). 
 
2.4.2 Emerging risk factors 
In addition to traditional risk factors are the emerging risk factors which are significant 
predictors of atherosclerosis and its complications. These are numerous, but we will 
examine, C-reactive protein (CRP), interleukin 6 (IL-6), tumour necrosis factor alpha 
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(TNF-α), soluble vascular adhesion molecules (sVCAM-1), soluble intercellular adhesion 
molecules (sICAM-1), homocysteine, fibrinogen and progenitor cells. 
 
C-reactive protein is a circulating acute phase reactant that is highly augmented all through 
the inflammatory reaction to tissue injury or infection (Hackam and Anand, 2003). The 
liver helps to synthesise CRP and IL-6 and other proinflammatory cytokines are 
responsible for stimulating its release (Pearson et al, 2003). C-reactive protein strongly 
predicts future CHD and type 2 diabetes mellitus in adults (Misra, 2004). Elevated CRP 
concentrations are associated with overweight, obesity and insulin resistance which may 
influence the development of atherosclerosis and type 2 diabetes mellitus in adulthood. C-
reactive protein concentrations are also positively associated with endothelial dysfunction 
and other CVD risk factors in children (Misra, 2004). C-reactive protein has limited clinical 
value in CVD risk stratification or predicting response to statin therapy in elderly people 
(Sattar et al, 2009). C-reactive protein concentrations are increased in heart failure and 
higher concentrations of CRP gravely affect the haemodynamic and neurohormonal 
profiles which have been related to more serious heart failure and poor quality of life. C-
reactive protein is also associated with mortality and morbidity in relation to CVD (Anand 
et al, 2004). 
 
Interleukin-6 is a major pro-inflammatory cytokine produced in a variety of tissues, 
including activated leukocytes, adipocytes, and endothelial cells (Pradhan et al, 2001). It 
acts on the liver to stimulate the production of several acute-phase proteins (Cardellini et al. 
2007). Contracting skeletal muscle has been found to be the main source of IL-6 in the 
circulation in response to exercise (Pederson, 2009). Circulating IL-6 levels have been 
reported to be elevated in subjects with IGT or type 2 diabetes (Muller et al, 2002) and 
have been shown to predict development of type 2 diabetes (Pradhan et al, 2001). Higher 
circulating IL-6 levels have been reported in severe congestive heart failure (Torre-Amione 
et al, 1996). They are prognostic indicators in multiple myeloma (Pelliniemi et al, 1995). 
Higher IL-6 levels may also reflect cellular damage, such as oxidative stress (Baeuerle et 
al, 1996). Lastly, IL-6 may counter regulate levels of tumour necrosis factor- α and 
interleukin-1β (Tilg et al, 1997, Xing et al, 1998) so that higher IL-6 levels may reflect 
damage from other cytokines. Interleukin-6 has been shown to predict all-cause mortality 
as well as cardiovascular mortality (Harris et al, 1997; Volpato et al, 2001). It is suggested 
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that IL-6 is more closely related to risk of fatal myocardial infarction and stroke (fatal 
CVD) than to nonfatal vascular events in the elderly at risk (Sattar et al, 2009). 
 
Tumour necrosis factor alpha (TNF-α) is a multifunctional cytokine that exerts a series of 
biological actions in different cells, tissues, organs and species. It has also been 
demonstrated to regulate and interfere with energy metabolism, especially lipid 
homeostasis (Chen et al, 2009). Thus, it plays an important role in both acute and chronic 
inflammation. Tumour necrosis factor alpha could have an effect on lipid metabolism as it 
suppresses free fatty acid (FFA) uptake and promotes lipogenesis. Furthermore, it induces 
lipolysis, inhibits lipid metabolism related enzyme activity, regulates cholesterol 
metabolism, and regulates other adipocyte derived adipokines. (Chen et al, 2009). The 
critical role of TNF-α in adipocytes, chronic inflammation and adipocytes biology has been 
found recently (Langin et al, 2006; Popa et al, 2007). Increased plasma TNF-α levels have 
been found in patients with hypercholesterolaemia. A positive correlation between TNF-α 
and very low density lipoprotein cholesterol (VLDL-C), triacylglycerol (TAG) and total 
cholesterol concentrations has been observed in hyperlipidaemic patients (Jovinge et al, 
1998). High concentrations of TNF-α induce the production of reactive oxygen species 
(ROS) which are chemically reactive molecules containing oxygen and this results in 
endothelial dysfunction in type 2 diabetes (Zhang et al, 2009). Endothelial dysfunction 
related with TNF-α in pathophysiological conditions is related to excess production of ROS 
and a decrease in nitric oxide bioavailability. The bioavailability of nitric oxide seems to be 
decreased by TNF-α because of the reduction in nitric oxide production and the augmented 
removal of nitric oxide (Goodwin et al, 2007; Picchi et al, 2006; Greenberg et al, 1993). 
 
Soluble vascular adhesion molecules and sICAM-1 play an important role in the adhesion 
of leukocytes to the vascular endothelium. Their involvement facilitates movement of 
circulating leukocytes across the endothelium into the vessel wall. This serves as a primary 
cause of atherogenesis. In inflammatory, neoplastic and CVD concentrations of sICAM-1 
and sVCAM-1 are elevated. Though this establishment serves to help in predicting clinical 
outcome, the mechanism and significance of the elevated concentrations are frequently 
ambiguous (Blann and Yip, 2000). Higher levels of sICAM-1 and sVCAM-1 are found in 
people with hypertriglyceridaemia (Ceriello et al, 2004). Ethnic differences in serum lipid 
levels may affect cellular adhesion pathways and present a possible mechanism for the 
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ethnic difference in CHD risk (Lupattelli et al, 2000; Abe et al, 1998). Adhesion molecule 
concentrations are positively related to serum cholesterol and TAG concentrations but 
negatively related to HDL-C concentration (Rohde et al, 1999). It is interesting to note that 
HDL-C is inversely related to CHD risk and it may assist in reducing cytokine-stimulated 
expression of endothelial cell adhesion molecules (Cockerill et al, 1995; Abe et al, 1998; 
Rohde et al, 1999). Increased levels of sICAM-1 have been associated with an increased 
risk of ischaemic stroke in patients with CHD (Tanne et al, 2002). In particular, sVCAM-1 
and CRP have been shown to be the most important predictors of the risk of future CVD 
death (Blankenberg et al, 2001). Interestingly, smoking is a great contributor to the 
concentrations of sICAM-1. Abstaining from smoking has a significant effect in reducing 
circulating sICAM-1 concentrations (Scott et al, 2000).  
 
Regulation of vascular tone, platelet aggregation, leukocyte adhesion, inflammation, 
thrombosis, fibrinolysis, and angiogenesis are numerous functions controlled by the 
vascular endothelium (Libby et al, 2002; Vogel, 1997). A shift to a proatherogenic 
phenotype, assisting the adhesion and trans-endothelial migration of circulating leukocytes 
is represented by the expression of adhesion molecules on activated endothelium cells. 
Levels of soluble adhesion molecules in the circulation reveal an augmented expression on 
the endothelium (Leeuwenberg et al 1992). Hence, soluble adhesion molecules are used as 
biomarkers of endothelial dysfunction.   
 
Homocysteine, is a highly reactive sulphur containing amino acid. It is formed as a 
consequence of the metabolism of the essential amino acid methionine (Mangoni and 
Jackson, 2002). Homocysteine is re-metabolised by cells in numerous probable pathways 
involving various enzymes. Folate, cobalamin (vitamin B12) and pyridoxine (vitamin B6) 
are B vitamins used as substrates by these enzymes (De Bree et al, 2002). Elevation in 
oxidative stress, endothelial dysfunction, platelet activation, hypercoagulability, vascular 
smooth muscle cell proliferation and endoplasmic reticulum stress can bring about vascular 
damage. Homocysteine may be responsible for inducing this damage (Mangoni and 
Jackson, 2002; De Bree et al, 2002; Werstuck et al, 2001). B vitamins are an effective 
therapy for reducing homocysteine concentrations (Chambers et al, 2000).   
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Fibrinogen is an acute phase reactant and a circulating glycoprotein. It acts at the last stage 
in the coagulation response to vascular and tissue injury (Herrick et al, 1999). Soluble 
fibrin fragments are the most abundant component of blood clots and they are produced by 
the cleavage of thrombin (Herrick et al, 1999). Determination of blood viscosity, 
stimulation of platelet aggregation, vasoconstriction at sites of vessel wall injury and 
regulation of cell adhesion, chemotaxis and proliferation are many of the possible roles it 
plays in vascular disease (Di Minno et al, 1990; Danesh et al, 1998; Fuster et al, 1992). 
Fibrinogen is associated with IHD and peripheral vascular disease (Fowkes, 1995). Patients 
with diabetes, hypertension, obesity and physically inactive lifestyles have been found to 
have high concentrations of fibrinogen (Maresca et al, 1999). 
 
Endothelial progenitor cells (EPCs) obtained from the bone marrow play a role in 
endothelial repair. Impaired mobilisation or depletion of endothelial progenitor cells 
contribute to endothelial dysfunction and progression of CVD (Hill et al, 2003). Hence, 
EPCs may have implications for endothelial health and homeostasis. Endothelial progenitor 
cells circulate in the blood and contribute to neovascularisation. Predisposition to CVD due 
to, for example, diabetes is associated with reduced circulating EPC numbers which may be 
indicative of chronic vascular injury (Loomans et al, 2004; Tepper et al, 2002). In addition, 
a study by Werner and colleagues (2005) found a significantly higher incidence of death 
from cardiovascular causes during a 12 month period in patients with low baseline levels of 
EPCs. They also established that patients with high numbers of EPCs had a reduced risk of 
revascularization. Moreover, circulating EPCs in patients with CVD can be used to identify 
patients at high risk for major adverse cardiac events (Werner et al, 2005). Furthermore, 
during a myocardial infarction a strong chemokine signal mobilises progenitors from the 
bone marrow into the circulation (Shintani et al, 2001). Hence elevated EPCs may be 
indicative of a myocardial infarction.  
 
2.4.3 Heart disease risk factors in South Asians 
South Asians are a population susceptible to CVD. Many risk factors give rise to this 
disease and thus we will examine some of the most prominent ones. South Asians appear to 
have more atherogenic lipid profiles than White Europeans as they have higher plasma 
TAG and lower HDL-C concentrations predisposing them to atherogenesis and this may 
   Chapter 2 
 
  ▏24 
also reflect underlying insulin resistance (Chowdhury & Lasker, 2002; Anand et al, 2000; 
McKeigue et al, 1991; Chambers et al, 2001). A large HDL-C size is associated with 
cardioprotection (Bhalodkar et al, 2004). In the Framingham Offspring Study 211 South 
Asian and 1684 European men were examined and although concentrations of HDL-C 
were similar in both populations concentrations of large, more protective HDL particles 
were found to be lower and concentrations of small HDL particles were found to be higher 
in South Asian than in European men (Bhalodkar et al, 2004). In addition, LDL particle 
size in South Asians is smaller though total LDL concentrations are comparable with other 
populations. This is critical because small LDL particles are more susceptible to oxidation 
and thus are more atherogenic (Kulkarni et al, 1999). 
 
Hypertension (a major CVD risk factor) is highly prevalent in South Asians (McKeigue et 
al, 1991; Agyemang & Bhopal, 2002). Several studies have reported lower mean systolic 
but higher diastolic blood pressure in South Asian men and women than in European men 
and women (Agyemang & Bhopal, 2002). The prevalence of hypertension is higher in 
South Asian men than in European men (Agyemang & Bhopal, 2002). Inconclusive results 
were found regarding the prevalence rates of hypertension in women of South Asian and 
European origin (Agyemang & Bhopal, 2002). Mean blood pressure and the prevalence of 
hypertension also differed within the South Asian population (Bhopal et al, 1999). The 
Newcastle Heart Project study and the 1999 Health Survey of England identified lower 
mean systolic and diastolic blood pressures in Bangladeshi males and females than in their 
Pakistani and Indian counterparts (Bhopal et al, 1999). The prevalence of hypertension was 
also lower among Bangladeshi males and females than among Pakistani and Indian men 
and women. It was also found that Indians had higher blood pressure levels than Pakistanis 
(Bhopal et al, 1999). Thus due to their lower HDL-C and higher blood pressure South 
Asians are highly vulnerable to CHD risk (Chowdhury and Lasker, 2002).  
  
The prevalence of type 2 diabetes mellitus is substantially higher in South Asians residing 
abroad than in White Europeans (Anand et al, 2000; McKeigue et al, 1991; Chambers et al, 
2001). One study revealed that about 20% of South Asians (whether in the UK or 
indigenous to Asia) over the age of 50 years are affected by diabetes (Mather & Keen, 
1985; Ramachandran et al, 1997). In South Asians, this disease seems to present itself at a 
younger age compared with Europeans (Mather & Keen, 1985; Ramachandran et al, 1997). 
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At diagnosis, South Asians have been shown to have greater complications with early-onset 
type 2 diabetes including established macrovascular disease, retinopathy and nephropathy 
(Chowdhury and Lasker, 2002). Compared with White Europeans, South Asians tend to 
have a higher risk of diabetic complications, especially renal disease and CHD (Mather & 
Keen, 1985; Ramachandran et al, 1997). South Asians also have a higher prevalence and 
faster progression of nephropathy than White Europeans. Poorer glycaemic, blood pressure 
and lipid control have been identified in South Asians with type 2 diabetes (Chowdhury et 
al, 2006). India’s diabetes patient population was estimated to be 50.8 million in 2010 and 
it is predicted to reach 79.4 million in 2030 (Misra & Khurana, 2011).  
 
In addition, South Asians also have a higher prevalence of IGT and increased fasting 
glucose levels than White Europeans (Anand et al, 2000; Chambers et al, 2001). Insulin 
resistance is also higher in South Asians compared with White Europeans (McKeigue et al, 
1991; Chambers et al, 2001). South Asians are also affected by acute coronary syndromes 
and the patients are younger, more likely to be diabetic and tend to report a higher intensity 
of pain over a greater area of the body (including over the backs) than White Europeans. In 
South Asians both in England and Wales, CHD is the primary cause of death and this risk 
is brought about by hyperinsulinaemia and central obesity which is common among this 
group (Mckeigue et al, 1993, Balarajan et al, 1991). 
 
Nearly 13% of Asian Indian children and young adults in India have subclinical 
inflammation, and almost 20% have insulin resistance, indicating a high risk for CHD in 
adulthood (Misra, 2004). Notably, higher CRP concentrations have been found in Asian 
Indian adults in comparison with Europeans (Misra, 2004). In addition to CHD; metabolic 
syndrome, carotid artery atherosclerosis, stroke, peripheral vascular disease and future 
development of type 2 diabetes can be correlated to CRP (Chambers et al, 2001; 
Tamakoshi et al, 2003; Cao et al, 2003; Han et al, 2002).  
 
It has been suggested that South Asians have a greater impairment of endothelial function 
than White Europeans and this is not accounted for by established CVD risk factors 
(Murphy et al, 2007). South Asians have lower levels of progenitor cells which are 
involved in endothelial repair and regeneration. The reduced EPCs in South Asians could 
be a defect responsible for CVD. It was also found that EPC count was independently 
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predicted by ethnicity (Murphy et al, 2007). In patients with established CVD an impaired 
functional capacity of EPCs is a known occurrence (Vasa et al, 2001, Heeschen et al, 
2004). The primary reason for lower circulating EPC numbers in South Asians may be due 
to a reduced systemic nitric oxide bioavailability. In both progenitor cell mobilisation and 
function, nitric oxide plays a critical role and this has been evident from several studies 
(Murphy et al, 2007). Insulin resistance is likely an initiator in this process (Loomans et al, 
2004; Tepper et al, 2002).  
 
Some studies report higher homocysteine concentrations in South Asians than White 
Europeans. It has been suggested that raised homocysteine concentrations may account for 
twice as many CHD deaths in South Asians than White Europeans and this may contribute 
to their increased CHD risk (Anand et al, 2000; Chambers et al, 2000).  Raised 
homocysteine concentrations in South Asians may also be related to their reduced vitamin 
B12, B6 and folate levels implying that the increased CHD risk in this group may be reduced 
by dietary vitamin supplementation (Chambers et al, 2000). 
 
The Wandsworth Heart and Stroke Study examined 664 males and females who were made 
up of 261 European White, 188 African Origin and 215 South Asians. All of these 
participants were free from diseases and treatments of any kind. This study investigated 
ethnic differences in circulating soluble adhesion molecules among the ethnic groups who 
were living in England (Miller et al, 2003). Those of Caribbean or West African descent 
were found to have lower levels of sICAM-1 and sVCAM-1 than White Europeans and 
South Asians. This finding may explain why there is a high risk of CHD in South Asians 
(Miller et al, 2003). On the contrary, though the morbidity and mortality rates from CHD in 
British South Asians are high, they did not have higher adhesion molecule values than 
White Europeans. Studies have identified that soluble adhesion molecules are associated 
with CHD (Miller et al, 2003) but it may be that adhesion molecules are not as critical in 
the development of CHD in South Asians and there may be some fundamental genetic 
vulnerability affecting them (Miller et al, 2003). 
 
Data suggest that the proposed cut-offs for defining overweight and obesity are not 
appropriate for South Asians and that they are at risk of developing obesity related 
comorbidities at lower levels of BMI and waist circumference (Deurenberg et al, 2001; 
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Vikram et al, 2003). A recent consensus statement for South Asians proposed BMI cut off 
points of 23 to 24.9 kg·m2 for overweight and ≥25 kg·m2 for obesity. These are lower than 
the internationally prescribed guidelines for overweight, (25 to 29.9·kg m2) and obesity 
(≥30 kg m2). (Misra et al, 2009). Similarly, due to high morbidities seen at lower waist 
circumferences in South Asians cut off points of ≥90 cm and ≥80 cm (for males and 
females respectively) have been proposed for South Asians in contrast to the international 
guidelines of ≥102 cm and ≥88 cm (for males and females respectively) (Misra et al, 2009). 
 
Sedentary lifestyles or physical inactivity have been associated with a 1.5 to 2.4 fold 
elevation in CHD risk (Pate et al, 1995). One study has demonstrated a strong and dose-
dependent inverse relationship between leisure-time exercise and non-fatal CHD among 
South Asians. This study also observed a positive association between sedentary activity 
and CHD risk (Rastogi et al, 2004). Physical inactivity is also associated with the various 
components of the metabolic syndrome (Mohan et al, 2005). Regular physical activity 
reduces the risk of obesity, blood lipid abnormalities, hypertension and non-insulin 
dependent diabetes mellitus and has been shown to substantially reduce the risk of CHD 
(Pate et al 1995; DHHS, 1996). In consideration of the severe CVD burden among South 
Asians, a recent consensus statement for physical activity guidelines has been outlined 
specifically for this ethnic group (Misra et al, 2012). According to these recommendations 
South Asians should perform 60 minutes of physical activity daily comprising of 30 
minutes of aerobic activity, 15 minutes of resistance activity and 15 minutes of work 
related activity (Misra et al 2012). 
2.5 Exercise and heart disease 
Exercise is a planned, structured and repetitive form of activity and it is a subset of physical 
activity. It has a final or an intermediate objective, the improvement or maintenance of 
physical fitness (Caspersen et al, 1985). Advancement of automation in today’s modern 
world has strongly affected the energy gradients between occupations. Automated 
machines have transformed several of the high energy occupations to almost a sedentary 
level. With this evolvement the protective benefits gained through physical activity are 
absent (Davies, 1997). Hence, energy expenditure during leisure time has to be increased to 
produce a beneficial effect. 
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In addressing the following section the terms exercise and physical activity will be used 
interchangeably. As exercise is a subset of physical activity, they will be subsumed as one 
to explain the studies conducted and the effects of physical activity/exercise on the risk of 
heart disease.  
 
2.5.1 Physical activity, heart disease and mortality 
Numerous studies have examined physical activity and illustrated its non-pharmacological 
benefits. In the following sections, a few selected studies and how their findings have 
served to emphasise the importance and relationship of physical activity and CVD will be 
elaborated. 
 
Any bodily movement produced by skeletal muscles is termed physical activity and its 
energy expenditure can be measured in kilojoules (kJ) or kilocalories (kcal). Occupational 
activity, sports activity, conditioning, household or other activities in daily life all involve 
physical activity (Caspersen et al, 1985). According to the American College of Sports 
Medicine (ACSM) (Haskell et al, 2007) and AHA (Haskell et al, 2007), adults are 
recommended to perform 30 minutes of moderate intensity physical activity 5 days a week 
or 20 minutes of vigorous intensity physical activity on 3 days a week or a combination of 
moderate and vigorous activity. This should equate to between 450 and 750 metabolic 
equivalent (MET) minutes a week. This value serves as the least required to achieve 
significant health benefits in addition to the routine activities of daily living (Haskell et al, 
2007). 
 
Many studies have investigated the relationship between physical activity and heart 
disease. Of these, possibly the most notable was a study on London transport workers 
published in 1953 which demonstrated a striking association between lower levels of 
exercise and heart disease (Morris et al 1953). It examined the bus, tram and trolleybus 
conductors who climbed an average of 500 to 750 steps per working day and the drivers 
who sat for most of their working time. Bus drivers were found to have a higher prevalence 
of heart disease than bus conductors and it was proposed that this was due to the difference 
in physical activity levels between these two occupations.  In the same study, Morris and 
colleagues also investigated postal workers and civil servants. This disclosed that the 
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physically active postmen were less likely to have CHD which struck less active civil 
servants (telephonists, clerks, executives) at an earlier age. Though the active group was 
not immune from diseases, they were affected by less severe disease in the case of angina 
pectoris which was more prevalent but less severe in the active individuals. Essentially, 
physical activity at work appeared to have a beneficial effect in terms of CHD risk in 
middle aged men.   
 
The San Francisco Longshoremen and Harvard College Alumni studies also identified an 
association between heart disease and physical inactivity. Paffenbarger and colleagues 
(1970) found that active cargo handlers (who expended more than 1000 kcal/day) had 
distinctly lower CHD rates than their sedentary colleagues. In 1975, Paffenbarger and Hale 
published a study which observed the outcome of repeated bursts of work activity in 6351 
longshoremen during an 8 hour shift. They found a defensive element innate in this high 
energy work in relation to CHD mortality. In a further investigation, 3975 longshoremen 
with a high energy work activity of 29.3 kJ per min were compared with the lowest energy 
work activity group of 4.19 kJ per min. The high energy group had half the rate of 
myocardial infarction (Brand et al, 1979). It was found that regardless of smoking or high 
systolic blood pressure cargo handling longshoremen experienced lower death rates than 
their sedentary counterparts. Physical activity and its energy expenditure provided 
protective measures (Paffenbarger et al, 1970). 
 
Being physically active when young and stopping its continuity in adulthood does not 
appear to protect against heart disease. In order to gain optimal protection it appears that 
one has to pursue physical activity throughout adult life. In a study of Harvard college 
alumni, activities were categorised according to their energy expenditures and a weekly 
physical activity index was calculated for each study participant. Low energy expenditure 
was classified as anything less than 8372 kJ/week and high energy expenditure was 
classified as anything above 8372 kJ/week. It was found that the high energy expenditure 
group had lower rates of heart attack and angina pectoris and were affected by cardiac 
death at an older age (Paffenbarger et al, 1978). In another study which examined physical 
activity, all-cause mortality and longevity of college alumni, Paffenbarger and colleagues 
(1986) noted positive effects until the age of 80 years in those men expending more than 
8374 kJ /week.  In addition, Sesso and colleagues (2000) followed 12,516 middle aged and 
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older men with an age range from 39 to 88 years. They found a 20% lower CHD risk in 
men who expended more than 4200 kJ/week in total physical activity. This relationship 
between physical activity and CHD also extended to men with multiple coronary risk 
factors. Furthermore, Hardman (2001) identified that critical to cardioprotection against 
CVD is intensity relative to one’s capacity. This is important because what could be warm-
up intensity for one person could be almost maximal load for someone else. Besides, VO2 
max also declines with age in middle age and beyond thus a given MET value may indicate 
a greater relative intensity for older people. 
 
Moreover, physical activity is associated with a lower risk of fatal heart attacks by 40% and 
non-fatal heart attacks by 50%. This was found in individuals who were involved in 
vigorous exercise (involving peaks in energy expenditure of ≥ 31.5 kJ/min/ ≥ 7.5 kcal/min) 
in comparison with their colleagues who failed to report vigorous leisure time activity. 
Morris and colleagues (1980) suggested that vigorous exercise provided a protective shield 
on the ageing heart against ischaemia and its effects. Family history of CVD increases the 
chances of cardiovascular mortality. Even with this situation as long as individuals were 
involved in vigorous exercise, they were able to halve their risk of mortality compared with 
those who did not take part in vigorous exercise (Morris et al, 1980).  
 
These studies have highlighted the importance of physical activity for optimal 
cardiovascular and general health. Likewise, studies comparing physically active women 
with inactive women have demonstrated that mortality can be delayed and this was 
revealed in a review paper assessing 38 studies conducted in the United States and Europe. 
There was a 20% difference on average in death rates between the most and least active 
women (Oguma et al, 2002). Even lower levels of energy expenditure may reduce mortality 
risk in women (Andersen et al, 2000; Lissner et al, 1996). The Iowa Women’s study 
observed an inverse relationship between moderate intensity physical activity and mortality 
(Kushi et al, 1997). Congruent with this, the Canadian Fitness Survey showed that men 
who expended more than 0.5 kilocalories per kilogram body weight per day had a 20% 
lower mortality risk than those who did not. Similarly, women experienced a 30% decrease 
in mortality risk when they expended more than 3.0 kilocalories per kilogram body weight 
per day. This study also found that modest participation in low intensity activities helps in 
the reduction in mortality risk (Villeneuve et al, 1998). Furthermore, the Nurses’ Health 
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study and the Women’s Health study observed associations between moderate intensity 
physical activity and lower risk of CHD (Manson et al, 1999; Lee et al, 2001). In addition 
higher levels of physical activity are also associated with fewer years of disability before 
death, helping women to live more fruitful lives (Ferrucci et al, 1999). These studies and 
many others over the past 10 to 20 years have shown that premature mortality in women 
can be averted by physical activity. Moderate intensity physical activity of 30 minutes per 
day on most days of the week can postpone mortality in women as well as men (Oguma et 
al, 2002).   
 
Sedentary lifestyle or physical inactivity has also been associated with an increased CHD 
risk (Pate et al, 1995). Rastogi and colleagues (2004) conducted a hospital based case-
control study and collected data from 350 cases of acute myocardial infarction and 700 
controls matched by age, gender and hospital in New Delhi and Bangalore.  They 
demonstrated that an equivalent of 3.6 hours per day of sedentary activities such as 
television viewing was associated with nearly a 90% increased risk of CHD. Long hours of 
standing while at work seem to also increase the risk. While low levels of physical activity 
lead to low energy expenditure and lower lean body mass, physical inactivity or sedentary 
activities may be associated with obesity and risk for chronic disease through not only 
increased energy intake but also lower energy expenditure. Therefore, these findings 
emphasise the association between increased sedentary activity and CHD (Rastogi et al, 
2004). As a result, this study was the first of its nature to demonstrate the harmful effects of 
physical inactivity on health and the significance of leisure time exercise in the prevention 
of CHD risk among Indians (Rastogi et al, 2004). 
 
The Nurses’ Health Study compared walking with vigorous exercise in the prevention of 
CHD in women. The findings from this study indicate that both walking and vigorous 
exercise are substantially associated with reductions in the incidence of CHD (Manson et 
al, 1999). In both of these activities, the magnitude of reduction was similar when total 
energy expenditure was similar (Manson et al, 1999). This suggests that 3 hours or more of 
brisk walking each week could elicit a 30% to 40% decrease in the risk of coronary events 
in women. A combination of increased walking time and vigorous exercise would enhance 
the risk reductions (Manson et al, 1999). The Iowa Women’s Health Study found that 
moderate and vigorous activity were inversely related to overall mortality and mortality 
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due to CVD. Even infrequent moderate intensity activity as little as once per week was 
associated with decreased death compared with a sedentary lifestyle (Kushi et al, 1997). 
Walking at least 4 hours per week was related with substantial reductions in cardiovascular 
risk among elderly women and men (LaCroix et al, 1996). The Honolulu Heart Program 
findings showed that walking was associated with a lower overall mortality rate in older 
physically capable men. The twelve-year cumulative mortality rate was significantly lower 
in men who walked more than a mile each day than in those who walked shorter distances 
(Hakim et al, 1998).  
 
Twenty-one year old follow-up of the Israeli Ischaemic Heart Study investigated self-
reported physical activity with long-term CHD and all-cause mortalities. Excluding those 
with known CVD, they examined 8463 male government employees aged 40 years or older 
representing six areas of birth (looking at various occupations such as clerks, teachers, 
drivers, cleaning personnel, longshoremen, postmen, jail workers, judges and physicians) in 
either 1963 or 1965 from an original base of 10,059 (Eaton et al, 1995). This study found 
that among middle-aged men baseline self-reported leisure-time exercise and not work 
related activity was related to a significantly lower risk of CHD and all-cause mortality. 
Moreover, low levels of physical activity, such as walking on a less than daily basis, were 
nearly as valuable as more moderate to vigorous forms of self-reported leisure time 
physical activity in predicting decreased rates of CHD and all-cause mortality. In addition, 
this inverse relationship of leisure-time physical activity and CHD death also appeared to 
be independent of age, blood pressure, cigarette smoking, HDL-C and total cholesterol 
levels, body mass and other potential confounders (Eaton et al, 1995). 
 
2.5.2 Physical fitness and heart disease 
Physical fitness is a set of characteristics one has or achieves. This could be categorised 
into health and skill components which can be measured with specific tests (Caspersen et 
al, 1985). The health components of fitness comprise of cardiovascular endurance, 
muscular strength, muscular endurance, flexibility and body composition. Skill based 
components comprise of agility, balance, coordination, speed, power, reaction time and are 
related to athletic performance.  
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The most commonly studied component of physical fitness in relation to health is aerobic 
power. This attribute is also called maximal oxygen uptake, cardiovascular fitness, 
cardiorespiratory fitness, or endurance fitness. Physical fitness, especially cardiorespiratory 
fitness is an essential element to assess health risks. According to Whaley and Kaminsky 
(1995), this provides greater accuracy than clinical or physical activity questionnaires in 
investigating health risks in individuals. On the contrary, they believe that non-exercise test 
prediction in large epidemiological studies estimating cardiorespiratory fitness is not 
sufficiently accurate to assess the value of fitness for health. 
 
Health equates to not only freedom of diseases but also the functional ability to participate 
and enjoy the variety of activities that life offers (Blair et al, 1992). Exercise improves an 
individual’s physical fitness and a higher level of fitness is seen in exercise trained 
individuals (Blair et al, 1992). During an eight and a half year follow up study, the heart 
rate attained at stage 2 of a submaximal treadmill test was used as an index of fitness to 
investigate the association between fitness and CHD mortality (Ekelund et al, 1988). In 
addition, middle aged executives were tested on a treadmill to evaluate their physical 
fitness (Blair et al, 1992). The results from these studies showed that the least fit 
individuals were significantly more likely to be affected by CHD compared with the fittest 
individuals.  Furthermore, a seven year study by Lie and colleagues (1985) examined CHD 
incidence among 122 middle aged Norwegian cross country skiers and among 2014 healthy 
men who were tested on a bicycle ergometer to elicit a VO2 peak. These studies noted a 
strong, graded and inverse association between physical fitness and a number of coronary 
risk factors and an inverse relationship between high physical fitness and the risk of dying 
from CHD (Lie et al, 1985). 
 
The Coronary Artery Risk Development in Young Adults (CARDIA) fitness study 
examined 3989 black and white men and women over 20 years. Baseline fitness was 
inversely associated with diabetes incidence in all race and sex groups (Carnethon et al, 
2009). Hence, low fitness was significantly associated with diabetes incidence. In addition, 
Carnethon and colleagues (2005) suggested that fitness decreases the risk for diabetes 
through the regulation of body mass. Fitness may also protect against diabetes development 
through improved muscle insulin sensitivity, improved endothelial function and autonomic 
function and a reduced inflammation and oxidative stress (LaMonte et al, 2005; Carnethon 
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& Craft, 2008). These studies are relevant here because diabetes is a major risk factor for 
CVD.  
 
Others have investigated relationships between physical fitness and hypertension incidence. 
It was reported that persons with low physical fitness had a relative risk of 1.5 times for the 
development of hypertension when compared with highly fit persons. This was after 
controlling for age, sex, body mass index, and blood pressure (Blair et al, 1984). In another 
study, the relative risk of hypertension in Japanese men, after adjusting for age, initial 
blood pressure, body fat, and other confounders, was 1.9 times higher in the least fit 
compared with the fittest group (Sawada et al, 1993). In addition, lower systolic blood 
pressure (127 versus 144 mm Hg) and lower diastolic blood pressure (79 versus 87 mm 
Hg) was found in men with high physical fitness compared with men with low physical 
fitness (Holtermann et al, 2010). 
 
In a study by Lee and colleagues (2010), it was found that men with higher 
cardiorespiratory fitness had a larger risk reduction in mortality than men who met the 
recommended physical activity level (≥500 MET - minutes/week). Furthermore, women 
who had a high cardiorespiratory fitness showed a 41% lower risk than women who met 
the recommended(≥500 MET - minutes/week)   physical activity level and the latter group 
did not reveal a significantly lower risk (Lee et al, 2010). The inverse association between 
cardiorespiratory fitness and mortality was approximately 40% to 70% stronger (lower 
mortality risk) than that of self-reported physical activity which indicated approximately a 
20% to 50% lower risk of mortality in the most active people (Lakka et al, 1994; Kampert 
et al, 1996; Park et al, 2009). In addition to these findings, an inverse association between 
cardiorespiratory fitness and mortality among sedentary but not active men were identified 
(Hein et al, 1992). On the contrary, cardiorespiratory fitness was significantly inversely 
associated with mortality in the group classed as active but not in the sedentary group in 
another study (Park et al, 2009). Thus, whether the effects of cardiorespiratory fitness on 
the reduction in risk of mortality vary between physical activity levels is an area that needs 
further research (Lee et al, 2010).  
 
The Copenhagen Male Study investigated physical demands at work, physical fitness and 
30 year IHD and all-cause mortality risk. They found increased risk of IHD mortality was 
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associated with increasing work demands among men of low and medium levels of 
physical fitness (Holtermann et al, 2010). However, this was not found in the highly fit 
men. Similar results were observed for all-cause mortality. Moreover, among men with 
high physical fitness there was a 45 % lower risk of IHD mortality and a 38 % lower risk 
for all-cause mortality compared with those who had low physical fitness. In this study, 
men reporting high levels of leisure time activity had a higher physical fitness than men 
classifying themselves as sedentary during leisure time (VO2 max: 36.9 ml/kg/min versus 
31.1ml/kg/min). High work demands generally have a minor influence on physical fitness 
thus this study emphasises the importance of physical activity during leisure time for 
improving aerobic capacity. These findings support the importance of physical fitness and 
its positive role against CVD and all-cause mortality (Holtermann et al, 2010).  
 
The Women’s Health Initiative Observational Study examined 73,743 postmenopausal 
women 50 to 79 years of age estimating total physical-activity, walking, vigorous exercise, 
and hours spent sitting as predictors of the incidence of coronary events and total 
cardiovascular events (Manson et al, 2002). Physical-activity scores displayed a strong, 
graded, inverse association with the risk of both coronary events and total cardiovascular 
events. There were similar findings among white women and black women. Both walking 
and vigorous exercise were associated with substantial reductions in the incidence of 
cardiovascular events among postmenopausal women, irrespective of race or ethnic group, 
age, and body-mass index. In contrast, prolonged sitting predicted increased cardiovascular 
risk (Manson et al, 2002).  
2.6 Exercise and heart disease risk factors 
Cardiovascular disease has been reviewed thus far from the clinical perspective. Now, we 
will assess it in the context of epidemiology in relation of exercise and heart disease risk 
factors. Exercise and its prevention of CHD has been evident in many studies (Morris et al, 
1953; Paffenbarger et al, 1970; Morris et al, 1980; Blair et al, 1992; Gill et al, 2003; 
McAuley et al, 2009; Williams et al, 2010). Exercise produces both acute (short-term) 
effects and chronic (long-term training adaptations) effects which will influence 
metabolism. Hence the next section will examine the acute effects of exercise and the 
section after will examine the chronic effects of exercise.   
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2.6.1 Acute effects of exercise 
This section will discuss the acute effects of exercise and its influence on selected CVD 
risk factors including lipid/lipoprotein metabolism, blood pressure, insulin sensitivity and 
platelet aggregation. Importantly, single bouts of exercise elicit acute, transient 
cardiovascular and metabolic responses. 
 
Prior exercise reduces the triglyceride response to a subsequent meal and this is known as 
the postprandial effect (Hardman, 2007). Postprandial lipaemia is associated with impaired 
endothelial function and inflammation (MacEneaney et al, 2009). Hence, the exercise 
effect is an important feature because an exaggerated postprandial triglyceride response is a 
risk factor for atherosclerosis (Hardman, 2007). A study compared African American 
women and white women to determine whether ethnicity influenced postprandial lipaemia 
after an acute bout of exercise. A walk test at 60% of maximal oxygen uptake was 
performed for 90 minutes, 12 hours before an oral fat tolerance test. African American 
women had a great reduction in postprandial lipaemia than white women (Shannon et al, 
2008). In another study, a 90 minute bout of exercise at 60% of maximal oxygen uptake 
was conducted in endurance trained and untrained women of similar age and body mass 
index (Tsetsonis et al, 1997). The aim was to compare the lipaemic response to a high fat 
meal in these two groups of women. Exercise caused a 30% reduction in postprandial 
lipaemia in trained women the next morning. In untrained women, exercise also reduced 
lipaemia but levels were 40 to 50 % higher in the untrained women than in the trained 
women. Furthermore, there was a reduction in plasma insulin concentrations in the trained 
women after exercise and fat oxidation was elevated after exercise in both groups 
(Tsetsonis et al, 1997).   
 
In a study by Ho and colleagues (2011) a single bout of 30 minutes of treadmill walking 
significantly decreased postprandial triglycerides in overweight and obese participants. 
They also demonstrated that 30 minutes of resistance exercise (leg press, leg curl, leg 
extension, bench press and rear deltoid row) was more effective in increasing insulin 
sensitivity when compared with aerobic exercise in these participants. Thus, Ho and 
colleagues (2011) suggest that overweight and obese individuals can reduce CVD risk 
factors through 30 minutes of aerobic exercise which helps to decrease the circulating 
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levels of triglycerides or 30 minutes of resistance exercise which helps to increase insulin 
sensitivity. These outcomes may help to reduce the risk of developing type 2 diabetes and 
CVD. 
 
Furthermore, physical inactivity reduces insulin sensitivity hence increasing insulin 
resistance. This reduced insulin sensitivity plays a detrimental role, increasing the risk of 
type 2 diabetes which in turn increases the risk of CVD. Regular exercise enhances insulin 
sensitivity and reduces the risk for diabetes and CVD (Knowler et al, 2002). In relation to 
CVD, studies have suggested that the augmented insulin sensitivity and reduced insulin 
secretion observed in people who exercise regularly are largely a consequence of the acute 
effects of the last bout of exercise rather than of long-term training adaptations. A study 
demonstrated that the insulin sensitising effects of exercise lasted for 3 days in middle aged 
people with normal glucose tolerance (King et al, 1995). Likewise, another study found a 
single bout of moderate intensity exercise lowered hepatic glucose production the next day 
in type 2 diabetic patients (Devlin and Horton, 1985). These outcomes could be associated 
with an increase in insulin sensitivity within skeletal muscle and an increased ability of 
muscle to synthesise glycogen (Perseghin et al, 1996). These in turn may be related to an 
increase in the number and activity of GLUT 4 glucose transporters in muscle (Houmard et 
al, 1993; 1995) and the content and activity of hexokinase which catalyses the 
phosphorylation of glucose. Its activity in increased by physical training (Koval et al, 
1998). This highlights the importance of maintaining the frequency of exercise to benefit 
insulin sensitivity.  
 
Exercise is also effective in reducing blood pressure in hypertensive participants. In 
hypertensive participants post-exercise blood pressure was lower for 12.7 hours and on 
exercise days the mean arterial pressure (MAP) was lower by 6 mm Hg than on non-
exercise days (Pescatello et al, 1991). Due to the recognised acute and chronic blood 
pressure lowering benefits of exercise, the American College of Sports Medicine 
recommends people with high blood pressure perform a minimum of 30 minutes of 
moderate intensity (40% - <60% peak oxygen consumption (VO2peak)) aerobic exercise on 
most days of the week (Pescatello et al, 2004).  
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Finally, platelets play an important role in the pathogenesis of CVD. Strenuous exercise 
activates platelets acutely while training at moderate intensity suppresses platelet 
aggregation in overweight middle-aged men, young healthy men and young women 
(Rauramaa et al, 1986; Wang et al, 1995; Wang et al, 1997). Physical activity increases the 
release of nitric oxide which is a potent mediator of anti-platelet effects that helps in 
platelet reactivity (Wang et al, 1995). However, the resting and exercise induced reductions 
in platelet aggregation reverses back to the pre-training value after de-training (Wang et al, 
1995; 1997). Hence, engaging in regular physical activity is essential. This was also 
evident in a study by Wang and colleagues (1994) involving strenuous and moderate 
intensity acute exercise on a bicycle ergometer. This revealed that platelet adhesiveness and 
aggregation may be increased by strenuous exercise in both healthy participants and 
patients with stable angina. On the other hand, platelet function can be significantly 
suppressed by moderate intensity exercise in the healthy and it tends to be depressed in 
patients with stable angina. The effects of acute exercise tend to be more pronounced in 
sedentary than in active people (Wang et al, 1994). Another study by Hurlen and 
colleagues (2000) found a fall in coagulation markers with a significant reduction in 
fibrinogen after an acute bout of exercise. This suggests that there was no generation of 
thrombin and fibrin during exercise. 
 
2.6.2 Chronic effects of exercise 
It is believed that long-term training induces non-transient adaptations which may assist in 
preventing CVD (Thompson et al, 2001). Here, discussion will be based on insulin 
sensitivity, platelet aggregation, vascular inflammation, blood pressure and 
lipid/lipoprotein metabolism. 
 
Exercise impacts lipoprotein metabolism and increases HDL-C. Exercise in the form of 
walking or jogging resulting in an expenditure of 5024 to 9211 kJ/week helped to increase 
HDL-C by 2 to 3 mg/dl and reduced triglycerides by 8 to 20 mg/dl (Durstine et al, 2001). A 
greater energy expenditure was found to increase HDL-C by 2 to 8 mg/dl and reduce TAG 
by 5 to 38 mg/dl. Training volume exerts a positive influence on blood lipids (Durstine et 
al, 2001). This is evident from many studies (Tsetsonis and Hardman 1996; Gill et al, 
2002). According to the US Runners’ Health Study the mileage and not speed (intensity) 
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covered by a runner is critical for predicting HDL-C concentration (Williams, 1998).  In 
addition, intervention studies have reported that a period of endurance training can reduce 
postprandial concentrations of TAG and TAG rich lipoproteins and in some instances 
increase TAG clearance (Weintraub et al, 1989; Thompson et al, 1988). In addition, Cohen 
and colleagues (1989) found enhanced TAG clearance in well-trained individuals 
compared with untrained individuals and they suggested that chronic exercise training 
decreases postprandial lipaemia more effectively than acute exercise. In a study by 
Thompson and colleagues (1988), 8-11 months of exercise training in previously sedentary 
men enhanced fat tolerance and increased HDL-C concentrations. 
 
There is a general belief that increased levels of physical activity will result in an 
improvement in both insulin sensitivity and glucose metabolism. In a 16 month study, 
Potteiger and colleagues (2003) investigated 66 healthy overweight young males and 
females (age range 17 to 35 years) for glucose and insulin responses. Both sexes performed 
the exercise at the same relative intensity and duration predominantly walking on a 
motorised treadmill. They were also allowed to exercise on stationary bikes and stationery 
elliptical trainers for 1 out of 5 days in a week. Improvements in insulin sensitivity were 
observed in males when cardiorespiratory fitness improved and there was a reduction in 
body mass and body fat. In females, improvements in 2OV  max without weight loss did 
not lead to improvement in insulin sensitivity (Potteiger et al, 2003). These findings may 
suggest the importance of both improvements in cardiovascular fitness and changes in body 
weight and body fat for improving insulin sensitivity. In another study, one week of daily 
intense exercise helped to reduce insulin resistance and improve glucose tolerance in men 
with type 2 diabetes mellitus. This result provided justification for the assertion that 
regularly performed vigorous exercise can be useful as a natural ‘medication’ for people 
with type 2 diabetes (Rogers et al, 1988). The increased insulin sensitivity and reduced 
insulin secretion associated with exercise have usually been observed when participants are 
studied 12-16 h after exercise (Heath et al, 1983; King et al, 1988a; King et al, 1988b; King 
et al, 1987; LeBlanc et al, 1981). This has important implications for exercise prescription 
and the prevention of conditions such as impaired glucose tolerance or insulin resistance.   
 
Many studies have examined the chronic effects of exercise on coagulation and 
fibrinolysis. One example of a well-controlled study is that of Rauramma and colleagues 
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(1986). In this study, moderate intensity regular exercise in middle aged, overweight and 
mildly hypertensive men in east Finland was conducted to examine platelet aggregation. 
The exercise intervention was effective in reducing platelet aggregation. Hence, regular 
exercise may have a long term inhibitory effect on platelet aggregation. This might also 
assist in protecting against atherosclerosis and IHD (Rauramma et al, 1986). Greater 
changes in fibrinolytic activity and venous occlusion were observed in active men involved 
in maximal exercise when compared with inactive men. This would improve the body’s 
ability to dissolve thrombi if they form. Individuals with CVD have been found to exhibit 
impaired fibrinolytic activity. Thus, regular physical activity may enhance fibrinolytic 
activity and this may serve as an additional exercise induced cardio protective mechanism 
(Szymanski et al, 1994).  
 
Besides these risk factors, inflammation has a pivotal role in the continual progression of 
atherosclerosis. Exercise, however, may alleviate this situation. A few studies have shown 
that chronic exercise training decreases the concentration of inflammatory markers (e.g., 
IL-6, TNF-α, CRP) elicited after an acute bout of exercise in untrained patients with CHD 
(Smith et al, 1999; Gielen et al, 2003; Kasapis & Thompson, 2005; Gleeson, 2007). A 
recent study also found this in untrained CHD patients where acute exercise caused a 
marked increase in CRP and sVCAM-1. With four months of training there was a 
significant decrease in the CRP response but no significant change was seen in sVCAM-1 
after acute exercise (Fernandes et al, 2011). This could have been the case as most studies 
have examined trained athletes while addressing the acute effects of exercise and hence this 
contradiction in inflammatory activity (Kasapis & Thompson, 2005). However, this study 
suggested that chronic exercise training may moderately reverse the inflammatory response 
caused by acute exercise in patients with CHD (Fernandes et al, 2011). 
 
Moreover, regular participation in physical activity reduces the risk of developing 
hypertension. Habitual physical activity is also associated with other health benefits that 
favourably modulate hypertension (Cornelissen & Fagard, 2005). Furthermore, the effect of 
exercise in 8 acute and 14 exercise training studies were conducted on European White 
men. They were overweight and sedentary with an average age of 44 years. The training 
studies suggested that exercise training produces greater blood pressure reductions than 
acute exercise and this was more evident in those who had the highest blood pressure 
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values initially. These findings may be related to the higher pre-exercise blood pressures in 
the exercise training participants (Thompson et al, 2001).  
 
The associations between different types of physical activity and the incidence of 
hypertension have been assessed in several different populations. A study of male 
university alumni reported that vigorous exercise in the post-college years protected against 
future hypertension (Paffenbarger et al, 1983; 1991). In middle-aged Finnish men the total 
amounts and intensities of baseline physical activity were inversely associated with the risk 
of future hypertension (Haapanen et al, 1997). In Japanese men, the duration of walk to 
work and leisure-time physical activity was significantly associated with a lower risk for 
hypertension (Hayashi et al, 1999). In the Atherosclerosis Risk in Communities Study, the 
incidence of hypertension was lower in white men in the highest quartile of leisure-time 
physical activity than in men in the least active quartile (Pereira et al, 1999).  
2.7 Exercise studies in South Asian populations 
In recent years there has been increasing interest in the exercise/physical activity levels of 
South Asians and the extent to which these may explain the increased CVD risk in South 
Asians. Fiscbacher and colleagues (2004) reviewed 12 studies in adults and 5 studies in 
children and young people which had compared physical activity levels between South 
Asians and Europeans. Data pertaining to activities in adults were collected mainly through 
questionnaires. One study utilised pedometers (over 7 days) in addition to questionnaires. 
Mean daily walking distance by pedometer was 1.8 km per day for the Indian origin group 
and 2.4 km per day for the Northern European group (Shaukat et al, 1995). Two of the five 
studies in children assessed physical fitness using bicycle ergometer tests, the other three 
used physical activity questionnaires. Hardy and Eston (1985) compared the level of fitness 
of ‘Anglo-Saxon’ and first generation expatriate Indian students none of whom were 
regularly active in sport. In the other fitness study, the cardiorespiratory fitness of ethnic 
minorities in Britain was examined due to the lack of information in this area (Bettiol et al, 
1999). In both studies, maximal oxygen uptake was estimated by a submaximal test and 
this only gave a predictive value. These studies revealed a considerable disparity in 
maximum oxygen uptake (Hardy and Eston, 1985) and poorer physical fitness and lack of 
cycling skills (Bettiol et al, 1999) in the South Asian children. Apart from these findings, a 
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12 week progressive resistance training programme in Asian Indians with type 2 diabetes 
was also conducted to evaluate its effectiveness. The training study assessed several 
exercises which included biceps flexion, shoulder flexion, hip flexion, finger grip, knee 
extension and heel rise at 10 repetitions of two sets (Misra et al, 2008). After three months 
of training, significant improvements were found in insulin sensitivity, blood glucose, 
lipids and truncal and peripheral subcutaneous adipose tissue. 
 
In addition, a study comparing premenopausal Indian and Pakistani women with American 
women of European descent revealed the South Asian women to be at greater risk of CVD 
than their American counterparts. However, the South Asian women in increasing their 
physical activity levels are likely to decrease overall and regional adiposity, thereby 
improving their lipid profiles (Kamath et al, 1999). This was ascertained using the Five-
City Project physical activity recall questionnaire (Sallis et al, 1985).  
  
A study by Davey and colleagues (2000) demonstrated a 12% increase in 2OV max with 
twelve weeks of supervised exercise. Ninety-two sedentary South Asian and European men 
and women aged 35-49 years participated in this study. Maximal oxygen uptake was 
measured using a graded exercise treadmill test based on a modified Bruce protocol and it 
was higher among Europeans than South Asians with significance persisting after 
adjustment for sex and age. Participants were given individually tailored exercise programs 
requiring them to perform three 30 minute sessions of interval walking/jogging later 
progressing to jogging/running.  Participants had to work at 65-70% of 2OV max. Exercise 
also improved mean insulin sensitivity by 40% within 24 hours of the final exercise session 
but not five days after it.  
 
A validated physical activity questionnaire was used in a hospital based case-control study 
investigating physical activity and CHD in India. Data from 350 cases of acute myocardial 
infarction and 700 controls matched by age, gender and hospital in New Delhi and 
Bangalore were collected. Brisk walking as much as 35-40 minutes per day appeared to 
protect from CHD. This study is the first of its nature to demonstrate the harmful effects of 
physical inactivity on health and the significance of leisure time exercise in the prevention 
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of CHD risk among Indians (Rastogi et al, 2004). This study also indicated the low 
physical activity levels among Indians in urban cities.  
 
The Chennai Urban Population Study was the first study conducted in South Asians in 
India that demonstrated physical inactivity’s association with components of the metabolic 
syndrome and CHD in this population. Using a validated questionnaire, the study 
emphasised the need for increased physical activity in preventing the metabolic syndrome 
and CHD in India. Strikingly, it also showed that only 6.2% of this urban population 
exercised regularly (Mohan et al, 2005). The INTERHEART study has also echoed the 
substantially lower prevalence of leisure time physical activity in South Asians (6.1%) 
compared with the rest of the world (21.6 %). 
 
Furthermore, an interview based study focusing on promoting physical activity among 
South Asian women with CHD and diabetes also documented low physical activity that 
was related to a lack of motivation, poverty, transport, time and competing respsonsibilities 
(Srikantharajah and Kai, 2007). Another study investigated ethnic differences among South 
Asian, Black African-Caribbean and White European origin children in physical activity 
levels assessed using the Actigraph activity monitor (Owen et al, 2009). The findings 
revealed that British South Asian children have lower physical activity levels than White 
European and black African-Caribbean children (Owen et al, 2009). 
 
Among these studies, it was also reported that South Asians have reduced cardiorespiratory 
fitness (assessed using a treadmill test) and a reduced capacity for fat oxidation during 
submaximal exercise compared with matched Europeans. These factors were associated 
with their lower insulin sensitivity, independent of adiposity both at the whole body level 
and at the skeletal muscle level (Hall et al, 2010), This study involved 20 participants from 
each ethnic group who were matched for age.  
 
There have been very few thorough accounts illustrating South Asian physical activity 
levels. Thus information from the Health Survey for England (1999 to 2004) were utilised 
to compare leisure time physical activity levels among 5421 South Asians and 8974 White 
Europeans aged 18 to 55 years. The results conveyed very low physical activity levels in 
UK South Asians. This evidence of physical inactivity exposes the vulnerability of South 
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Asians to CVD (Williams et al, 2011). In addition, Yates and colleagues (2010) examined 
physical activity levels (using the International Physical Activity Questionnaire) among 
1164 South Asians and 4310 White Europeans (males and females were almost equally 
represented) and relationships between physical activity and markers of diabetes and CVD. 
This study, which took place in Leicester, UK, showed that in White Europeans physical 
activity was inversely associated, with BMI, waist-circumference (men and women), 2-h 
glucose (women), and TAG (men) and positively associated with HDL-C (men). In South 
Asians physical activity was significantly inversely associated with waist-circumference 
(women) and positively associated with HDL-C (men). Importantly, the study also 
disclosed considerably lower levels of physical activity among South Asians than White 
Europeans (Yates et al, 2010). 
 
One final point worth mentioning before closing this section is that physical activity 
questionnaires have often been the only feasible choice in large epidemiological studies, 
but they have limitations and can result in large measurement error (Shephard, 2003). 
These limitations are likely to become more pronounced in minority ethnic populations 
(Fischbacher et al, 2004) leading to further potential for inaccuracy. Thus, a potential area 
for future research is the development of physical activity questionnaires specifically for 
the South Asian population.  
2.8 Summary and conclusions 
Thus far this review has outlined clinical and epidemiological evidence in substantiating 
physical activity as a “pharmacological” tool. South Asians’ physical inactivity is likely to 
contribute to their high risk of CHD. Increasing physical activity in all South Asians should 
be a health priority for health professionals. Critically, there has not been any acute 
exercise study investigating postprandial lipaemia and other CVD risk factors in the South 
Asian population. Thus, the studies reported in this thesis are an attempt to explore and 
examine the acute effects of exercise on CVD risk factors in South Asian men. 
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3 General methods 
This chapter describes the experimental methods used in the studies presented within this 
thesis as certain aspects of the methodology are common between studies. Loughborough 
University’s Ethical Advisory Committee approved each of the studies described in this 
thesis and written informed consent was gained from study participants before participating 
in these research investigations. The information presented here describes the methods used 
in studies one (Chapter 4), two (Chapter 5), three (Chapter 6) and four (Chapter 7).   
 
3.1 Participants 
For the studies reported in this thesis participants were recruited from Loughborough 
University by e-mail advertisement, through friends, word of mouth and direct approach. 
Volunteers were given a participant information sheet (Appendix A) describing the 
demands of the study and the associated risks and discomforts. Volunteers provided written 
informed consent (Appendix B) and completed a health screen questionnaire (Appendix C) 
before any experimental procedures began. Participants also completed questionnaires 
assessing physical activity (Appendix D – studies one and two & Appendix E – study 
three) and verification forms (for South Asians only) to verify their country of birth, their 
mother tongue language, their religion and race, the country of their parents’ birth and their 
family history of migration if there was any (Appendix F). All of the white European 
participants were UK citizens. All the participants were students completing their studies at 
Loughborough University and were reasonably physically active. Prior training was not a 
pre-requisite for participation in these studies but the physical demands of the test protocols 
ensured that all of the participants were reasonably fit. 
 
Inclusion criteria for the recruitment of participants were as follows:  
 
 male  
 aged 18 to 40 years 
 no personal history of cardiovascular disease, metabolic disease or dyslipidaemia 
 not dieting or undertaking any extreme dietary habits  
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 not taking drugs known to affect digestion or metabolism – medical or illegal (for 
example anabolic steroids, marijuana, amphetamines, thyroid prescription drugs) 
 weight stable within the last three months i.e. < 2.3 kg change in body weight (St 
Jeor et al, 1997) 
 sufficient ability to complete the demands of the exercise protocols  
 Body mass index (BMI) < 30 kg m-2 
3.2 Anthropometry 
A digital weighing scale (Seca Ltd, Germany) was used to measure body weight to the 
nearest 0.1 kg and a portable stadiometer (Avery Industrial Ltd, Leicester, UK) was used to 
measure height to the nearest 0.1 cm. For both of these measurements participants wore 
light clothing and bare feet. Body mass index was calculated as weight (in kilograms) 
divided by height (in metres squared). Waist circumference was determined as the 
narrowest part of the torso above the umbilicus and below the xiphoid process (Stewart et 
al, 2011) using an inelastic polyfibre measuring tape (Hokanson, Washington, USA). 
 
Subcutaneous fat measurements were taken to estimate body fatness. Skinfold 
measurement was taken using skinfold calipers (Harpenden, Burgess Hill, UK) at four 
anatomical sites (biceps, triceps, subscapular and suprailiac). These measurements were 
made in triplicate on the right hand side of the body with participants in a standing position. 
Measurements were made by rotating through the anatomical sites to allow the skin time to 
regain normal texture and thickness. Body density was calculated using Durnin and 
Womersley’s (1974) predictive equations. Percentage body fat was determined using the 
Siri equation (Siri, 1956).  
3.3 Heart rate measurement 
During preliminary exercise tests and main trials heart rate was measured using a short-
range telemetry (Sports tester PE3000; Polar T31; Polar Electro, Kempele, Finland). 
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3.4 Rating of perceived exertion 
Rating of perceived exertion (RPE) was assessed periodically using the Borg scale during 
preliminary exercise tests and main trials to determine participants’ subjective exercise 
intensity (Borg, 1973). This scale ranges from six (no exertion) to 20 (maximal exertion). 
3.5 Arterial blood pressure measurement 
A digital blood pressure monitor (Omron M5-1, Matsusaka Co., Ltd, Japan) was used to 
measure blood pressure during preliminary screening and main trials. Measurements were 
taken in duplicate after a 5 minute rest in a semi-supine position and the mean of these 
measurements was used as the value. 
3.6 Exercise tests 
After familiarization with motorized treadmill walking/running (RUNRACE, Techno gym, 
Gambettola, Italy) participants completed two preliminary exercise tests: a submaximal, 
incremental treadmill running test (to determine the relationship between walking/running 
speed and oxygen uptake) and a maximum oxygen uptake ( 2OV max) test.  
 
3.6.1 Submaximal treadmill test 
In studies one, two and three (Chapters 4, 5 and 6), a continuous submaximal test was 
performed on a level treadmill. This test involved four, four-minute stages of increasing 
intensity. Participants exercised at various speeds ranging from light/moderate to vigorous 
but not maximum. Initial running speed was between 5.5 and 9 km h-1 (Chapters 5 and 6) 
and walking speed was between 4 and 5 km·h-1 (Chapter 4). The speed was increased by 
0.5 or 1 km·h-1 at the end of each 4 minute stage depending on each participant’s level of 
fitness. A one minute sample of expired air was collected into Douglas bags (Plysu 
Protection Systems, Milton Keynes, UK) in the final minute of each stage of the tests for 
the determination of oxygen consumption and carbon dioxide production. Short range 
telemetry (Sports tester PE3000; Polar T31; Polar Electro, Finland) was used to evaluate 
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heart rate throughout the tests. Ratings of perceived exertion were assessed periodically 
during the tests using the Borg scale. Oxygen consumption was plotted against exercise 
speed at each stage to identify the relationship between submaximal running speed and 
oxygen consumption. 
 
3.6.2 Maximal oxygen uptake test 
After the submaximal test, participants were given 30 minutes to recover before the 
2OV max test. This test involved an incremental uphill protocol at a constant speed until 
participants reached volitional exhaustion (Taylor, Buskirk and Henschel, 1955). The speed 
was ascertained from each participant’s submaximal test performance.  The initial treadmill 
gradient was set at 3.5% and the gradient was increased by 2.5% every 3 minutes. Expired 
air samples were collected for one minute between minutes 1:45 and 2:45 of each stage. 
Maximal oxygen consumption was determined from an expired air sample collected during 
the final minute of the test when participants signaled that they could only continue for one 
additional minute. Heart rate and RPE were monitored throughout the test. Participants 
were strongly motivated with verbal encouragement so as to enable them to complete the 
final collection.  
3.7 Expired air analysis 
Oxygen consumption and carbon dioxide production were determined from expired air 
samples using a paramagnetic oxygen analyser and an infrared carbon dioxide analyser, 
respectively (Series 1440; Servomex, Crowborough, Sussex, UK). These analysers were 
calibrated using gases of known concentration prior to testing. Expired air volumes were 
measured using a dry gas meter (Harvard Apparatus, Edenbridge, UK) and corrected to 
standard temperature and pressure dry. The temperature of the expired air was determined 
using a thermometer (Edale, type 2984, Model C, Cambridge, UK) during evacuation of 
Douglas Bags. Barometric pressure was measured using a Fortin barometer (F.D. and 
Company, Watford, UK).  
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3.8 Calculation of energy expenditure 
Oxygen consumption and carbon dioxide production values were used to determine energy 
expenditure and substrate oxidation using the equations described by Frayn (1983).  
 
Carbohydrate oxidation rate (g·min-1) = (VO2 L·min-1 - (1.989*fat oxidized in 
grams))/0.828 
 
Fat oxidation rate (g·min-1) = (VO2 L·min-1 – VCO2 L·min-1)/0.57 
 
Energy expenditure (kJ) = (fat oxidized (grams)*39) + (CHO oxidized (grams)*17) 
3.9 Physical activity and dietary control 
The day before each main trial and on the first day of each main trial, participants recorded 
their food intake using a weighed food diary. The same food intake was consumed prior to 
the next main trial. Participants were also told not to consume coffee, tea or alcohol before 
the main trials. In addition, no strenuous physical activity was permitted during the day 
preceding the main trials and between day 1 and day 2 of the main trials. For study three, 
participants were asked to refrain from strenuous physical activity for four full days on 
each of the main trials (other than the activity performed as part of the experiment).  
 
Participants fasted overnight (no food or drink except water) for 10 hours prior to the main 
experimental trials for each study. During this time water was permitted ad libitum and this 
was encouraged to avoid dehydration. 
3.10 Test meals 
The test meals were the same for all three studies. They consisted of white bread, butter, 
cheese, mayonnaise, crisps, chocolate milk shake powder and high fat milk. The amount of 
food consumed was adjusted for each participant based on their body weight and was kept 
constant throughout the trials. The macronutrient content of the test meal was 57% fat, 32% 
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carbohydrate and 11% protein and each meal provided 60 kJ (14.3 kcal) per kg body mass 
for a 70 kg participant. Participants consumed each meal within 15 minutes (Chapters 4 and 
5) and 20 minutes (Chapter 6). Water was available ad libitum throughout the main trials. 
 
The meal itself was designed at the laboratory by previous researchers (Miyashita et al, 
2006). The meal provided enough fat to exaggerate postprandial lipaemia and it was 
palatable.  Carbohydrate was included to invoke a realistic insulin response as people do 
not eat macronutrients in isolation. There is no standardized version of an oral fat tolerance 
test (OFTT), either clinically or experimentally, but this meal has been used in many 
studies from this laboratory.  In addition, the food was halal/vegetarian which made it 
edible for South Asian Muslim/vegetarian participants. No one has tested the meal for 
repeatability which is one weakness. 
3.11 Blood sample collection 
On the morning of main trials participants arrived at the laboratory between 7.45 and 8.00 
am for the first two studies (Chapters 4 and 5) and by 8.30 am for the third study (Chapter 
6). On arrival at the laboratory, participants sat on a bed in a semi-supine position for 5 
minutes while a cannula (BD Ven-flon, Becton-Dickinson, Helsingborg, Sweden) was 
inserted into an antecubital vein and a baseline blood sample was collected.  
 
In all studies blood samples were drawn into pre-cooled 9 mL EDTA monovette tubes 
(Starstedt, Leicester, United Kingdom). The samples were immediately centrifuged at 1500 
x g (3000 revs/min) for 10 minutes in a refrigerated centrifuge (Labofuge 400R, Thermo 
Scientific, Langenselbold, Germany) at 4ºC. The plasma supernatant was dispensed into 
eppendorf tubes and stored at -80ºC / -20ºC (depending on freezer availability) before 
analysis. After each blood sample collection 10 mL of non-heparinised saline solution 
(0.9% (v/w) sodium chloride, Baxter Healthcare Ltd, Norfolk, United Kingdom) was 
flushed through the cannula to maintain cannula patency. Participants adopted the semi 
supine position 5 minutes before blood was drawn. Two mL of blood was drawn into a 
syringe and discarded at the start of each blood collection to prevent sample contamination 
from saline. Prior to centrifugation of the blood samples collected at baseline and at the end 
of each trial, two 20 µL blood samples were collected from monovettes into micropippettes 
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for the measurement of haemoglobin and three 20 µL blood samples were collected from 
monovettes into microhaematocrit tubes for the measurement of haematocrit. Haemoglobin 
and haematocrit values were used to estimate changes in plasma volume across the main 
trial days (Dill and Costill, 1974). 
 
3.12 Blood biochemistry 
3.12.1 Haemoglobin and haemotocrit 
Haemoglobin was determined using the cyanmethaemoglobin method with the aid of an 
ultra-violet spectrophotometer (CECIL CE 1011, Cecil Instruments Ltd., Cambridge, UK). 
Haematocrit was determined using a microliter-haematocrit centrifuge (MIKRO, 20, 
Andreas Hettich GmbH and Co. KG, Tuttlingen, Germany).  
 
3.12.2 Lipids, lipoproteins and glucose 
Plasma total cholesterol, high density lipoprotein cholesterol, low density lipoprotein 
cholesterol, triacylglycerol and glucose concentrations were determined by enzymatic 
colorimetric methods using an automated bench top analyser (Pentra 400, HORIBA ABX 
Diagnostics, Montpellier, France). To ensure precision of analysis internal quality controls 
exhibiting normal and pathological values were run prior to sample analysis.  
 
3.12.3 Insulin 
Plasma insulin concentrations were determined using a commercially available enzyme-
linked immuno sorbent assay (Mercodia, Sylveniusgatan, Uppsala, Sweden) with the aid of 
a plate reader (Expert Plus, ASYS, Eugendorf, Austria) to measure absorbance. To ensure 
precision of analysis internal quality controls (Mercodia diabetic antigen control) 
exhibiting low and high levels were assayed. 
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3.12.4 Interleukin 6 and soluble intercellular adhesion molecules 
Plasma interleukin-6 (IL-6) concentrations were determined using commercially available 
enzyme-linked immuno sorbent assay kits (high sensitivity kit; R&D Systems, Abingdon, 
UK for IL-6 in study one, high sensitivity kit; Diaclone, Besançon, France for study two). 
For soluble intercellular adhesion molecule-1 (sICAM-1) a commercially available kit was 
also used (Diaclone, Besançon, France). For these assays a plate reader was used to 
measure absorbance (Expert Plus, ASYS, Eugendorf, Austria). To ensure precision of 
analysis internal quality controls exhibiting normal and pathological values were run during 
sample analysis. 
 
3.12.5 Precision of analysis 
To eliminate inter assay variation, samples from each participant were analysed in the same 
run. For TAG, glucose and insulin the within batch coefficient of variation for each assay 
was calculated by repeated measurements of a single plasma sample 10 times. Whereas, for 
IL-6 and sICAM-1 the within standard and quality control coefficient of variation was 
determined by the variation between each duplicate pair. Coefficient of variation values for 
each assay are displayed within the methods section of each experimental chapter. 
 
3.13 Statistical analysis 
Data were analysed using Predictive Analytics Software version 18.0 for Windows (SPSS, 
Inc., Somers, NY, USA). Data are presented as mean ± standard deviation (SD) in the text 
and tables and as mean ± the standard error of the mean (SEM) in figures. Area under the 
plasma concentration versus time curve (AUC) values have also been calculated using the 
trapezoidal method. The following statistical tests have been used in the experimental 
chapters within this thesis: 
 
• Independent samples t tests 
• Paired samples t tests 
• Pearson Product Moment correlation 
• One way analysis of variance (ANOVA) 
• Two way ANOVA 
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• Three way ANOVA  
• Bonferroni post-hoc tests (after ANOVA) 
 
Statistical significance is accepted at the 5% level throughout this thesis. Further details 
about the statistical analysis are provided within each experimental chapter.  
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4 The effect of prior walking on postprandial lipaemia 
and resting blood pressure in South Asian versus 
European men 
4.1 Introduction 
Coronary heart disease (CHD) has emerged as the major cause of morbidity and mortality 
globally (World Health Organisation, 2012) and among South Asians in the recent past 
(Goswami et al, 2012). This is evident among South Asians in UK (Wild et al, 2007), the 
USA (Palaniappan et al, 2004) and Canada (Sheth et al, 1999). Since the 1950s, there has 
been an increased awareness that people with ancestral origins in the Indian subcontinent 
(India, Pakistan, Bangladesh, Sri Lanka and Nepal) known as South Asians are highly 
susceptible to CHD (Patel and Bhopal, 2004). Danaraj and colleagues (1959) made a 
definitive finding that the prevalence of CHD was seven fold higher in Indians than in 
Chinese in Singapore. In 1963, Adelstein identified this phenomenon in South Africa 
where mortality rates from cardiovascular disease (CVD)/CHD in mainly Indian men and 
women were much higher than in White men and women. Estimates suggest a three to five 
fold increased risk of myocardial infarction and cardiovascular death among migrant South 
Asians compared with other ethnic groups (Eapen et al, 2009). 
 
South Asians, who are a heterogeneous group, comprise the largest ethnic minority (4.1%) 
in the United Kingdom (UK) (Wild & McKeigue et al, 1997). The incidence rate of 
myocardial infarction has been reported to be higher in South Asians compared with other 
ethnic groups. Mortality ratios of CVD, CHD and stroke are also higher in South Asians in 
the UK than the local population (Wild et al, 2007). This is further evident from a recent 
cardiovascular risk assessment study conducted in the UK which screened almost equal 
numbers of male and female South Asians. It identified that 92% of them had at least one 
modifiable CVD risk factor which places them in a high CVD risk population (Rao et al, 
2012).  
 
   Chapter 4 
 
 ▏55 
South Asians have higher plasma triacylglycerol (TAG), lower high density lipoprotein 
cholesterol (HDL-C) and higher low density lipoprotein cholesterol (LDL-C) 
concentrations than other groups. South Asians also appear to be more susceptible to 
hypertension, type 2 diabetes, impaired glucose tolerance, increased fasting glucose 
concentration, insulin resistance and the metabolic syndrome than other ethnic groups 
(Tziomalos et al, 2008). Despite documenting the higher rates of earlier CHD in South 
Asians, few studies have shed light on the reasons for this. 
 
Several reasons have proposed to explain the elevated CVD/CHD risk experienced by 
South Asians (Reddy & Yusuf, 1998). Firstly, the increased risk may be due to genetic 
factors predisposing to high levels of metabolic cardiovascular risk factors associated with 
insulin resistance e.g. central adiposity, glucose intolerance, hyperinsulinaemia, and 
dyslipidaemia (metabolic syndrome). Secondly, the increased risk may be due to 
environmental influences which lead to weight gain as well as rises in blood cholesterol 
and blood pressure (Reddy & Yusuf, 1998). One possible environmental risk factor might 
be the prevalence of physical inactivity and numerous studies have identified that South 
Asians have low levels of physical activity (Kamath et al, 1999; Fischbacher et al, 2004; 
Owen et al, 2009; Williams et al, 2011; Yates et al, 2010; Misra et al, 2012). Furthermore, 
it has been estimated that physical inactivity explains > 20% of the excess CHD mortality 
experienced by UK South Asians even after adjsutment for potential confounders including 
socioeconomic status, smoking, diabetes and existing CVD (Williams et al, 2011). 
 
Physical inactivity is a well-established risk factor for CHD (Wannamethee & Shaper, 
2001; Rastogi et al, 2004; Mohan et al, 2005; Rao et al, 2012). Despite documenting higher 
rates of earlier CHD in South Asians and a tendency for low levels of physical activity no 
studies have addressed the acute effects of exercise in this population. Observational 
evidence suggests the cardio-protective role of physical activity on CHD and CHD risk 
markers in South Asians (Rastogi et al, 2004; Mohan et al, 2005; Rao et al, 2012). 
Furthermore, regular moderate intensity physical activity such as brisk walking is 
associated with a 30% to 50% reduction in the risk of CHD, obesity, diabetes and stroke in 
Western populations (Wannamethee et al, 2000; Batty, 2002). Whether the cardiovascular 
effects of physical activity have any cardio-protective elements in South Asians remains to 
be determined. 
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Thus, this study sought to evaluate the influence of an acute bout of brisk walking on 
postprandial triacylglycerol concentrations, a risk marker for CVD (Nordestgaard et al, 
2007; Bansal et al, 2007) in South Asian and White European men. Walking was chosen 
because it is a popular and accessible activity that can be incorporated into daily activity 
routines with little risk (Morris and Hardman, 1997). Numerous studies have shown that an 
acute bout of exercise helps to lower postprandial TAG concentration but most of these 
studies have been conducted in Western populations (Miyashita et al, 2008; Hurren et al, 
2011). In addition to postprandial lipaemia, this study examined other CVD risk markers 
including glucose, interleukin-6 and resting blood pressure. 
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4.2 Methods 
4.2.1 Participants 
With the approval of Loughborough University’s Ethics Advisory Committee 15 South 
Asian and 14 White European men were recruited and they gave their written informed 
consent to participate in this study. The study sample size was calculated using G Power 
(version 3.1.3, Franz Faul, Universitat Kiel, Germany) which indicated that for TAG (the 
primary outcome variable) 10 participants per group would be sufficient to detect a 
difference in TAG with a power of 0.75 and a 5% level of significance. When calculating 
power using G-power, postprandial AUC TAG values were used in preference to fasting 
TAG values. This was done due to the strong correlation between postprandial TAG levels 
and elevated risk of developing cardiovascular disease. Participants were healthy and 
recreationally active and ranged in age from 21 to 30 years. Participants were non-smokers, 
with no personal history of CVD or metabolic disease, and none of them reported taking 
medication. They had a BMI < 30 kg·m-2. Participants were not dieting and did not have 
any extreme dietary habits. To verify ethnicity each South Asian participant completed a 
form providing details of their place and country of birth, their mother tongue language, 
their religion and race, the country of their parents’ birth and their family history of 
migration. This revealed that seven of the participants were Indian nationals, five were UK 
Indians, one was a UK Pakistani and two were Sri Lankans from Sri Lanka.  
 
4.2.2 Anthropometry 
Prior to the main trials participants attended the laboratory for a screening and 
familiarization visit lasting approximately two hours. During this visit they completed a 
participant information form and questionnaires assessing health status, usual physical 
activity and ethnicity (South Asians only). Subsequently, weight was measured to the 
nearest 0.01 kg using a digital scale (Seca Ltd, Germany) and height was measured to the 
nearest to 0.1 cm using a stadiometer (Avery Industrial Ltd, Leicester, UK). Skinfold 
thickness was measured with calipers (Harpenden, Burgess Hill, U.K.) on the right hand 
side of the body at the biceps, triceps, subscapular and suprailliac. The sum of these four 
skinfold measurements was used to determine body density (Durnin & Wormersley, 1974) 
and body fat percentage (Siri, 1956). In addition, waist circumference was determined as 
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the narrowest part of the torso above the umbilicus and below the xiphoid process using a 
measuring tape (Hokanson, Washington, USA). Lastly, blood pressure was measured using 
a digital monitor (Omron M5-1, Matsusaka Co., Ltd, Japan). 
 
4.2.3 Preliminary exercise tests 
After familiarization with motorized treadmill walking (RUNRACE, Techno gym, 
Gambettola, Italy) participants completed two preliminary exercise tests: a submaximal, 
incremental treadmill walking test (to determine the relationship between walking speed 
and oxygen uptake) and a maximal oxygen uptake ( maxOV 2 ) test. The submaximal test 
was performed on a level treadmill and involved four, four-minute stages of increasing 
intensity. Initial walking speed was set between 4 and 5 km·h-1 and the speed was increased 
by 0.5 or 1 km·h-1 (depending on each participant’s level of fitness) at the end of each 
stage. After a 30 minute recovery, maxOV 2 was determined with the use of an incremental 
uphill protocol at a constant speed until participants reached volitional exhaustion (Taylor, 
Buskirk and Henschel, 1955). The initial treadmill gradient was set at 3.5% for this test and 
the gradient was increased by 2.5% every 3 minutes. Short range telemetry (Polar T31; 
Polar Electro, Kempele, Finland) was used to evaluate heart rate throughout both tests. 
Ratings of perceived exertion (RPE) were assessed periodically during these tests using the 
Borg scale (Borg, 1973).  
  
Expired air samples were collected into Douglas bags (Plysu Protection Systems, Milton 
Keynes, United Kingdom) during both of the preliminary exercise tests. An O2/CO2 
analyser (Servomex 1440, Crowborough, Sussex, United Kingdom) was used to measure 
the oxygen and carbon dioxide percentages within the expired air samples. The analysers 
were calibrated using gases of known concentration prior to testing. A dry gas meter 
(Harvard Apparatus, Edenbridge, United Kingdom) was used to measure expired air 
volumes which were corrected to standard temperature and pressure dry. Data from the two 
preliminary exercise tests were used to determine the relative exercise intensity adopted by 
each participant at their self-selected brisk walking pace. 
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4.2.4 Main trials 
Participants completed two, 2 - day trials (exercise and control) in a random order 
separated by an interval of at least one week. Trials were undertaken in block random order 
(block size of two) using software available at http://www.randomization.com/. On day one 
of the exercise trial, participants arrived at the laboratory between 8.00 am and 9.00 am and 
rested (reading, working at a computer, watching television, listening to music or playing 
video games) throughout the day until 5.00 pm. Participants consumed a standardized 
lunch at approximately 12.00 pm. At 3.30 pm, participants performed a 60 minute brisk 
walk at a pace which they were able to sustain i.e. participants were asked to walk as fast as 
was comfortably possible. The objective was to simulate a natural setting/daily activity 
hence intensity was not fixed. One minute samples of expired air were collected at 15 
minute intervals during the walk to monitor the intensity of the walk i.e. minutes 14-15, 29-
30, 44-45 and 59-60 during the walk. If necessary adjustments were made to the treadmill 
speed to ensure participants were walking as briskly as they could. Heart rate and RPE 
were also monitored during the walk. During day one of the control trial procedures were 
exactly the same as on day one of the exercise trial except that no walking was performed 
and four, five-minute resting expired air samples were collected at the time when walking 
was performed on day 1 of the exercise trial i.e. between 3.30 pm and 4.30 pm equivalent 
to minutes 10-15, 25-30, 40-45 and 55-60 during the walk.  Oxygen consumption and 
carbon dioxide production were calculated from expired air samples as described 
previously. Energy expenditure was estimated from oxygen consumption and carbon 
dioxide production values using the equations of Frayn (1983).   
 
On day two of the main trials participants arrived at the laboratory between 7.45 and 8.00 
am having fasted overnight (no food or drink except water) for 10 hours. On arrival at the 
laboratory, participants sat on a bed in a semi-supine position for 5 minutes while a cannula 
(BD Ven-flon, Becton-Dickinson, Helsingborg, Sweden) was inserted into an antecubital 
vein and a baseline blood sample was collected. After this blood sample, baseline resting 
blood pressure was measured. Participants then consumed a prescribed test meal (see 
below) for breakfast. A clock was started the moment they commenced their meal and this 
was identified as 0 hour. The trial continued on for nine hours during which a total of 14 
(including the fasting sample), 9 mL venous blood samples were collected and 10 
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(including the baseline measurement) blood pressure readings were taken.  At 4 hours, a 
second test meal, identical to the first, was served as lunch to participants. Participants 
rested throughout day two of both the control and exercise trials and hence day two of these 
trials was identical. A schematic representation of the main trial protocol is displayed in 
Figure 4.1.  
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4.2.5 Control of diet and exercise 
The day before each main trial and on the first day of each main trial, participants recorded 
their food intake using a weighed food diary. Participants replicated this food intake for the 
next main trial. Participants were told not to consume coffee, tea or alcohol on the day prior 
to and during the main trials. Participants were also asked to refrain from strenuous 
physical activity during the day preceding the main trials and on day 1 and day 2 of the 
main trials.  
 
4.2.6 Test meals 
The test meals consisted of white bread, butter, cheese, mayonnaise, crisps, chocolate milk 
shake powder and high fat milk. The amount of food consumed was adjusted for each 
participant based on their body weight and was kept constant throughout the trials. The 
macronutrient content of the test meal was 57% fat, 32% carbohydrate and 11% protein and 
each meal provided 60 kJ (14.3 kcal) per kg body mass for a 70 kg participant. Participants 
consumed each meal within 15 minutes and water was available ad libitum. 
 
4.2.7 Blood sampling 
Venous blood samples were collected for the measurement of total cholesterol, HDL-C, 
TAG, glucose and IL-6. Samples were collected at 0, 0.25, 0.5, 1, 2, 3, 4, 4.25, 4.5, 5, 6, 7, 
8, 9 hours. Total cholesterol and HDL cholesterol were only measured from baseline 
samples; IL-6 concentrations were measured from samples collected at 0, 3, 6 and 9 hours, 
glucose and TAG were measured from all samples. Participants rested in a semi-supine 
position during blood sampling. Venous blood samples were drawn into pre-cooled 9 mL 
EDTA monovette tubes (Starstedt, Leicester, United Kingdom) and immediately 
centrifuged at 1500 x g (3000 revs/min) for 10 minutes in a refrigerated centrifuge 
(Labofuge 400R, Thermo Scientific, Langenselbold, Germany) at 4ºC. The plasma 
supernatant was dispensed into eppendorf tubes and stored at -20ºC before analysis. After 
each blood sample collection 10 mL of non-heparinised saline solution (0.9% (v/w) sodium 
chloride, Baxter Healthcare Ltd, Norfolk, United Kingdom) was flushed through the 
cannula to maintain cannula patency. Two mL of blood was drawn into a syringe and 
discarded at the start of each blood collection to prevent sample contamination from saline. 
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Prior to the centrifugation of the blood samples at baseline and at nine hours, two 20 µL 
blood samples were collected from monovettes into micropipettes for the measurement of 
haemoglobin and three 20 µL blood samples were collected from monovettes into 
microhaematocrit tubes for the measurement of haematocrit. Haemoglobin and haematocrit 
values were used to estimate changes in plasma volume across the nine-hour main trial day 
(Dill and Costill, 1974).  
 
4.2.8 Blood biochemistry 
Plasma total cholesterol, HDL cholesterol, TAG and glucose concentrations were 
determined spectrophotometrically using commercially available kits and a bench top 
analyser (Pentra 400, HORIBA ABX Diagnostics, Montpellier, France). Enzyme linked 
immuno sorbent assays (ELISA) assays were used to determine the concentrations of IL-6 
(high sensitivity kit; R&D Systems, Abingdon, UK) with the aid of a plate reader (Expert 
Plus, ASYS, Eugendorf, Austria). To eliminate inter assay variation, samples from each 
participant were analysed in the same run. Coefficients of variation for each assay were as 
follows: 0.7% for total cholesterol, 0.7% for HDL cholesterol, 0.7% for TAG, 0.9% for 
glucose, and 4.3% for IL-6. 
 
4.2.9 Statistical analysis  
Data were analysed using Predictive Analytics Software version 18.0 for Windows (SPSS, 
Inc., Somers, NY, USA). Physical characteristics and exercise responses were compared 
between South Asians and Europeans using the Students t-test. Three-way repeated 
measures ANOVA with Bonferroni post-hoc tests was used to examine differences 
between trials for plasma constituents (TAG, glucose and IL-6) with the three factors 
being: a) trial (exercise versus control), b) ethnic group (South Asians versus Europeans) 
and c) time (serial measurements over 9 hours). Effect sizes (Cohen’s d) were also 
calculated for each of these variables by dividing the difference between the mean values 
(exercise versus control or South Asian versus European) with the standard deviation (i.e. 
the average standard deviation from both trials and ethnic groups combined). Area under 
the plasma concentration versus time curve (AUC) values were calculated for TAG, 
glucose and IL-6 using the trapezoidal method. These values were compared using two-
way repeated measures ANOVA with the two factors being trial (exercise versus control) 
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and ethnic group (South Asian versus European).  Two-way repeated measures ANOVA 
was also used to assess between trial and ethnic group differences for fasting plasma 
metabolite concentrations. Statistical significance was accepted at the 5% level. Results are 
presented as mean ± SD in the text and tables and as mean ± SEM in figures. 
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4.3 Results 
4.3.1 Participant characteristics 
The physical characteristics of the participants are displayed in Table 4.1. There were no 
significant differences between South Asian and White European participants for weight, 
resting systolic blood pressure and resting diastolic blood pressure. Age, body mass index, 
percentage of body fat and waist circumference were significantly higher in South Asian 
than in White European participants while height and 2OV max were significantly lower in 
South Asian than in White European participants 
 
 
Table  4.1: Physical characteristics of South Asian and European descent participants 
measured during the preliminary tests. 
Variables South Asians 
(n=15) 
 Europeans 
(n=14) 
P value 
Age (years)  24.0 ± 2.9  22.0 ± 0.7    0.017 
Height (cm)  170.5 ± 8.4  180.2 ± 3.9    0.001 
Weight (kg)   74.1 ± 11.5  73.6 ± 8.3    0.903 
Body mass index (kg·m-2)  25.4 ± 3.3  22.7 ± 2.2    0.013 
Body fat (%)  21.7 ± 6.0  12.5 ± 4.6 < 0.001 
Waist circumference (cm) 82 ± 9.2  75 ± 5.2    0.037 
Resting SBP (mm Hg)  129 ± 10.0  136 ± 13.6    0.103 
Resting DBP (mm Hg) 77 ± 7.4  77 ± 6.4    0.859 
maxOV 2  (mL·kg
-1·min-1)  40.7 ± 7.2  49.2 ± 8.0    0.005 
All values are in mean ± SD. P values for differences between South Asians and Europeans 
were based on t tests for independent samples. SBP, systolic blood pressure; DBP, diastolic 
blood pressure; 2OV max, maximal oxygen uptake. 
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4.3.2 Responses to treadmill brisk walking 
The physiological responses to the 60 minute brisk walking are displayed in Table 4.2. The 
White Europeans walked significantly faster than the South Asians while the South Asians 
had a significantly higher average heart rate than White Europeans. There were no 
significant differences between ethnic groups in % 2OV max, energy expenditure, substrate 
(carbohydrate/fat) utilisation and RPE attained during the brisk walk. There was a tendency 
for exercise 2OV  to be slightly higher in White European than South Asian participants.    
 
 
 
Table  4.2: Responses during the 60 minute treadmill walk in South Asian and European 
men.  
Variable 
 
South Asians 
(n=15) 
 Europeans 
(n=14) 
P value 
 
 
Speed (km·h-1) 6.4 ± 0.5   7.1 ± 0.3 < 0.001 
2OV  (mL·kg
-1·min-1)  21.1 ± 3.3  23.5 ± 3.2    0.073 
% 2OV  max 52.7 ± 8.0  48.3 ± 6.8    0.129 
Average heart rate (beats·min-1) 145 ± 16.5  126 ± 11.1    0.001 
Respiratory exchange ratio 0.95 ± 0.05  0.95 ± 0.05    0.672 
Ratings of perceived exertion 11.5 ± 2.2  11.3 ± 1.6    0.853 
Exercise energy expenditure (kJ·h-1) 1860 ± 3745   2068 ± 364    0.141 
Net energy expenditure (kJ·h-1) 1555 ± 359  1715 ± 343    0.231 
% Energy from fat 18.4 ± 17.6  15.7 ± 17.4    0.676 
% Energy from carbohydrate 81.6 ± 17.6  84.3 ± 17.4    0.676 
All values are in mean ± SD. P values for differences between South Asians and Europeans 
were based on t tests for independent samples. 2OV , volume of oxygen consumed.
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4.3.3 Fasting plasma concentrations 
Fasting concentrations of plasma metabolites (on day two of the main trials) are displayed 
in Table 4.3. There were significant main effects of trial for TAG indicating lower values 
on the exercise trial for fasting TAG concentration. There was a tendency (P = 0.093) for 
fasting glucose concentration to be lower on the exercise than the control trial. In addition, 
there were significant main effects of group for fasting HDL-C , total cholesterol/HDL-C 
ratio and glucose indicating higher total cholesterol/HDL-C and glucose concentrations in 
the South Asians than the White Europeans and lower HDL-C concentrations in the South 
Asians. There was a tendency (P = 0.077) for fasting IL-6 concentrations to be elevated in 
the South Asians especially after exercise.  
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4.3.4 Postprandial plasma metabolite concentrations 
Three-way ANOVA revealed main effects of group for TAG (P = 0.031), glucose (P = 
0.045) and IL-6 (P = 0.034) indicating higher postprandial TAG, glucose and interleukin-6 
in South Asians than White Europeans (Figure 4.2). The effect sizes for these ethnic group 
comparisons were large for TAG (0.87) and IL-6 (0.82) and medium for glucose (0.67). As 
body fat percentage was higher in the South Asians than White Europeans it might have 
confounded the association between ethnicity and plasma metabolite concentrations. 
Hence, three-way ANOVA was conducted again with body fat added as a covariate to 
remove its confounding influence. The between group differences for TAG, glucose and 
IL-6 disappeared after control for percentage body fat.  
 
Three-way ANOVA revealed near main effects of trial for TAG (P = 0.058) indicating that 
TAG concentration (Figure 4.2) was lower on the exercise trial. The effect size for this 
TAG comparison was small (0.11). There were main group effects for TAG (P = 0.031), 
glucose (P = 0.045) and IL-6 (P = 0.34) (Figure 4.3) indicating higher TAG, glucose and 
IL-6 concentrations in South Asians than White Europeans. Two-way ANOVA for AUC 
also indicated main effects of group for TAG (P = 0.027), glucose (P = 0.029) and IL-6 (P 
= 0.040) indicating higher values in South Asians as shown in Table 4.4. 
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Figure  4.2: Mean (± SEM) postprandial plasma triacylglycerol (top panel) and glucose 
(bottom panel) concentrations measured on day 2 of the walking and control trials for 
South Asians (n = 15) and White Europeans (n = 14). Data was analyzed using three-factor 
ANOVA with repeated-measures followed by a Bonferroni multiple comparisons test. A 
borderline effect was observed for trial (P = 0.058) in relation to TAG. A main effect of 
time (P < 0.001) was observed for postprandial plasma TAG and glucose concentrations.   
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Figure  4.3: Mean (± SEM) postprandial plasma concentrations of interleukin-6 measured 
on day 2 of the walking and control trials for South Asians (n = 10) and White Europeans 
(n = 10). Data was analyzed using three-factor ANOVA with repeated-measures followed 
by a Bonferroni multiple comparisons test. A main effect of time was observed for 
postprandial plasma interleukin-6 (P = 0.004) concentrations. 
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Figure 4.4 displays the difference in the TAG AUC values between the exercise and the 
control trial for each individual participant. Negative values indicate a lowering of 
postprandial TAG concentration on the exercise trial compared with the control trial. This 
figure demonstrates that postprandial TAG concentration was lowered by exercise in eight 
out of 15 South Asian participants and ten out of 14 European participants.  
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4.3.5 Resting blood pressure responses 
Resting systolic blood pressure (SBP) and diastolic blood pressure (DBP) values are shown 
in Figure 4.5. Baseline resting SBP and DBP measured on day 2 did not differ significantly 
between trials as shown in Table 4.3. However, a significant effect of time was observed 
for resting SBP (P = 0.003) and DBP (P < 0.001). In addition, there was a tendency for 
SBP (P = 0.082) to be lower in South Asians than White Europeans. 
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Figure  4.5: Mean (± SEM) systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) values on day 2 of the control (top panel) and walking (bottom panel) trials for 
South Asians (n = 15) and White Europeans (n = 14). Data was analyzed using three-factor 
ANOVA with repeated-measures followed by a Bonferroni multiple comparisons test.  A 
main effect of time was observed for SBP (P = 0.005) and DBP (P < 0.001).  
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4.3.6 Correlations 
The South Asians and White Europeans were combined to assess correlations between 
baseline measures and trial outcomes. Waist circumference was positively correlated with 
baseline TAG during both the control (r = 0.428, P = 0.021) and exercise (r = 0.462,           
P = 0.012) trials. Body fat was positively correlated with baseline TAG during both the 
control (r = 0.407, P = 0.027) and exercise (r = 0.454, P = 0.013) trials. Maximal oxygen 
uptake was negatively correlated with waist circumference (r = - 0.482, P = 0.008), BMI                
(r = - 0.461, P = 0.012) and body fat (r = - 0.612, P < 0.001). In addition,  2OV  max was 
negatively correlated with postprandial TAG on both the control (r = - 0.402, P = 0.031) 
and exercise     (r = - 0.477, P = 0.009) trials.  
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4.4 Discussion 
The findings of the present study reveal that South Asians exhibit elevated postprandial 
plasma TAG concentrations to a much greater extent than White Europeans after 
consuming high fat meals. Surprisingly exercise had a small, borderline effect on 
postprandial plasma TAG concentrations in both South Asians and White Europeans. 
Postprandial plasma glucose and plasma IL-6 concentrations were higher in South Asians 
than in White Europeans.  
 
The distinctive elevation in postprandial TAG concentrations in response to high fat meals 
was clearly exhibited in South Asians compared with White Europeans. A few studies have 
observed higher fasting TAG concentrations in South Asians than in white people (Anand 
et al, 2000; Tziomalos et al, 2008). Nonetheless, this study is the first to report a difference 
in postprandial TAG concentrations between these ethnic groups. Only one other study has 
compared postprandial lipaemia in South Asians and White Europeans and this study did 
not observe a difference in the lipaemic response to high fat meals although postprandial 
glucose and insulin concentrations were elevated in South Asians (Cruz et al, 2001). A 
possible explanation for these different findings is that percentage body fat did not differ 
between ethnic groups in the study conducted by Cruz and colleagues (2001) but body fat 
percentage was higher in the South Asians in this study as is often the case (Wang et al, 
1994). Although there were between group differences in postprandial lipaemia this was 
not displayed after controlling for differences in percentage body fat so perhaps the 
different lipaemic responses were related to the differences in body fat percentage between 
the two groups. Another possible reason for the disparate findings is the test meals used. 
The percentage fat provided in the test meals was similar between studies (52% of energy 
from fat in the study by Cruz and colleagues versus 57% of energy from fat in the present 
study) but the total amount of food consumed (which is not stated in the paper by Cruz and 
colleagues 2001) may have differed. Whatever the explanation for the disparity between 
these studies the contrast in postprandial TAG concentrations between South Asians and 
White Europeans is very evident in this study and certainly worthy of further investigation.  
 
Another important finding from this study is the (non-significant) tendency for brisk 
walking to reduce postprandial TAG concentrations. Previous studies have reported that a 
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single session of prior exercise alleviates postprandial TAG (for reviews see Katsanos 
2006; Malkova and Gill, 2006, Miyashita et al, 2008; Hurren, 2011) however this is the 
first study to report this in South Asians. Surprisingly, studies which examined intermittent 
(ten, 3 minute bouts) and continuous (30 minutes) walking, running and cycling revealed a 
significant lowering of postprandial TAG concentrations (Miyashita et al, 2006; 2008; 
2008a). In particular, the exercise intensity of the walking study by Miyashita and 
colleagues (2008) was even lower than that in the present study. The relative percentage of 
2OV max for intermittent and continuous walking reported by Miyashita et al (2008) was 
41 to 42% whereas in the present study it was 53% for the South Asians and 48% for the 
White Europeans. Even though exercise intensity and duration were greater in the present 
study there was only a borderline effect for postprandial TAG lowering in both groups. In a 
study by Tsetsonis and Hardman (1996), it was observed that 1.5 h of walking at 60% of 
2OV  max elicited a significant effect whereas the same duration at 30% of 2OV  max did 
not have a significant effect. According to Tsetsonis and Hardman (1996), the energy 
expenditure of an exercise bout is the main determinant of its potential to reduce 
postprandial lipaemia. In the present study the exercise energy expenditure was 1860 and 
2068 kJ respectively which should have been sufficient to elicit a lowering of postprandial 
lipaemia based on the previously cited studies.  
 
Whilst it is well established that exercise of a moderate intensity can reduce fasting and 
postprandial TAG concentrations (for reviews see Katsanos 2006; Malkova and Gill, 2006, 
Miyashita et al, 2008; Hurren, 2011) studies have also shown that this level of exercise did 
not lead to significant increases in either leg skeletal muscle lipoprotein lipase (LPL) 
activity (Herd et al. 2001) or absolute TAG uptake across the leg (Malkova et al. 2000) 
when these were measured 18 h after exercise. Body tissues other than skeletal leg muscle 
play a quantitatively important role in whole-body TAG uptake (Jensen 1995; Nguyen et 
al. 1996). It is possible that there was an insufficient increase in LPL activity in tissues 
other than the legs and this may explain the borderline TAG attenuation seen after brisk 
walking in the present study. 
 
The TAG AUC values of the South Asian participants were still 56% higher after exercise 
than the control trial values displayed by White Europeans. If these findings are translated 
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into larger samples they would suggest that South Asians are at a much higher risk of 
experiencing exaggerated postprandial lipaemia in response to high fat meals than White 
Europeans and this may be a contributing factor to their elevated risk of CHD. In addition 
to elevated postprandial TAG concentrations, fasting TAG concentrations in the exercise 
trial were reduced by 23% in South Asians compared with 7% in the Europeans. Fasting 
glucose concentrations were 6% higher and postprandial glucose concentrations were 9% 
higher in South Asians than White Europeans. This finding is consistent with the findings 
of Cruz and colleagues (2001) who observed higher postprandial glucose concentrations in 
South Asians and also with the finding that fasting glucose concentrations are elevated in 
those of South Asian descent (Anand et al, 2000). Moreover, it is also postulated that 
exercise intensity and duration affects glucose uptake. In the post-absorptive state the 
volume of glucose uptake is critically affected by the exercise intensity. The higher the 
exercise intensity, the higher the skeletal muscle glucose uptake (Romijin et al, 1993). With 
a borderline significance, this study did not indicate any differences in trial. Importantly, a 
moderately elevated glucose concentration is a risk factor for myocardial infarction in non-
diabetic South Asians. This may suggest a degree of glucose intolerance in South Asians 
(Gerstein et al, 1999). 
 
It may also be speculated that hyperinsulinaemia resulting from insulin insensitivity might 
have decreased LPL activity (Pollare et al, 1991) in this study thereby affecting the 
mechanisms responsible for removing TAG from the blood (Pollare et al, 1991). This may 
be a reason for the elevated postprandial lipaemia exhibited in the South Asians in the 
present study. Prospective epidemiological studies across several populations have 
indicated that insulin resistance is the central feature of the metabolic syndrome and the 
primary defect in the development of type 2 diabetes (Misra et al, 2008). Insulin resistance 
often precedes diabetes by several years and is reported to be a risk factor for development 
of CVD (Misra et al, 2008).  
 
South Asians exhibited lower fasting HDL cholesterol concentrations and higher fasting 
total cholesterol/HDL cholesterol ratio values and glucose concentrations than the White 
Europeans. There was also a tendency for fasting plasma IL-6 concentration to be elevated 
in the South Asians, especially on the exercise trial. Lowering of fasting TAG 
concentration in both South Asians and White Europeans was identified on the exercise 
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trials. Even with this reduction, South Asians exhibited a striking 48% elevation in TAG 
concentration in comparison with White Europeans. There was also a tendency for fasting 
glucose to be lowered during the exercise trial. 
 
The differences observed between ethnic groups in this study confirm the findings of 
previous studies (Anand et al, 2000; Tziomalos et al, 2008) indicating  that South Asians 
have a tendency for higher fasting TAG concentrations, higher fasting total cholesterol to 
HDL-C ratio values and lower fasting HDL-C concentrations than other ethnic groups. 
These findings not only expose but also reiterate the greater CHD risk South Asians face 
(Joshi et al, 2007). 
 
Interleukin-6 was also assessed in the present study as it is an indicator of chronic low 
grade inflammation and a predictor of future development of CVD and non-insulin 
dependent diabetes mellitus (NIDDM) (Mathur and Pedersen, 2008). There was a tendency 
for fasting IL-6 concentrations to be elevated in South Asians and this was also the case 
with the postprandial IL-6 concentrations. A recent study reported South Asian women to 
exhibit significantly higher IL-6 concentrations than European women. Thirty per cent of 
the observed difference in IL-6 was explained by differences in fat distribution (Peters et al, 
2012). In similarity, there is an ethnic difference in the present study where body fat 
percentage is significantly higher in the South Asian men. This could be one possible 
reason for the elevated IL-6 in South Asians in the present study. In contrast, Peters and 
colleagues (2013) did not detect an ethnic difference in IL-6 in men. Additionally, a study 
by Indulekha and colleagues (2011) found high concentrations of IL-6 in Asian Indian men 
and women with the metabolic syndrome. From these, it is postulated that South Asians 
may be more susceptible to inflammation and as a result have a tendency to have higher 
concentrations of IL-6 than others. This susceptibility poses a CVD threat in South Asians.  
 
The present study had a few notable limitations. Firstly, the sample size is small and hence 
the findings require confirmation with a larger sample. Secondly, it is possible that the 
group differences observed here are confounded by differences in percentage body fat 
(although South Asians are known to have a higher body fat percentage for a given BMI, 
Wang et al, 1994) as well as differences in age, height and fitness level and this may 
explain in part their elevated CHD risk. Thirdly, most of the participants in the present 
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study were Indian South Asians and South Asians are a heterogeneous group and hence 
these findings require confirmation in other South Asian groups (e.g. Bangladeshis, 
Pakistanis and Nepalese). It would be interesting to examine the postprandial responses to 
exercise in overweight/obese South Asian participants and in females as well as males. 
Lastly, the intensity of the brisk walk may not have been optimal hence it would be 
interesting to examine the effects of a higher intensity of exercise on postprandial TAG in 
South Asian participants.  
 
In conclusion, the findings of this study indicate notable elevations in postprandial lipaemia 
in response to high fat meals in South Asians compared with Europeans. Exercise had a 
borderline influence on postprandial lipaemia in the South Asian and European men 
examined in the present study. However, bearing in mind the low physical activity levels 
typical among South Asians and the exaggerated postprandial lipaemia observed here, 
further research into the potential of exercise for lowering postprandial lipaemia in South 
Asians would appear to be warranted.  
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5 The influence of a one hour treadmill run on coronary 
heart disease risk markers in South Asian and 
European men 
5.1 Introduction 
Coronary heart disease (CHD) is responsible for more deaths in the UK (Scarborough et al, 
2010), the USA (Roger et al, 2012), and globally (World Health Organisation (WHO, 2011)) 
than any other single cause and prevention and treatment of CHD remain a public health 
priority. The prevalence of CHD varies among nations and ethnic groups and one group who 
are particularly susceptible are South Asians; a heterogeneous group originating from the 
Indian sub-continent e.g. India, Pakistan, Bangladesh, Sri Lanka and Nepal. Possibly the first 
to highlight this issue were Danaraj and colleagues (1959) who reported a relatively high 
prevalence of CHD among Indian compared with Chinese people living in Singapore. More 
recent reports have confirmed high prevalence rates of CHD among South Asians living in 
the UK (Wild et al, 2007), the USA (Palaniappan et al, 2004) and Canada (Sheth et al, 1999) 
and estimates suggest a three to five fold increased risk of myocardial infarction and 
cardiovascular death among migrant South Asians compared with other ethnic groups (Eapen 
et al).  
 
A variety of interacting factors may explain the elevated risk of CHD in South Asians and 
one of these is physical inactivity. In their review of physical activity levels among South 
Asians living in the UK Fischbacher and colleagues (2004) identifed 12 studies in adults and 
five in children all of which reported lower levels of physical activity among UK South 
Asians than the general population. These findings have since been confirmed by data from a 
diabetes screening programme in Leicester, UK (Yates et al, 2010) and by the Health Survey 
for England (Williams et al, 2011). Moreover, it has been estimated that physical inactivity 
explains >20% of the excess CHD mortality experienced by UK South Asians even after 
adjustment for potential confounders including socioeconomic status, smoking, diabetes and 
existing cardiovascular disease (CVD) (Williams et al, 2011a). Outside of the UK the 
INTERHEART study found that only 6.1% of South Asians reported participation in 
moderate or high intensity exercise compared with 21.6% of participants from other countries 
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(Joshi et al, 2007). In light of such findings consensus physical activity guidelines for Asian 
Indians have recently been published in an attempt to promote physical activity among this 
group (Misra et al, 2012).  Despite the high prevalence of CHD and low levels of physical 
activity among South Asians few studies have examined the effects of physical 
activity/exercise on CHD or on risk factors for CHD in this group although observational 
evidence suggests a protective role of physical activity in South Asians (Rastogi et al, 2004).   
 
The study reported in the previous chapter is the first to evaluate the influence of an acute 
bout of exercise (i.e. brisk walking) on postprandial triacylglycerol (TAG) concentrations in 
South Asians. This study revealed that South Asians have higher postprandial TAG after a 
high fat meal than White Europeans. There was a trend for lower postprandial TAG 
concentrations after walking exercise (in comparison with control conditions) in South 
Asians but this was not significant. Among the possible reasons for the lack of an exercise 
effect in the previous study is the mode of exercise which may have provided insufficient 
energy expenditure to lower postprandial TAG.  
 
Hence the purpose of the present study was to examine the influence of a one-hour run on 
CVD risk markers in South Asian and European men to see if the higher energy expenditure 
elicited by the run would have any effect. The primary outcome variable in this study was 
postprandial TAG concentration but several other disease risk markers were examined 
including total cholesterol, high density lipoprotein cholesterol (HDL-C), glucose, insulin, 
interleukin-6 (IL-6) and soluble intercellular adhesion molecule-1 (sICAM-1).  
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5.2 Methods 
5.2.1 Participants 
With the approval of Loughborough University’s Ethics Advisory Committee 10 South Asian 
men and 10 men of white European descent were recruited and they gave their written 
informed consent to participate in this study. G Power (version 3.1.3, Franz Faul, Universitat 
Kiel, Germany) was used to calculate the study sample size and this indicated that 10 
participants per group would be sufficient to detect a difference in TAG AUC (the primary 
outcome variable) with a power of 0.8 and a 5% level of significance. When calculating 
power using G-power, postprandial AUC TAG values were used in preference to fasting 
TAG values. This was done due to the strong correlation between postprandial TAG levels 
and elevated risk of developing cardiovascular disease. Participants were healthy and 
recreationally active and ranged in age from 20 to 28 years. Participants were non-smokers, 
with no personal history of CVD or metabolic disease, and none of them reported taking 
medication. Participants had a BMI < 30 kg·m-2. They were not dieting and did not have any 
extreme dietary habits. To verify ethnicity each South Asian participant completed a form 
providing details of their place and country of birth, their mother tongue language, their 
religion and race, the country of their parents’ birth and their family history of migration. 
This revealed that seven of the participants were Indian nationals, two were UK Indians and 
one was from Pakistan.  
 
5.2.2 Anthropometry 
Prior to the main trials participants attended the laboratory for a screening and familiarization 
visit lasting approximately two hours. During this visit they completed a participant 
information form and questionnaires assessing health status, usual physical activity and 
ethnicity (South Asians only). Subsequently, weight was measured to the nearest 0.01 kg 
using a digital scale (Seca Ltd, Germany) and height was measured to the nearest 0.1 cm 
using a stadiometer (Avery Industrial Ltd, Leicester, UK). Skinfold thickness was measured 
with calipers (Harpenden, Burgess Hill, U.K.) on the right hand side of the body at the 
biceps, triceps, subscapular and suprailiac. The sum of these four skinfold measurements was 
used to determine body density (Durnin and Womersley, 1974) and body fat percentage (Siri, 
1956). In addition, waist circumference was determined at the narrowest part of the torso 
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above the umbilicus and below the xiphoid process using a measuring tape. Lastly, blood 
pressure was measured using a digital monitor (Omron M5-1, Matsusaka Co., Ltd, Japan).  
 
5.2.3 Preliminary exercise tests 
After familiarization with motorized treadmill running (RUNRACE, Techno gym, 
Gambettola, Italy) participants completed two preliminary exercise tests: a submaximal, 
incremental treadmill running test (to determine the relationship between running speed and 
oxygen uptake) and a maximal oxygen uptake ( maxOV 2 ) test. The submaximal test was 
performed on a level treadmill and involved four, four-minute stages of increasing intensity. 
Initial running speed was set between 6 and 9.5 km·h-1 and the speed was increased by 0.5 or 
1 km·h-1 (depending on each participant’s level of fitness) at the end of each stage. After a 30 
minute recovery, maxOV 2  was determined with the use of an incremental uphill protocol at 
a constant speed until participants reached volitional exhaustion (Taylor et al, 1955). The 
initial treadmill gradient was set at 3.5% for this test and the gradient was increased by 2.5% 
every 3 minutes. Short range telemetry (Sports tester PE3000, Polar Electro, Finland) was used 
to evaluate heart rate throughout both tests. Ratings of perceived exertion (RPE) were 
assessed periodically during these tests using the Borg scale (Borg, 1973).  
  
Expired air samples were collected into Douglas bags (Plysu Protection Systems, Milton 
Keynes, United Kingdom) during both of the preliminary exercise tests. An O2/CO2 analyser 
(Servomex 1440, Crowborough, Sussex, United Kingdom) was used to measure the oxygen 
and carbon dioxide percentages within the expired air samples. The analysers were calibrated 
using gases of known concentration prior to testing. A dry gas meter (Harvard Apparatus, 
Edenbridge, United Kingdom) was used to measure expired air volumes which were 
corrected to standard temperature and pressure dry. The oxygen consumption values from the 
two preliminary exercise tests were used together to determine the running speed required to 
elicit 70% of each participant’s maxOV 2 .  
 
5.2.4 Main trials 
Participants completed two, two day trials (exercise and control) in a random order separated 
by an interval of at least one week. Trials were undertaken in block random order (block size 
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of two) using software available at http://www.randomization.com/. On day one of the 
exercise trial, participants arrived at the laboratory between 8.00 and 9.00 am and rested 
(reading, working at a computer, watching television, listening to music or playing video 
games) throughout the day until 5.00 pm. Participants consumed a standardized lunch at 
approximately 12.00 pm. At 3.30 pm, participants performed a 60 minute run at a speed 
predicted to elicit 70% of their maxOV 2 . One minute samples of expired air were collected 
at 15 minute intervals during the run to monitor the exercise intensity i.e. minutes 14-15, 29-
30, 44-45 and 59-60 during the run. If necessary adjustments were made to the treadmill 
speed to ensure that participants were at the correct intensity. Heart rate and RPE were also 
monitored during the run. During day one of the control trial procedures were exactly the 
same as on day one of the exercise trial except that no running was performed and four, five-
minute resting expired air samples were collected at the time when running was performed on 
day 1 of the exercise trial. Oxygen consumption and carbon dioxide production were 
calculated from expired air samples as described previously. Energy expenditure was 
estimated from oxygen consumption and carbon dioxide production values using 
stoichiometric equations (Frayn, 1983).   
 
On day two of the main trials participants arrived at the laboratory between 7.45 and 8.00 am 
having fasted overnight (no food or drink except water) for 10 hours. On arrival at the 
laboratory, participants sat on a bed in a semi-supine position for 5 minutes while a cannula 
(BD Ven-flon, Becton-Dickinson, Helsingborg, Sweden) was inserted into an antecubital 
vein and a baseline blood sample was collected. Participants then consumed a prescribed test 
meal (see below) for breakfast. A clock was started the moment they commenced their meal 
and this was identified as the 0 hour. The trial continued on for nine hours during which a 
total of 14 (including the fasting sample), 9 mL venous blood samples were collected. At 4 
hours, a second test meal, identical to the first, was served to participants. Participants rested 
throughout day two of both the control and exercise trials and hence day two of these trials 
was identical. A schematic representation of the main trial protocol is displayed in Figure 5.1. 
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5.2.5 Control of diet and exercise 
The day before each main trial and on the first day of each main trial, participants recorded 
their food intake using a weighed food diary. Participants replicated this food intake for the 
next main trial. Participants were told not to consume tea, coffee, or alcohol on the day prior 
to and during the main trials. Participants were also asked to refrain from strenuous physical 
activity during the day preceding the main trials and on day 1 and day 2 of the main trials.  
 
5.2.6 Test meals 
The test meals consisted of white bread, butter, cheese, mayonnaise, crisps, chocolate milk 
shake powder and high fat milk. The amount of food consumed was adjusted for each 
participant based on their body weight and was kept constant throughout the trials. The 
macronutrient content of the test meal was 57% fat, 32% carbohydrate and 11% protein and 
each meal provided 60 kJ (14.3 kcal) per kg body mass for a 70 kg participant. Participants 
consumed each meal within 15 minutes and water was available ad libitum. 
 
5.2.7 Blood sampling 
Venous blood samples were collected for the measurement of total cholesterol, high density 
lipoprotein (HDL) cholesterol, TAG, glucose, insulin, IL-6 and sICAM-1. Samples were 
collected at 0, 0.25, 0.5, 1, 2, 3, 4, 4.25, 4.5, 5, 6, 7, 8, 9 hours. Total cholesterol and HDL 
cholesterol were only measured from baseline samples; IL-6 and sICAM-1 concentrations 
were measured from samples collected at 0, 3, 6 and 9 hours; glucose, insulin and TAG were 
measured from all samples. Participants rested in a semi-supine position during blood 
sampling. Venous blood samples were drawn into pre-cooled 9 mL EDTA monovette tubes 
(Starstedt, Leicester, United Kingdom) and immediately centrifuged at 1500 x g (3000 
revs/min) for 10 minutes in a refrigerated centrifuge (Burkard, Hertfordshire, United 
Kingdom) at 4ºC. The plasma supernatant was dispensed into eppendorf tubes and stored at -
80ºC before analysis. After each blood sample collection 10 mL of non-heparinised saline 
solution (0.9% (v/w) sodium chloride, Baxter Healthcare Ltd, Norfolk, United Kingdom) was 
flushed through the cannula to maintain cannula patency. Two mL of blood was drawn into a 
syringe and discarded at the start of each blood collection to prevent sample contamination 
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from saline. Haemoglobin and haematocrit values were used to estimate changes in plasma 
volume across the nine-hour main trial day (Dill and Costill, 1974).  
 
5.2.8 Blood biochemistry 
Plasma total cholesterol, HDL-C, TAG and glucose concentrations were determined 
spectrophotometrically using commercially available kits and a bench top analyser (Pentra 
400, HORIBA ABX Diagnostics, Montpellier, France). Enzyme linked immuno sorbent 
assays (ELISA) assays were used to determine the concentrations of plasma insulin 
(Mercodia, Sylveniusgatan, Uppsala, Sweden), IL-6 (high sensitivity kit; Diaclone, Besançon, 
France) and sICAM-1 (Diaclone, Besançon, France) with the aid of a plate reader (Expert 
Plus, ASYS, Eugendorf, Austria). To eliminate inter assay variation, samples from each 
participant were analysed in the same run. Coefficients of variation for each assay were as 
follows: 0.7% for total cholesterol, 0.7% for HDL-C, 3.0% for TAG, 0.5% for glucose, 6.0% 
for insulin, 3.4% for IL-6 and 4.9% for sICAM-1.   
 
5.2.9 Statistical analysis 
Data were analysed using Predictive Analytics Software version 18.0 for Windows (SPSS, 
Inc., Somers, NY, USA). Physical characteristics and exercise responses were compared 
between South Asians and Europeans using Students t-tests for independent samples. Three-
way repeated measures ANOVA with Bonferroni post-hoc tests was used to examine 
differences between trials for plasma constituents (TAG, glucose, insulin, IL-6 and sICAM-1) 
with the three factors being: a) trial (exercise versus control), b) ethnic group (South Asians 
versus Europeans) and c) time (serial measurements over 9 hours). Effect sizes (Cohen’s d) 
were also calculated for each of these variables by dividing the differences between the mean 
values (exercise versus control or South Asian versus European) with the standard deviation 
(i.e. the average standard deviation from both trials and ethnic groups combined). Area under 
the plasma concentration versus time curve (AUC) values were calculated for TAG, glucose, 
insulin, IL-6 and sICAM-1 using the trapezoidal method. These values were compared using 
two-way repeated measures ANOVA with the two factors being trial (exercise versus control) 
and ethnic group (South Asian versus European).  Two-way repeated measures ANOVA was 
also used to assess between trial and ethnic group differences for fasting plasma 
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concentrations. Statistical significance was accepted at the 5% level. Results are presented as 
mean ± SD in the text and tables and as mean ± SEM in figures. 
   Chapter 5 
 
l 
 ▏92 
5.3 Results 
5.3.1 Participant characteristics 
The physical characteristics of the participants are displayed in Table 5.1. There were no 
significant differences between South Asian and European participants for age, height, 
weight, BMI, waist circumference and resting diastolic blood pressure. Percentage body fat 
was higher in South Asians than Europeans while resting systolic blood pressure 
and maxOV 2  were lower in South Asians than in Europeans.    
 
Table  5.1: Participant characteristics.  
Variable South Asians       
(n = 10) 
Europeans        
(n = 10) 
P value 
Age (years)  22.3 ± 1.3 23.2 ± 2.0 0.259 
Height (cm)  173.0 ± 5.7 177.0 ± 6.0 0.133 
Weight (kg)   76.3 ± 9.1 79.2 ± 8.6 0.471 
Body mass index (kg·m-2)  25.4 ± 2.5 25.2 ± 1.6 0.818 
Body fat (%)  23.0 ± 4.4  16.4 ± 4.2 0.003 
Waist circumference (cm) 82.8 ± 4.9 80.0 ± 3.3 0.144 
Resting SBP (mm Hg)  128 ± 8  138 ± 11 0.032 
Resting DBP (mm Hg) 75 ± 8 76 ± 6 0.757 
maxOV 2  (mL·kg
-1·min-1)  48.2 ± 7.3  56.6 ± 6.7 0.015 
All values are mean ± SD. Means were compared using independent samples Student’s 
t-tests. SBP, systolic blood pressure; DBP, diastolic blood pressure; 2OV
  max, maximal 
oxygen uptake. 
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5.3.2 Responses to treadmill running 
The physiological responses to the 60 minute treadmill run are displayed in Table 5.2. The 
White European participants ran significantly faster and expended more energy during the 
run than the South Asian participants. There were no significant differences between groups 
in % 2OV  max, average heart rate, average RPE or substrate (carbohydrate/fat) utilisation 
attained during the run. There was a tendency for exercise 2OV  to be slightly higher in White 
Europeans than South Asians.  
  
Table  5.2: Responses to treadmill running.  
Variable 
 
South Asians 
(n = 10) 
Europeans 
(n = 10) 
P value 
Running speed (km·h-1) 7.6 ± 1.4 9.6 ± 1.6 0.008 
2OV  (mL·kg
-1·min-1)  35.5 ± 5.6 39.9 ± 4.4 0.061 
% maxOV 2  (mL·kg
-1·min-1) 73.5 ± 4.5 70.6 ± 2.2 0.087 
Average heart rate (beats·min-1) 172 ± 14 172 ± 20 0.958 
Rating of perceived exertion 12 ± 2 12 ± 1 0.347 
Respiratory exchange ratio 0.93 ± 0.06 0.97 ± 0.06 0.300 
Exercise energy expenditure (kJ·h-1) 3313 ± 623 3901 ± 473 0.029 
% Energy from fat 22.2 ± 20.3 11.6 ± 20.8 0.265 
% Energy from carbohydrate 77.8 ± 20.3 88.4 ± 20.8 0.265 
All values are mean ± SD. Means were compared using independent samples Student’s t-
tests. 2OV , volume of oxygen consumed; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; 2OV
  max, maximal oxygen uptake. 
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5.3.3 Fasting plasma concentrations 
There were significant main effects of trial for fasting total cholesterol, TAG and sICAM-1 
indicating lower values on the exercise trial for fasting total cholesterol and TAG and higher 
values for fasting sICAM-1 (Table 5.3). There were significant main effects of group for 
fasting plasma insulin, HDL-C and the ratio of total cholesterol/HDL-C indicating higher 
insulin and total cholesterol/HDL-C concentrations in the South Asian than the European 
participants and lower HDL-C concentrations in the South Asian participants. There was a 
tendency (P = 0.074) for fasting TAG to be elevated in the South Asian participants.  
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5.3.4 Postprandial plasma concentrations 
Three-way ANOVA revealed main effects of group for TAG (P < 0.001), insulin (P < 0.010) 
and glucose (P < 0.05) indicating higher postprandial TAG and insulin values in South Asian 
participants and higher postprandial glucose values in European participants (Figure 5.2). The 
effect sizes for these ethnic group comparisons were all large: 1.22, 1.06 and 0.85 
respectively. Body fat percentage was higher in the South Asian participants than the 
European participants and this might confound the relationship between ethnicity and plasma 
concentrations, therefore, three-way ANOVA was conducted a second time with body fat 
added as a covariate to remove its confounding influence. Between group differences 
remained significant for TAG and glucose but were not significant for insulin after control for 
percentage body fat.  
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Figure  5.2:  Mean ± (SEM) postprandial plasma triacylglycerol (top panel), glucose (middle 
panel) and insulin (bottom panel) concentrations measured on day two of the exercise and 
control trials for South Asian (n=10) and European (n=10) men. Data were analysed using 
three-way repeated measures ANOVA. There were significant main effects of trial (P = 
0.001) for triacylglycerol and significant main effects of ethnicity for triacylglycerol (P = 
0.001), glucose (P = 0.043) and insulin (P = 0.010). There was also a trial x ethnicity effect 
for triacylglycerol (P = 0.031).    
   Chapter 5 
 
l 
 ▏98 
Three-way ANOVA revealed main effects of trial for TAG (P < 0.001), IL-6 (P < 0.003) and 
sICAM-1 (P < 0.001) indicating that TAG (Figure 5.2) and IL-6 (Figure 5.3) concentrations 
were lower on the exercise trial while sICAM-1 concentrations were higher on the exercise 
trial (Figure 5.3). The effect size for these comparisons (based on AUC values) was medium 
for TAG (0.52) and IL-6 (0.55) and large for sICAM-1 (1.04).  
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Figure  5.3: Mean ± (SEM) postprandial plasma concentrations of soluble intercellular 
adhesion molecule-1 (sICAM-1) and interleukin-6 (IL-6) measured on day two of the 
exercise and control trials for South Asian (n=10) and European (n=10) men. Data were 
analysed using three-way repeated measures ANOVA. A main effect of trial was observed 
for sICAM-1 (P < 0.001) and IL-6 (P = 0.003). There were no main effects for ethnicity. 
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Trial and ethnic group differences were confirmed when assessing AUC values using two-
way ANOVA (Table 5.4). Again plasma TAG and insulin concentrations were higher in 
South Asian participants while plasma glucose concentrations were higher in European 
participants. The TAG and IL-6 lowering effects of exercise were also confirmed as was the 
exercise induced elevation in sICAM-1. Finally, a significant trial by group interaction effect 
was observed for TAG indicating a greater decrease after exercise in the South Asian men 
than the European men (22% versus 10%).    
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Figure 5.4 displays the difference in the TAG AUC values between the exercise and the 
control trials for each participant. Negative values indicate a lowering of postprandial TAG 
concentration on the exercise trial. This figure demonstrates that postprandial TAG 
concentration was lower on the exercise trial in nine out of 10 South Asian participants and 
eight out of 10 European participants. It is also clear from the figure that the TAG lowering 
effect of exercise is greater in the South Asian than in the European participants.  
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5.4 Discussion 
 The novel findings arising from this study are: 1) postprandial plasma TAG concentrations 
were elevated to a much greater extent in the South Asian men than in the European men in 
response to high fat meals; 2) exercise was equally effective if not more so for lowering 
postprandial plasma TAG concentrations in the South Asian men than in the European men. 
Another key finding arising from this study is that postprandial plasma insulin concentrations 
were higher in the South Asian men than in the European men. No ethnic group differences 
were apparent for IL-6 and sICAM-1 but postprandial plasma IL-6 concentrations were lower 
after exercise while postprandial sICAM-1 concentrations were higher.  
 
The most striking finding from this study is the clear elevation in postprandial TAG 
concentrations in response to high fat meals in the South Asian participants compared with 
the White European participants. Previous studies have observed higher fasting TAG 
concentrations in South Asians than in white people (Anand et al, 2000; Tziomalos et al, 
2008) but there are no published reports of exaggerated postprandial TAG in response to high 
fat meals in South Asians. The findings in the present study are consistent with those reported 
in the previous chapter. Importantly, individuals with exaggerated postprandial TAG are 
more susceptible to CVD and the findings of the present study suggest that exaggerated 
postprandial lipaemia may be prevalent among South Asian people exposed to high fat diets. 
Interestingly, one other study which has compared postprandial lipaemia in South Asians and 
Europeans did not observe a difference in the lipaemic response to high fat meals although 
postprandial glucose and insulin concentrations were elevated in South Asians (Cruz et al, 
2001). A possible explanation for these different findings is that percentage body fat did not 
differ between ethnic groups in the study conducted by Cruz and colleagues (2001) whereas 
body fat percentage was higher in the South Asian participants in the present study as is often 
the case (Wang et al, 1994). Nevertheless, between group differences in postprandial 
lipaemia remained significant in the present study even after controlling for differences in 
percentage body fat. Another possible explanation for the disparate findings is the test meals 
used. The percentage fat provided in the test meals was similar between studies (52% of 
energy from fat in the study by Cruz and colleagues (2001) versus 57% of energy from fat in 
the present study) but the total amount of food consumed (which is not stated in the paper by 
Cruz and colleagues) may have differed.  
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Another important finding from the present study is the effectiveness of running exercise for 
lowering postprandial TAG concentrations in the South Asian participants. The finding that 
postprandial TAG concentrations are lowered by a single session of prior exercise has been 
reported in many previous studies (for a review see Katsanos (2006)) but the present study is 
the first to report this in South Asians. Exercise was particularly effective in the South Asian 
group eliciting a 22% reduction in the TAG AUC values compared with only a 10% 
reduction in the European participants. This difference in the apparent effectiveness of 
exercise may have been due to the elevated TAG values in the South Asian participants i.e. 
higher values may provide a greater potential for reductions. Despite the effectiveness of 
exercise in the South Asian participants it is important to note that their TAG AUC values 
were still 33% higher after exercise than the control trial values exhibited by the European 
participants. If these findings are replicated in larger samples they would suggest that South 
Asians are at a much higher risk of experiencing exaggerated postprandial lipaemia in 
response to high fat meals than Europeans and this may be a contributing factor to their 
elevated risk of CHD.   
 
In addition to elevated postprandial TAG concentrations, fasting insulin concentrations were 
nearly six times higher and postprandial insulin concentrations were nearly three times higher 
in the South Asian versus the European participants. These differences suggest a degree of 
insulin resistance in the South Asian participants and this is consistent with the findings of 
Cruz and colleagues (2001). Insulin resistance is thought to be a major contributor to the 
increased risk of type 2 diabetes and CHD experienced by those of South Asian descent 
(Sandeep et al, 2011; Tziomalos et al, 2008). Hyperinsulinaemia resulting from insulin 
resistance is thought to decrease muscle lipoprotein lipase activity (Pollare et al, 1991) and 
this would impair one of the major mechanisms for removal of TAG from blood. Thus, it is 
possible that the elevated postprandial lipaemia exhibited by the South Asian participants in 
the present study is linked to their elevated plasma insulin concentrations.  
 
Surprisingly, and in contrast to the differences noted for insulin, there was a small but 
significant difference in postprandial plasma glucose concentrations between ethnic groups 
with higher values in the European participants. This finding conflicts with that of Cruz and 
colleagues (2001) who observed higher postprandial glucose concentrations in South Asian 
participants and also with the finding that fasting glucose concentrations are elevated in those 
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of South Asian descent (Anand et al, 2000). It is possible that the difference observed in the 
present study is a random (chance) finding. Aside from this finding the other differences 
observed between ethnic groups are consistent with previous research (Anand et al, 2000, 
Tziomalos et al, 2008) i.e. South Asian participants in the present study had a tendency for 
higher fasting TAG concentrations, higher fasting total cholesterol to HDL-C ratio values and 
lower fasting HDL-C concentrations. These findings indicate a higher risk of CHD in the 
South Asian participants (Joshi et al, 2007).  
     
Interleukin-6 and sICAM-1 were assessed in the present study because both are indicative of 
chronic low grade inflammation which in turn is associated with an increased risk of type 2 
diabetes and CHD (Hwang et al, 1997; Libby et al, 2002; Ridker et al, 1998). It has been 
suggested that an increased predisposition to chronic low grade inflammation, due to higher 
visceral and overall adiposity, might explain the elevated CHD risk in South Asians but the 
evidence to support this proposal is equivocal (Tziomalos et al, 2008). There were no 
differences in IL-6 and sICAM-1 between the South Asian and European men in the present 
study but IL-6 concentrations were suppressed the day after exercise while sICAM-1 
concentrations were elevated. It is well documented that exercise causes a transient increase 
in the myokine IL-6 and this is known to stimulate an anti-inflammatory cascade involving 
increased concentrations of IL-10 and IL-1 receptor antagonist (Petersen and Pedersen, 2005; 
Gleeson et al, 2011). The lower IL-6 concentrations observed the day after exercise are 
possibly reflective of an anti-inflammatory effect of exercise subsequent to an initial increase 
in IL-6. The elevated sICAM-1 concentrations are probably related to an increased blood 
shear stress during exercise and it is clear that this elevation lasts for at least 24 h although 
the significance of this elevation is uncertain. Finally, there was a small but significant 
reduction in fasting total cholesterol concentration the day after exercise in the present study. 
If genuine this represents a beneficial influence of exercise but this is not a consistent finding 
in the literature and hence caution is warranted when interpreting this outcome.    
 
This study had three notable limitations. Firstly, the sample size is small and hence these 
findings require confirmation with a larger sample. Secondly, it is possible that the group 
differences observed here are confounded by the differences in percentage body fat although 
South Asians are known to have a higher body fat percentage for a given BMI (Wang et al, 
1994) and this may explain in part their elevated CHD risk. Thirdly, most of the participants 
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in the present study were Indian South Asians and South Asians are a heterogeneous group 
and hence these findings require confirmation in other South Asian groups (e.g. Bangladeshis 
and Pakistanis) and also in South Asian females.   
 
In conclusion; the findings of this study indicate striking elevations in postprandial lipaemia 
in response to high fat meals in South Asian men. This study also demonstrates that running 
exercise is effective for lowering postprandial lipaemia in South Asian men. The relationship 
between elevated postprandial lipaemia and CHD risk in South Asians and the role of 
exercise in lowering postprandial lipaemia and CHD risk in South Asians should be a priority 
for future research.   
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6 The effects of a single bout of running versus three 
consecutive days of running on postprandial lipaemia 
in men of South Asian descent  
6.1 Introduction 
Cardiovascular disease is a major cause of death in the UK (British Heart Foundation, 
2010), the USA (American Heart Association, 2012) and globally (World Health 
Organisation, 2011). South Asians regardless of where they live experience a higher rate of 
CHD than the general population. High morbidity and mortality rates from CVD/CHD in 
South Asians have been identified in Singapore (Danaraj et al, 1959), South Africa 
(Adelstein, 1963), Canada (Sheth et al, 1999), the USA (Palaniappan et al, 2004), and the 
UK (Wild et al, 2007). Estimates suggest a three to five fold increased risk of myocardial 
infarction and cardiovascular death among migrant South Asians compared with other 
ethnic groups (Eapen et al, 2009) and South Asians are generally younger when affected by 
CVD (Ramaraj & Chellappa, 2008). The reasons for these are uncertain.  
 
Genetics and/or environment (diet, physical activity, psychosocial, socio-economic 
conditions, etc.) may act as catalysts inducing CVD in South Asians. One under researched 
environmental factor is physical inactivity which represents an independent vascular risk 
factor (Yusuf et al, 2004; Rastogi et al, 2004; Mohan et al, 2005; Rao et al, 2012) and can 
assist in preventing CVD and promoting and maintain health (Pearson et al, 2002; Haskell 
et al, 2007). Lower physical activity levels have been recorded in South Asian compared 
with white populations (Fischbacher et al, 2004, Owen et al, 2009; Yates et al, 2010; 
Williams et al, 2011; Misra et al, 2012). Levels of physical activity are inversely correlated 
with BMI, waist circumference, glucose and insulin levels in South Asians and Europeans 
(Hayes et al, 2002). Yet, there remains little evidence of successful exercise interventions 
among South Asians.   
 
It is not uncommon for people in industrialised nations to spend considerable time each day 
in a postprandial state and this is critical because high TAG concentrations are a strong and 
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independent predictor for CVD risk (Nordestgaard et al, 2007; Bansal et al, 2007). The 
vascular complications associated with exaggerated postprandial lipaemia and its clinical 
relevance, given that the development of atherosclerosis is initiated at a young age, is vital 
in addressing CVD (Sternby et al, 1999; McGill et al, 2000).  
 
Studies have shown that a single bout of aerobic exercise reduces postprandial lipaemia 
(Miyashita et al, 2006; Miyashita et al, 2008; Miyashita et al, 2008a; MacEneaney et al, 
2009; Hurren et al, 2011). However, this reduction appears to be transient since detraining 
leads to a prompt elevation in postprandial lipaemia (Hardman et al, 1998). Therefore, for 
continued benefit exercise must be performed regularly. In addition, insulin action is 
enhanced in people who exercise regularly and vigorously and a reversal of this action 
takes place when individuals stop exercising (Leblanc et al, 1979). The exercise induced 
improvement in insulin action and glucose tolerance lasts for approximately 3 days (King 
et al, 1995). 
 
Only one study has compared the effect of a single bout of exercise with that of bouts of 
exercise on three consecutive days on postprandial lipaemia and this study was conducted 
in overweight/obese European men (Farah et al, 2010). The exercise duration ranged from 
65 minutes to 110 minutes per participant in this study and the investigators observed a 
reduction in postprandial TAG in both exercise trials compared with a control trial. Hence, 
the present study sought to examine this exercise protocol in men of South Asian descent 
using an exercise duration of 30 minutes (as recommended by the American College of 
Sports Medicine and the American Heart Association (Haskell et al, 2007)). In addition, 
this study also examined the effects of exercise on fasting and postprandial glucose 
concentrations, and on fasting total cholesterol, fasting high density lipoprotein cholesterol 
(HDL-C), fasting low density lipoprotein cholesterol (LDL-C), the fasting total 
cholesterol/HDL-C ratio and resting systolic and diastolic blood pressure.   
 
 
   Chapter 6 
 
 ▏110 
6.2 Methods 
6.2.1 Participants 
With the approval of Loughborough University’s Ethics Advisory Committee 11 South 
Asian men were recruited and they gave their written informed consent to participate in this 
study. The study sample size was calculated using G Power (version 3.1.3, Franz Faul, 
Universitat Kiel, Germany) which indicated that for the primary outcome variable (TAG) 14 
participants would be sufficient to detect a difference in TAG with a power of 0.8 and a 5% 
level of significance. When calculating power using G-power, postprandial AUC TAG 
values were used in preference to fasting TAG values. This was done due to the strong 
correlation between postprandial TAG levels and elevated risk of developing 
cardiovascular disease. Participants were healthy and recreationally active and ranged in 
age from 18 to 28 years. Participants were non-smokers, with no personal history of CVD 
or metabolic disease, and none of them reported taking medication. They had a BMI < 30 
kg·m-2. Participants were not dieting and did not have any extreme dietary habits. To verify 
ethnicity each South Asian participant completed a form providing details of their place 
and country of birth, their mother tongue language, their religion and race, the country of 
their parents’ birth and their family history of migration. This revealed that six of the 
participants were Indian nationals, three were UK Indians and two were Sri Lankans from 
Sri Lanka.  
 
6.2.2 Anthropometry 
Prior to the main trials participants attended the laboratory for a screening and 
familiarization visit lasting approximately two hours. During this visit they completed a 
participant information form and questionnaires assessing health status, usual physical 
activity and ethnicity. Subsequently, weight was measured to the nearest 0.01 kg using a 
digital scale (Seca Ltd, Germany) and height was measured to the nearest to 0.1 cm using a 
stadiometer (Avery Industrial Ltd, Leicester, UK). Skinfold thickness was measured with 
calipers (Harpenden, Burgess Hill, U.K.) on the right hand side of the body at the biceps, 
triceps, subscapular and suprailliac. The sum of these four skinfold measurements was used 
to determine body density (Durnin & Wormersley, 1974) and body fat percentage (Siri, 
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1956). In addition, waist circumference was determined as the narrowest part of the torso 
above the umbilicus and below the xiphoid process using a measuring tape.  
 
6.2.3 Preliminary exercise tests 
After familiarization with motorized treadmill running (RUNRACE, Techno gym, 
Gambettola, Italy) participants completed two preliminary exercise tests: a submaximal, 
incremental treadmill running test (to determine the relationship between running speed 
and oxygen uptake) and a maximum oxygen uptake ( maxOV 2 ) test. The submaximal test 
was performed on a level treadmill and involved four, four-minute stages of increasing 
intensity. Initial running speed was set between 5.5 and 8 km·h-1 and the speed was 
increased by 0.5 or 1 km·h-1 (depending on each participant’s level of fitness) at the end of 
each stage. After a 30 minute recovery, maxOV 2  was determined with the use of an 
incremental uphill protocol at a constant speed until participants reached volitional 
exhaustion (Taylor, Buskirk and Henschel, 1955). The initial treadmill gradient was set at 
3.5% for this test and the gradient was increased by 2.5% every 3 minutes. Short range 
telemetry (Polar T31; Polar Electro, Kempele, Finland) was used to evaluate heart rate 
throughout both tests. Ratings of perceived exertion (RPE) were assessed periodically 
during these tests using the Borg scale (Borg, 1973).  
  
Expired air samples were collected into Douglas bags (Plysu Protection Systems, Milton 
Keynes, United Kingdom) during both of the preliminary exercise tests. An O2/CO2 
analyser (Servomex 1440, Crowborough, Sussex, United Kingdom) was used to measure 
the oxygen and carbon dioxide percentages within the expired air samples. The analysers 
were calibrated using gases of known concentration prior to testing. A dry gas meter 
(Harvard Apparatus, Edenbridge, United Kingdom) was used to measure expired air 
volumes which were corrected to standard temperature and pressure dry. The oxygen 
consumption values from the two preliminary exercise tests were used together to 
determine the running speed required to elicit 70% of each participant’s 2OV max. 
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6.2.4 Main trials 
Participants completed three main experimental trials each over 4 days. These were: one-
day exercise (1-D Ex), three-day exercise (3-D Ex) and resting (control). These trials were 
conducted in a random order and separated by an interval of at least one week. Trials were 
undertaken in block random order (block size of one) using software available at 
http://www.randomization.com/. During the 1-D Ex trial, participants rested on days 1 and 
2. On day 3, they arrived at the laboratory at 2.30 pm. After resting for an hour participants 
performed a 30 minute treadmill run at a speed predicted to elicit 70 % of their 2OV max. 
A 30 minute treadmill duration was chosen because this duration has been shown to be 
effective for lowering postprandial lipaemia in European participants (Miyashita et al, 
2006) and also to minimise the potential for injury with longer bouts. One minute samples 
of expired air were collected at 10 minute intervals during the run to monitor the exercise 
intensity i.e. minutes 9-10, 19-20 and 29-30 during the run. If it was necessary adjustments 
were made to the treadmill speed to ensure that participants were at the correct intensity. 
Heart rate and RPE were also monitored during the run. During the control trial, 
participants rested from day 1 to day 3 and on day 3, procedures were exactly the same as 
on day 3 of the 1-D Ex trial except that no running was performed. Two, five minute 
resting expired air samples were collected at the time when running was performed on day 
3 of the 1-D Ex trial i.e. between 3.30 pm and 4.00 pm equivalent to minutes 10-15 and 25-
30. The 3-D Ex procedures were also identical to the 1-D Ex trial with the addition of 30 
minute runs on days 1 and 2. Oxygen consumption and carbon dioxide production were 
determined from expired air samples as described for the preliminary exercise trials. 
Energy expenditure was estimated from oxygen consumption and carbon dioxide 
production values using stoichiometric equations (Frayn, 1983). 
 
On day 4 of each main trial participants arrived at the laboratory by 8.30 am having fasted 
overnight (no food or drink except water) for 10 hours. On arrival, participants’ body mass 
was measured. They then sat on a bed in a semi-supine position for 10 minutes after which 
a 5 minute expired air sample was collected. After the baseline expired air sample a 
cannula (BD Ven-flon, Becton-Dickinson, Helsingborg, Sweden) was inserted into an 
antecubital vein and a baseline blood sample was collected. After this, baseline resting 
blood pressure was measured using a digital monitor (Omron M5-1, Matsusaka Co., Ltd, 
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Japan). Participants then consumed a prescribed test meal for breakfast (see details below). 
A clock was started the moment participants commenced their meal and this was identified 
as 0 hour. The trial continued on for seven hours during which a total of 10 (including the 
fasting sample), 9 mL venous blood samples were collected. At 3 hours, a second test meal, 
identical to the first, was served to participants. Further measurements of blood pressure 
were performed at hourly intervals for 7 hours after the start of breakfast. Additional 5 
minute expired air samples were collected at 1 h, 3 h, 4 h and 7 h). Participants rested 
throughout day four of the main trials and hence the final day of each experimental trial 
was identical. A schematic representation of the main trial protocol is displayed in Figure 
6.1. 
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6.2.5 Control of diet and exercise 
The day before day 4 of each main trial participants recorded their food intake using a 
weighed food diary. Participants replicated this food intake on the day prior to each of the 
subsequent main trials. Participants were told not to consume coffee, tea or alcohol on the 
day prior to and during the main trials. They were also asked to refrain from strenuous 
physical activity (other than that performed as part of the study) on the day prior to and on 
all four days of each main trial).  
 
6.2.6 Test meals 
The meals consisted of white bread, butter, cheese, mayonnaise, crisps, chocolate milk 
shake powder and high fat milk. The amount of food consumed was adjusted for each 
participant based on their body weight and was kept constant throughout the trials. The 
macronutrient content of the test meal was 57% fat, 32% carbohydrate and 11% protein and 
each meal provided 60 kJ (14.3 kcal) per kg body mass for a 70 kg participant. Participants 
consumed each meal within 20 minutes and water was available ad libitum. 
 
6.2.7 Blood sampling 
Venous blood samples were collected for the measurement of total cholesterol, high density 
lipoprotein cholesterol (HDL-C), TAG and glucose. Samples were collected at 0, 0.5, 1, 2, 
3, 3.5, 4, 5, 6 and 7 hours. Total cholesterol and HDL-C were only measured from baseline 
samples; TAG and glucose were measured from all samples. Participants rested in a semi-
supine position during blood sampling. Venous blood samples were drawn into pre-cooled 
9 mL EDTA monovette tubes (Starstedt, Leicester, United Kingdom) and immediately 
centrifuged at 1500 x g (3000 revs/min) for 10 minutes in a refrigerated centrifuge 
(Labofuge 400R, Thermo Scientific, Langenselbold, Germany) at 4ºC. The plasma 
supernatant was dispensed into eppendorf tubes and stored at -20ºC before analysis. After 
each blood sample collection 10 mL non-heparinised saline solution (0.9% (v/w) sodium 
chloride, Baxter Healthcare Ltd, Norfolk, United Kingdom) was flushed through the 
cannula to maintain cannula patency. Two mL of blood was drawn into a syringe and 
discarded at the start of each blood collection to prevent sample contamination from saline. 
Prior to the centrifugation of the blood samples at baseline and at seven hours, two 20 µL 
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blood samples were collected from monovettes into micropipettes for the measurement of 
haemoglobin and three 20 µL blood samples were collected from monovettes into 
microhaematocrit tubes for the measurement of haematocrit. Haemoglobin and haematocrit 
values were used to estimate changes in plasma volume across the seven-hour main trial 
day (Dill and Costill, 1974).  
 
6.2.8 Blood biochemistry 
Plasma total cholesterol, HDL-C, TAG and glucose concentrations were determined 
spectrophotometrically using commercially available kits and a bench top analyser (Pentra 
400, HORIBA ABX Diagnostics, Montpellier, France). To eliminate inter assay variation, 
samples from each participant were analysed in the same run. Coefficients of variation for 
each assay were as follows: 1.9% for total cholesterol, 3.1% for HDL-C, 3.2% for LDL-C, 
2.8 % for TAG and 0.6 % for glucose.   
 
6.2.9 Statistical analysis 
Data was analysed using Predictive Analytics Software version 18.0 for Windows (SPSS 
Inc., Somers, NY, USA). Exercise responses were compared between the two experimental 
trials using t - tests for paired samples. Two-way repeated measures ANOVA was used to 
examine differences between trials for plasma constituents (TAG and glucose) and blood 
pressure with the two factors being: a) trial (exercise 1-D, exercise 3-D and control) and b) 
time: (serial measurements over 7 hours). Effect sizes (Cohen’s d) were also calculated for 
each of these variables by dividing the difference between the mean values (exercise versus 
control) with the average standard deviation from the respective trials combined). Area 
under the plasma concentration versus time curve (AUC) values were calculated for TAG 
and glucose using the trapezoidal method. These values were compared using one-way 
repeated measures ANOVA. One-way repeated measures ANOVA was also used to assess 
between trial differences for fasting plasma metabolite concentrations. Statistical 
significance was accepted at the 5% level. Results are presented as mean ± SD in the text 
and tables and as mean ± SEM in figures. 
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6.3 Results 
6.3.1 Participant characteristics 
The physical characteristics of the participants are displayed in Table 6.1. 
 
 
Table  6.1: Physical characteristics of South Asian men . 
 
Variables 
    
South Asians (n=11) 
 
Age (years)   22.3 ± 2.8 
Height (cm)   175.3 ± 7.2 
Weight (kg)    73.1 ± 11.4 
Waist circumference (cm)  77.2 ± 8.5 
Body mass index (kg·m-2)   23.8 ± 3.2 
Body fat (%)   18.4 ± 5.3 
Resting SBP (mm Hg)   124 ± 9 
Resting DBP (mm Hg)  74 ± 8 
maxOV 2  (mL·kg
-1·min-1)   52.4 ± 5.8 
Data are displayed as mean ± SD. SBP = systolic blood pressure; DBP = diastolic  
blood pressure; maxOV 2 = maximum oxygen uptake. 
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6.3.2 Responses to treadmill running 
The physiological responses to the 30 minute runs during the 1-D Ex and 3-D Ex trials are 
displayed in Table 6.2. Participants ran significantly faster during the 3-D Ex than the 1-D 
Ex trials. A few of the participants experienced a ‘training effect’ and thus their running 
speed had to be increased to elicit 70% of maxOV 2 . There was also a tendency for 
exercise 2OV , percentage maxOV 2  and energy expenditure to be slightly higher during 
the 3-D Ex trial than the 1-D Ex trial. There were no significant differences between 
exercise trials for respiratory exchange ratio, substrate (carbohydrate/fat) utilization, 
average heart rate and RPE. 
 
 
Table  6.2: Responses during the 30 minute treadmill runs (n = 11).  
 
Variable 
 
 
1-Day Ex 
 
  
3-Day Ex 
 
P value 
Speed (km·h-1) 8.0 ± 1.0  8.3 ± 1.2 0.022 
2OV  (mL·kg
-1·min-1)  35.7 ± 3.8  37.1 ± 4.1 0.067 
% 2OV  max 68.4 ± 5.1  70.9 ± 2.8 0.071 
Respiratory Exchange ratio 0.95 ± 0.05  0.95 ± 0.04 0.690 
Energy Expenditure (kJ·h-1) 1571 ± 195  1632 ± 200 0.092 
Net Energy Expenditure (kJ·h-1) 1396 ± 169  1458 ± 173 0.091 
% Energy Fat 16.8 ± 16.7  18.0 ± 14.2 0.736 
% Energy Carbohydrate 83.2 ± 16.7  82.0 ± 14.2 0.736 
Average Heart Rate (beats·min-1) 174 ± 10.1  172 ± 11.9 0.508 
Rating of Perceived Exertion 11.3 ± 2.0  11.9 ± 2.0 0.237 
Data are displayed as mean ± SD.  For the 3-Day Ex trial the mean of three values was 
used. P values for differences between one day exercise and three day exercise trials are 
based on paired samples t tests. 2OV  = volume of oxygen consumed.  
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6.3.3 Fasting plasma metabolite concentrations 
Fasting concentrations of plasma metabolites (on day four of the main trials) are displayed 
in Table 6.3. There were no significant differences between trials for total cholesterol, 
HDL-C, LDL-C, total cholesterol/HDL-C, TAG or glucose.  
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6.3.4 Postprandial plasma metabolite concentrations 
Two-way ANOVA did not reveal any differences between trials for plasma TAG and 
glucose but a significant (P < 0.001) effect of time was observed for both these metabolites 
(Figure 6.2, Table 6.4). The effect sizes for TAG were small for all comparisons ≤ 0.24. 
Likewise, the effect sizes for glucose were small for all comparisons ≤ 0.06. 
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Figure  6.1: Postprandial plasma triacylglycerol (top panel) and glucose (bottom panel) 
concentrations measured on day four of the exercise and control trials (n=11). Data are 
displayed as mean ± SEM. 
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Figure 6.3 displays the difference in the TAG AUC values between the 1-D Ex and control 
trials and the 3-D Ex and control trials for each individual participant. Negative values 
indicate a lowering of postprandial TAG concentration on the exercise trial compared with 
the control trial. This figure demonstrates that postprandial TAG concentration was 
lowered in 6 out of 11 participants in the 1-D Ex trial and 8 out of 11 participants in the 3-
D Ex trial.  
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6.3.5 Resting blood pressure responses 
Resting systolic blood pressure (SBP) and diastolic blood pressure (DBP) values are shown 
in Figure 6.4. Two-way ANOVA did not reveal any main effects of trial for SBP or DBP 
but a significant effect of time was observed for both: P = 0.006 for SBP and P = 0.024 for 
DBP.  
 
 
Figure  6.3: Resting systolic and diastolic blood pressure measured on day four of the 
exercise and control trials (n=11). Data are displayed as mean ± SEM. 
 
 
 
   Chapter 6 
 
 ▏127 
6.3.6 Resting energy expenditure during main trials (day 4) 
There were no differences in resting energy expenditure or substrate oxidation during day 
four of the 1-D Ex and 3-D Ex trials when compared with the control trial. 
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6.4 Discussion 
The main finding in the present study is that neither a single bout of exercise nor three 
consecutive days of exercise influenced postprandial TAG in response to high fat meals 
when compared with the response on a control trial. These findings are in contrast to a 
study by Farah and colleagues (2010) who examined the effects of exercise on postprandial 
responses to ad libitum feeding in overweight/obese men and observed that TAG total 
AUC was 27% lower in 1-D Ex and 25% lower in 3-D Ex trials compared with a control. 
The present study also failed to identify differences in fasting plasma TAG and fat 
oxidation in either exercise trials in comparison with the control trial. These results are also 
in conflict with those of Farah and colleagues (2010). Fasting TAG were 17% lower in 1-D 
Ex and 15% lower in 3-D Ex trials, whereas, fat oxidation was 16% higher in 1-D Ex and 
39% higher in 3-D Ex trials in comparison with the control trial (Farah et al, 2010). 
 
These findings indicate that the duration of the aerobic exercise, 30 minutes of treadmill 
running at 70% 2OV  max, may not have been effective considering the adiposity and lipid 
profile of the South Asian participants. South Asians are known to have a higher body fat 
percentage for a given body mass index (Wang et al, 1994) and for their predisposition to 
an adverse lipid profile (Tziomalos et al, 2008). In Farah and colleagues’ (2010) study, the 
participants exercised at 50% of 2OV  max for between 65 and 110 minutes expending 
33.5 kJ·kg-1 body mass. Another study showed a significantly greater reduction in 
postprandial plasma TAG (23%) after a 2 hour exercise bout compared with a 1 hour 
exercise bout (9%) at 50% of 2OV  max (Gill et al, 2002) indicating that the duration of 
exercise is an important factor determining the reduction in postprandial lipaemia. It was 
thought that a higher intensity of exercise may have compensated for the shorter exercise 
duration in the present study but this does not appear to be the case. Thus, perhaps the 
South Asians in the present study did not expend sufficient energy to elicit a reduced 
lipaemic response. In the present study average energy expenditure during the 30 minute 
exercise bouts was 1571 kJ in the 1 D Ex trial and 1632 kJ in the 3 D Ex trial. In previous 
studies examining the acute effects of exercise on postprandial lipaemia, the average gross 
energy expenditure found to attenuate the lipaemic response ranged from 1500 kJ to 7200 
kJ (Petitt & Cureton, 2003). Confirming this, the study presented in the previous chapter 
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demonstrated a significant lowering of postprandial TAG after a 60 minute treadmill run in 
South Asians. The exercise energy expenditure of the South Asians in the study reported in 
the previous chapter was 3313 kJ which is over twice as high as the energy expenditure in 
the present study. 
 
Many studies have demonstrated significantly lower postprandial TAG responses after an 
acute bout of exercise (Tsetsonis et al, 1996; Gill et al, 2001; 2003; 2004; Miyashita et al, 
2006; Miyashita et al, 2008; Miyashita et al, 2008a; MacEneaney et al, 2009; Farah et al, 
2010; Hurren et al, 2011). Similarly, Farah and colleagues’ 3-D Ex trial elicited a 
significant lowering of postprandial plasma TAG. Thus, the disparate findings of the 
present study where there was no difference between the exercise trials and the control trial 
is perplexing. However, some previous studies have failed to show a lowering of 
postprandial lipaemia in response to exercise. For example, attenuation of postprandial 
lipaemia was not evident 60 hours after exercise in individuals with normal fasting plasma 
TAG (Herd et al, 2000) or even 24 hours after exercise in individuals with elevated fasting 
plasma TAG (Zhang et al, 2004). Muscle TAG and LPL activity have been shown to return 
to pre-exercise values within 42 hours after exercise. Thus, the TAG lowering effects of 
exercise on the first two days of the 3-D Ex trial may not have persisted until the main trial 
(day 4). Perhaps the energy expenditure threshold for lowering TAG was not reached. 
Ferguson and colleagues (1998) identified an exercise induced change in blood lipid and 
lipoprotein concentrations and demonstrated that the lowering in fasting TAG 
concentrations 24 h after an exercise bout was similar after exercise bouts expending 
between 3300 and 6300 kJ. Hence, an energy expenditure threshold may exist and it is even 
possible that different exercise thresholds exist for different populations. A final possibility 
is that a lack of monitoring/control for activities of daily living explains these finding i.e. 
participants may have expended more energy in activities of daily living in the control and 
1-D Ex trials than they did in the 3-D Ex trial and this may explain the lack of overall 
difference in postprandial lipaemia (Hamilton et al, 2007; Latouche et al 2013). 
 
 
Exercise intensity and duration also affects glucose uptake. In the post-absorptive state the 
volume of glucose uptake is affected by the exercise intensity. The higher the intensity, the 
higher the skeletal muscle glucose uptake (Romijin et al, 1993). Again, these factors may 
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have influenced postprandial glucose and perhaps the exercise intensity was insufficient to 
elicit reductions in postprandial glucose concentration.  
 
It is reasonable to speculate that hyperinsulinaemia resulting from insulin insensitivity 
might have decreased LPL activity. Pollare and colleagues (1991) demonstrated that insulin 
itself or the increased glucose uptake in muscle cells during hyperinsulinaemia 
downregulates LPL activity. Regulation of muscle LPL activity is not insulin resistant and 
thus it is downregulated in a hyperinsulinaemic state (Pollare et al, 1991) and therefore the 
non-significant postprandial TAG response in the present study may be related to this 
factor. The accumulation of both hepatically derived TAG-rich VLDL and intestinally 
derived chylomicrons after a fat rich meal (Levy and Zoltowska, 1999) may be another 
possible reason for the non-significant findings reported here. Individuals with insulin 
resistance often demonstrate high TAG or amplified TAG (Zhang et al, 2006) and this is 
also described as the common underlying mechanism that causes the metabolic syndrome 
and the development of type 2 diabetes (Misra et al, 2008). Insulin resistance often 
precedes diabetes by several years and it is reported to be a risk factor for the development 
of CVD (Misra et al, 2008).  
 
Whilst it is well established that exercise of a moderate intensity can reduce fasting and 
postprandial TAG concentrations (Katsanos 2006; Malkova and Gill, 2006; Miyashita et al, 
2006; Hurren et al, 2011), studies have shown that this level of exercise did not lead to 
significant increases in either leg skeletal LPL activity (Herd et al. 2001) or absolute TAG 
uptake across the leg (Malkova et al. 2000) when these were measured 18 h after exercise. 
However, as body tissues other than leg skeletal muscle play a quantitatively important role 
in whole-body TAG uptake (Jensen 1995; Nguyen et al. 1996), it is possible that there was 
an insufficient increase in LPL activity in tissues other than the leg and hence there was no 
TAG attenuation after the running exercise in the present study. 
 
As mentioned earlier some previous studies have also failed to demonstrate a significant 
reduction in postprandial TAG after exercise. An investigation involving a single bout of 
resistance exercise in European participants did not reveal any reduction in postprandial 
TAG in comparison with a no exercise control trial (Burns et al, 2005). Similarly, Zhang 
and colleagues (2007) also failed to identify a reduction in postprandial TAG after 30 
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minutes of treadmill running at 60% of 2OV  peak in ten sedentary male participants with 
the metabolic syndrome. Interestingly, 45 minute and 60 minute duration treadmill runs in 
the same participants resulted in significant reductions in postprandial TAG (Zhang et al, 
2007).   Moreover, Zhang and colleagues (2007) also observed a significant lowering of 
fasting plasma insulin and a reduced plasma insulin response to a high fat meal (Zhang et 
al, 2007).  
 
In addition, in view of the lack of change in postprandial lipaemia in response to 30 
minutes of daily exercise in the present study, it is interesting to note that recent consensus 
guidelines on physical activity for Asian Indians (Misra et al, 2012) have recommended 
one hour of activity every day comprising 30 minutes of moderate-intensity aerobic 
activity, 15 minutes of work-related activity and 15 minutes of muscle-strengthening 
exercise. This would be an addition of 30 minutes to the general guidelines recommended 
by the American College of Sports Medicine and American Heart Association which 
recommend 30 minutes of moderate-intensity physical activity 5 days a week or 20 minutes 
of vigorous activity 3 days a week or a mixture of both (Haskell et al, 2007). The World 
Health Organisation (WHO) recommends 150 minutes of moderate-intensity aerobic 
physical activity throughout the week or at least 75 minutes of vigorous-intensity aerobic 
physical activity for adults (WHO, 2010). It may be presumed that the prescription for 
Asian Indians (Misra et al 2012) has arisen as a result of South Asians’ strong CVD burden 
and the growing awareness of the pivotal role of physical activity/exercise in counteracting 
CVD. Though Misra and colleagues’ (2012) guidelines send out a clear message in 
addressing CVD/CHD in South Asians, the recommendations may be a ‘tall order’ to 
follow for this ethnic group who are already struggling to meet the ACSM/AHA 
guidelines.  
 
It is important to acknowledge that there were limitations to the present study. Firstly, the 
sample size was small and hence possibly underpowered to detect significant changes 
although some previous studies have detected exercise induced changes in TAG with 
similar sample sizes to that used in the present study. Secondly, a comparison with White 
European participants would have revealed whether the lack of an exercise effect was 
related specifically to ethnicity or was evident in Europeans also. Thirdly, a limitation of 
the study design was that total physical activity outside the lab was not quantified. 
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In conclusion, the findings of the present study are at odds with those of the only other 
study which has examined the relationship between a single bout of exercise and 
cumulative bouts of exercise on postprandial lipaemia. Further research is required to 
clarify whether this non-significant finding is due to the nature of the participants (i.e. 
South Asians) or to an insufficient exercise stimulus. It is important to clarify this because 
individuals with exaggerated postprandial TAG are more susceptible to CVD and this may 
apply to many South Asians. Hence, fully characterizing the optimal exercise mode, 
volume, intensity and duration for lowering postprandial lipaemia in South Asians is an 
important challenge for future research. 
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7 A comparison of fasting and postprandial 
cardiovascular disease risk markers in South Asian 
and White European men   
7.1 Introduction 
High coronary heart disease rates and mortality are common among South Asian groups of 
different geographical origin, religion and language (McKeigue et al 1989). In England and 
Wales, male and female migrants from the Indian sub-continent (India, Pakistan, 
Bangladesh, Nepal, Sri Lanka) have higher morbidity and mortality from cardiovascular 
disease (CVD) than the local population (McKeigue et al, 1991; Wild et al, 2007). Thus, 
the control measures, proven effective in other populations have clearly failed to address 
CVD related morbidity and mortality and its rise among South Asians in the UK and 
elsewhere (Mallika et al, 2007).  
 
Increasing urbanization, industrialization and energy consumption in the form of 
concentrated calories and fat in developing countries have resulted in an increased 
prevalence of obesity, metabolic syndrome and diabetes which are contributing factors for 
CVD (Srikanthan et al, 2008). Hypercholesterolaemia is a known risk factor for CVD and 
the typical lipid profile in South Asians varies from that in other populations. High 
concentrations of triacylglycerol and low density lipoprotein cholesterol (LDL-C), together 
with low concentrations of high density lipoprotein cholesterol (HDL-C), increased visceral 
fat, hypertension, and insulin resistance are more prevalent among South Asians 
(McKeigue et al, 1989; McKeigue et al, 1993; Miller et al, 1989; Anand et al, 2000; 
Ahmad & Frossard, 2006; Tziomalos et al, 2008).  
 
In addition to the actual concentrations of these lipids, particle size appears to be an 
important predictor of CVD risk. The LDL-C particle size in South Asians tends to be 
smaller. This small particle size increases the susceptibility of LDL-C to oxidation, thereby 
rendering these particles more atherogenic than the larger ones (Kulkarni et al, 1999). 
South Asians are also reported to have lower values of HDL-C and higher concentrations 
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of small particles that are less protective (Superko et al, 2005). This type of HDL-C has 
also been observed in South Asians who have normal HDL-C values (Bhalodkar et al, 
2004).  
 
Physical inactivity is another well-established risk factor for CVD (Wannamethee & 
Shaper, 2001; Rastogi et al, 2004; Mohan et al, 2005; Rao et al, 2012). Unfortunately, 
several studies have documented low physical activity levels in South Asians compared 
with other populations (Kamath et al, 1999; Fischbacher et al, 2004; Owen et al, 2009; 
Williams et al, 2011; Yates et al, 2010; Misra et al, 2012). There is substantial, consistent 
and strong evidence that physical activity is effective for lowering the risk of several forms 
of CVD (Fletcher et al, 1992; Haskell et al, 2007). Yet, few, if any, studies have addressed 
the acute effect of exercise in South Asians. 
 
Hence, the purpose of this chapter is twofold: 1) this chapter seeks to clarify ethnic group 
differences in a variety of CVD risk markers by combining data from the first three 
experimental chapters in this thesis to provide a larger sample size; 2) this chapter seeks in 
the same way to clarify the acute effects of exercise on several fasting and postprandial 
CVD risk markers by again combining the data from the first three experimental chapters.  
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7.2 Methods 
7.2.1 Participants and procedures 
These analyses are based on the data presented in Chapters four, five and six which have 
been merged here into one dataset. The outcome variables examined in this chapter are as 
follows: fasting total cholesterol (TC), fasting HDL-C, fasting TC/HDL-C, fasting LDL-C, 
fasting TAG, fasting glucose, fasting IL-6, postprandial TAG, postprandial glucose and 
postprandial IL-6, resting systolic blood pressure (SBP) and resting diastolic blood pressure 
(DBP). For the fasting variables data was used from all three of the previous experimental 
chapters yielding a sample size of 30 South Asians and 24 Europeans. For postprandial 
TAG, glucose and IL-6 concentrations only data from Chapters 4 and 5 was used because 
the protocols employed involved nine hour postprandial observation periods whereas the 
protocol employed in Chapter 6 involved a seven hour postprandial observation period 
which was not directly comparable with the other data. Although all our participants from 
these studies were recruited from the University’s student population based on convenience 
it was made sure that each participant included in this chapter was unique (i.e. if a 
participant completed more than one study they are only included once here). 
 
7.2.2 Statistical analysis 
Data were analysed using Predictive Analytics Software version 18.0 for Windows (SPSS, 
Inc., Somers, NY, USA). Physical characteristics were compared between South Asians 
and Europeans using independent samples Students t-tests. Two-way repeated measures 
ANOVA with Bonferroni post-hoc tests was used to examine differences between trials for 
fasting plasma constituents (total cholesterol, HDL-C, LDL-C, total cholesterol/HDL-C, 
TAG, glucose, IL-6) and resting blood pressure with the two factors being: a) trial (exercise 
versus control) and b) ethnic group (South Asian versus European). Area under the plasma 
concentration versus time curve (AUC) values were calculated for postprandial TAG, 
glucose and IL-6 using the trapezoidal method. These values were also compared using 
two-way repeated measures ANOVA with the two factors being trial (exercise versus 
control) and ethnic group (South Asian versus European). Effect sizes (Cohen’s d) were 
calculated by dividing the difference between the mean values (exercise versus control or 
South Asian versus European) with the standard deviation (i.e. the average standard 
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deviation from both trials and ethnic groups combined). Statistical significance was 
accepted at the 5% level. Results are presented as mean ± SD in the text and tables and as 
mean ± SEM in figures. 
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7.3 Results 
7.3.1 Participant characteristics 
The physical characteristics of the participants are displayed in Table 7.1. There were no 
significant differences between South Asian and White European participants for age, 
weight, body mass index, waist circumference and resting diastolic blood pressure. Height 
and resting systolic blood pressure were lower while percentage body fat was higher in the 
South Asians than the White Europeans. 
 
 
Table  7.1: Physical characteristics of South Asian and European participants. 
Variables   South Asians    
(n = 30) 
   Europeans     
(n = 24) 
P value 
Age (years)  23.0 ±  2.7 22.5 ± 1.5    0.392 
Height (cm)  172.6 ±  7.6 178.9 ± 5.0    0.001 
Weight (kg)   73.9 ±  10.4 76.0 ± 8.7    0.441 
Body mass index (kg·m-2)  24.8 ±  3.1 23.7 ± 2.3    0.165 
Body fat (%)  20.9 ±  5.6 14.1 ± 4.8 < 0.001 
Waist circumference (cm) 80.3 ±  7.7 77.3 ± 5.0    0.107 
Resting SBP (mm Hg)  128 ±  10 137 ± 12    0.003 
Resting DBP (mm Hg) 75 ±  8 77 ± 6    0.468 
Data are displayed as mean ± SD. P values for differences between South Asians and  
Europeans are based on independent samples t tests. SBP = systolic blood pressure;      
DBP = diastolic blood pressure. 
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7.3.2 Fasting plasma metabolite concentrations and resting blood pressure 
Fasting concentrations of plasma metabolites and resting blood pressure are displayed in 
Table 7.2. There were significant main effects of trial for TAG, and glucose indicating 
lower values on the exercise trial. The effect sizes for each of these were small: TAG 0.3, 
and glucose 0.3. In addition, there were significant main effects of ethnic group for HDL-
C, total cholesterol/HDL-C, IL-6 and SBP indicating lower values of HDL-C and SBP and 
higher values of total cholesterol/HDL-C and IL-6 in South Asian than White European 
participants. The effect sizes for these ethnic group comparisons were large for HDL-C 
(1.0), TC/HDL-C (0.8), IL-6 (0.5) and SBP (0.8). Finally, a significant trial by group effect 
was observed for DBP indicating a decrease in DBP in response to exercise in South 
Asians which did not occur in White Europeans.  
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7.3.3 Postprandial plasma metabolite concentrations 
Postprandial concentrations of plasma metabolites are displayed in Table 7.3. There was a 
significant main effect of trial for AUC TAG indicating lower values on exercise trial. The 
effect size was small for AUC TAG 0.2. Additionally, there were significant main effects 
of ethnic group for AUC TAG and AUC IL-6 indicating higher values of AUC TAG and 
AUC IL-6 in South Asian than White European participants. The effect size for these ethnic 
group comparisons was large for AUC TAG (0.9), and small for AUC IL-6 (0.2).  
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7.3.4 Correlations 
Table 7.4 displays some of the more notable correlations identified in this study. Total 
cholesterol was positively correlated to TC/HDL-C, TAG and SBP in both ethnic groups. 
Of these, the correlation between TC and TC/HDL-C was very high in the White European 
participants. HDL-C was negatively correlated with TC/HDL-C, TAG and percentage body 
fat (this latter correlation only applying in South Asians).  A high negative correlation was 
seen between HDL-C and TC/HDL-C in both groups. In both South Asians and White 
Europeans a positive correlation was observed between TC/HDL-C and TAG. However, 
TC/HDL-C was positively correlated with percentage body fat and DBP only in the South 
Asians. A positive correlation between TAG and waist circumference and between TAG 
and percentage body fat was also seen in the South Asians only. Body composition 
variables (weight, BMI, waist circumference and percentage body fat) were highly 
correlated with each other in both ethnic groups.  Systolic and DBP were correlated only in 
South Asians.  
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Table  7.4: Correlation coefficients describing the relationship between plasma metabolites, 
blood pressure and anthropometric measurements 
Variables South Asians 
(n = 30) 
 White Europeans 
( n = 24) 
  r value P value  r value P value 
TC TC/HDL-C   0.518   0.003    0.827 < 0.001 
 TAG   0.391   0.032    0.450    0.027 
 SBP   0.371   0.044    0.441    0.031 
       
HDL-C TC/HDL-C - 0.720 < 0.001  - 0.744 < 0.001 
 TAG - 0.449   0.013  - 0.476    0.019 
 Percentage body fat - 0.396   0.030   - 0.038    0.859 
       
TC/HDL-C TAG 0.680 < 0.001   0.560    0.004 
 Percentage body fat 0.365   0.047   0.219    0.305 
 DBP 0.460   0.010   0.134    0.534 
       
TAG Waist Circumference 0.439   0.015   0.121    0.574 
 Percentage body fat 0.462   0.010   0.252    0.235 
       
Weight BMI 0.787 < 0.001   0.868 < 0.001 
 Waist Circumference 0.897 < 0.001   0.823 < 0.001 
 Percentage body fat 0.618 < 0.001   0.622    0.001 
       
BMI Waist Circumference 0.878 < 0.001   0.867 < 0.001 
 Percentage body fat 0.807 < 0.001   0.683 < 0.001 
       
Waist circumference Percentage body fat 0.801 < 0.001   0.789 < 0.001 
       
SBP DBP 0.444   0.014   0.064    0.767 
TC = total cholesterol; HDL-C = high density lipoprotein cholesterol; TAG = 
triacylglycerol; SBP = systolic blood pressure; DBP = diastolic blood pressure.  
NB: Correlations were computed using mean values for each variable i.e. exercise trial 
value plus control trial value divided by 2.  
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7.4 Discussion 
This cross-sectional study identified the following: a) exercise appears to be effective in 
lowering fasting TAG and glucose and postprandial TAG; b) HDL-C concentrations and 
resting SBP were significantly lower in the South Asian than the White European 
participants; c) total cholesterol/HDL-C, postprandial TAG and fasting and postprandial 
IL-6 concentrations were significantly higher in South Asian than White European 
participants; and d) exercise appeared to result in a small lowering of resting diastolic 
blood pressure in South Asian participants but not in White European participants. 
 
Importantly, this study revealed the effectiveness of exercise in lowering postprandial TAG 
in South Asian and White European participants. Many studies have reported that a single 
bout of exercise lowers postprandial TAG concentrations (Katsanos, 2006; Miyashita et al, 
2006; Miyashita et al, 2008; McEneaney et al, 2009; Hurren et al, 2011) and the present 
study confirms these findings. Exercise was slightly more effective in South Asian 
participants eliciting a 12% reduction in TAG AUC values compared with a 9% reduction 
in White European participants. Despite the effectiveness of exercise in the South Asian 
participants it is important to note that their TAG AUC values were still nearly 50% higher 
after exercise than the control trial values shown by the White European participants. In 
addition, exercise also reduced fasting TAG concentrations by 23% in South Asians and 
10% in White Europeans. Fasting glucose concentrations were reduced by 2% in both 
ethnic groups. Blood glucose concentrations even at the higher end of the normal range are 
associated with an increased risk of CVD in South Asians (Pais et al, 1996). Higher fasting 
TAG and glucose in South Asians have been documented in several studies (Anand et al, 
2000; Tziomalos et al, 2008) and the findings of the present study confirm this.  
 
South Asians have a higher susceptibility to CVD morbidity and mortality (McKeigue et al, 
1991; Wild et al, 2007) and this susceptibility may be exacerbated by their low physical 
activity levels (Fischbacher et al, 2004, Williams et al, 2011, Yates et al, 2010). The 
findings of the present study suggest that regular exercise may serve to partially offset the 
elevated postprandial TAG experienced by South Asians. Observational evidence also 
suggests a cardio-protective role of physical activity for CHD and CHD risk markers in 
South Asians (Rastogi et al, 2004; Mohan et al, 2005; Rao et al, 2012). In Western 
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populations, regular moderate intensity exercise is associated with a 30% to 50% reduction 
in the risk of CHD, obesity, diabetes and stroke (Wannamethee et al, 2000; Batty, 2002). 
Further research is required to establish the effectiveness of exercise for lowering the risk 
of these conditions in South Asians.  
 
Another key finding in the present study is the significant ethnic group difference in 
postprandial TAG. Mean postprandial TAG concentrations (the average value across the 
two trials) were 64% higher in South Asian than White European participants. This is 
concerning for South Asians and reiterates their vulnerability to CVD. South Asians 
exhibited lower fasting HDL-C concentrations and resting systolic blood pressure than the 
White European participants. Baseline HDL-C is a significant predictor of subsequent 
CHD events (Gotto et al, 2000) and recent epidemiological studies have confirmed the 
inverse relationship between HDL-C and CHD risk (Barter, 2011).  
 
Total cholesterol/HDL-C ratio values and fasting and postprandial IL-6 concentrations 
were elevated in the South Asians. Fasting IL-6 concentrations were 55% higher and 
postprandial IL-6 concentrations were 72% higher in the South Asians than the White 
Europeans. These differences observed between ethnic groups in the present study confirm 
the findings of previous studies (Anand et al, 2000; Peters et al, 2013; Tziomalos et al, 
2008) indicating that South Asians have a tendency for higher fasting TAG and IL-6 
concentrations, higher fasting total cholesterol to HDL-C ratio values, and lower fasting 
HDL-C concentrations than other ethnic groups. Thus, these findings confirm and extend 
previous research demonstrating adverse CVD risk factor profiles in South Asians (Joshi et 
al, 2007). 
 
In conclusion, the findings of the present study confirm previous reports that South Asian 
ethnicity is related to an adverse CVD risk factor profile. Moreover, the present findings 
demonstrate that an acute bout of exercise is effective for modifying several CVD risk 
markers in South Asians – at least transiently. Further research is required to examine the 
effects of exercise training on CVD risk markers in South Asians. Further research is also 
required to determine if these findings hold true in female South Asians.   
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8 General discussion 
This chapter aims to integrate and reflect on the major findings of the investigations in this 
thesis. Previous research suggests that acute exercise attenuates postprandial lipaemia in 
mostly European participants. The main aim of this thesis was to examine the effect of 
acute bouts of exercise on postprandial lipaemia and several other cardiovascular disease 
(CVD) risk markers in South Asian participants and to compare their responses with those 
of White European participants.  There is growing body of evidence suggesting that South 
Asians are predisposed to CVD.  In the recent past, studies have been ‘unearthing’ the high 
susceptibility of South Asians to CVD related morbidity and mortality (Gupta et al, 2006; 
Tziomalos et al, 2008; Rao et al, 2012).  
 
The first experimental chapter of this thesis (the walking study) revealed that South Asians 
exhibit elevated postprandial plasma triacylglycerol (TAG) concentrations to a much 
greater extent than White Europeans after consuming high fat meals. Brisk walking for 60 
minutes at 48% to 52% of 2OV max exhibited a borderline effect, eliciting a small 
lowering of postprandial plasma TAG concentrations in both South Asians and White 
Europeans. Postprandial plasma glucose and plasma interleukin-6 (IL-6) concentrations 
were higher in South Asians than in White Europeans.  
 
In the second experimental chapter, a one hour run, elicited a significant lowering of 
postprandial TAG in South Asians and White Europeans with the reduction being greater in 
the South Asians than the Europeans. The exercise was prescribed at 70% of 2OV max in 
this study. As the exercise was prescribed according to individual ability and fitness, the 
least fit participants performed less exercise in absolute terms than their fitter counterparts 
but, importantly, most of these participants experienced substantial reductions in plasma 
TAG concentrations. Consistent with the findings of the walking study, the running study 
also demonstrated a greater elevation in postprandial plasma TAG concentration in 
response to high fat meals in the South Asian men compared with the White European men.  
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The South Asian men also had higher postprandial plasma insulin concentrations than the 
White European men in the running study. No ethnic group differences were apparent for 
IL-6 and soluble intercellular adhesion molecule-1 (sICAM-1) but postprandial plasma IL-
6 concentrations were lower after exercise while postprandial sICAM-1 concentrations 
were higher. The lower IL-6 concentrations observed the day after exercise in the running 
study are possibly reflective of an anti-inflammatory effect of exercise subsequent to an 
initial increase in IL-6. The elevated sICAM-1 concentrations are probably related to an 
increased blood shear stress during exercise and it is clear that this elevation lasts for at 
least 24 h although the significance of this elevation is uncertain.  
 
In the third experimental chapter, a thirty minute run at 70 % of 2OV max performed on 
one day and three consecutive days did not influence postprandial TAG in response to high 
fat meals in either of the trials. Additionally, fasting TAG and fat oxidation were not 
influenced by exercise in this study. A limitation of this study is that there was no European 
participant group with which to compare responses. The findings of the third study are in 
contrast to the findings of the study by Farah and colleagues’ (2010) which has employed a 
similar protocol in overweight/obese Europeans. 
 
In combining the first three studies, Chapter 7 gained a greater sample size and this helped 
to clarify the effects of an acute exercise. This data identified that fasting TAG and glucose 
concentrations are significantly reduced by an acute bout of exercise in South Asians and 
additionally that postprandial TAG concentrations are significantly reduced by exercise. 
This data also revealed significant main effects of ethnic group confirming that South 
Asians have lower fasting high density lipoprotein cholesterol (HDL-C) and resting systolic 
blood pressure and higher fasting total cholesterol/HDL-C and IL-6 concentrations than 
Europeans. Additionally, the significant main effects of ethnic group also showed South 
Asians to have higher postprandial TAG and IL-6 concentrations. 
 
In general, all experimental chapters except Chapter 6 (where there was no comparison 
group) revealed that South Asians have markedly higher postprandial TAG than White 
European participants. This confirms the findings of many studies which have shown South 
Asians to have high fasting TAG concentrations in comparison with other populations 
(Anand et al, 2000; Tziomalos et al, 2008). Importantly, exaggerated postprandial TAG, a 
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strong predictor for CVD morbidity and mortality (Bansal et al, 2007; Nordestgaard et al, 
2007) may play a causative role in the premature atherosclerosis observed in South Asians 
(Gupta and Brister, 2006). It is possible that genetically susceptible individuals develop 
abdominal obesity and insulin resistance when exposed to an unfavourable environment of 
reduced energy expenditure and increased caloric consumption. This trend is increasingly 
observed in parallel with urbanisation, suggesting that the increased risk in South Asians 
may be preventable through lifestyle interventions to attain optimal levels of blood pressure, 
lipids and glucose (Gupta and Brister, 2006).  
 
South Asians have a higher risk of developing CVD at a younger age in comparison with 
other ethnic groups (Ramaraj and Chellappa, 2008). This somewhat relates to the South 
Asian participants assessed in this thesis who were all relatively young and displayed 
higher values for postprandial TAG than White Europeans. It is also important to 
acknowledge that TAG-rich particles are produced mainly postprandially (Castro et al, 
2001).  
 
The data from Chapters 5 and 7 have shown that acute exercise has a beneficial effect on 
postprandial lipaemia in both South Asian and White European participants. This adds to 
the body of evidence which suggests that exercise, both walking and running, can attenuate 
postprandial lipaemia (Gill et al, 2004; Miyashita et al, 2006, Miyashita et al, 2008). This is 
particularly relevant in South Asians who are at an increased risk of CVD. These metabolic 
improvements are likely to contribute to the reduced CHD risk often observed in physically 
active individuals but additional longitudinal research will be required to confirm this. 
Despite the effectiveness of exercise in the South Asian participants it is important to note 
that their postprandial TAG concentrations were still markedly higher after exercise than 
the control trial values shown by the White European participants. Therefore, South Asians 
are at a much higher risk of experiencing exaggerated postprandial lipaemia in response to 
high fat meals than Europeans and this may be a contributing factor to their elevated risk of 
CHD.   
 
Even though moderate intensity exercise did not significantly attenuate postprandial TAG 
in the South Asian and White European participants in Chapter 4, (60 minute brisk walk) 
and in South Asians in Chapter 6 (30 minutes run on one day or on three consecutive days), 
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it cannot be used as a yardstick to generalise that exercise would not attenuate postprandial 
TAG. In contrast, the 60 minute running study (Chapter 5) clearly demonstrated a 
significant effect of exercise, especially in the South Asian participants. Possibly, the 
exercise duration and intensity may have been optimal in this study. Moreover, fasting 
hypertriglyceridaemia could have a number of underlying causes and moderate intensity 
exercise might have a substantial impact on fasting and postprandial plasma TAG 
concentrations in some individuals and a minimal effect in others.  
 
The reason for the insignificant results displayed in Chapter 4 (60 minutes brisk walking) 
and Chapter 6 (30 minutes run on one day or on three consecutive days) may also be 
related to intramuscular TAG (IMTG) concentrations. South Asians have been reported to 
have 30% higher IMTG concentrations than BMI matched Europeans (Forouhi et al, 1999). 
Thus, the elevated IMTG in South Asians is suggestive of a deficiency in skeletal muscle 
lipid metabolism. Accumulating evidence indicates that deficits in skeletal muscle 
oxidative capacity and low rates of skeletal muscle lipid oxidation are likely to contribute 
to skeletal muscle lipid accumulation and consequent insulin resistance (Kelley and 
Goodpaster, 2001; Bruce and Hawley, 2004; Kelley et al, 1999), even though the 
underlying mechanisms are unknown. 
 
Furthermore, available evidence indicates that South Asians have lower 2OV max values, 
an index of oxidative capacity at the whole-body level, than matched European 
counterparts (Davey et al, 2000; Hardy and Eston, 1985) and 2OV max is a strong 
independent predictor of whole body insulin sensitivity (Bruce et al, 2003, Nyholm et al, 
2004). While it is known that cardiorespiratory fitness is closely associated with skeletal 
muscle lipid oxidative capacity (Sahlin et al, 2007; Venables et al, 2005; Helge et al, 2006), 
it is not known whether capacity for lipid oxidation is reduced in South Asians compared 
with Europeans or whether these factors contribute to increased insulin resistance in South 
Asians.  
 
Taking all of the experimental studies together, exercise attenuated postprandial lipaemia in 
21 out of 30 South Asian and 18 out of 24 White European participants. This suggests that 
exercise could be an instrument for the improvement of TAG metabolism. Numerous 
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studies have demonstrated the effect of exercise on postprandial lipaemia in White 
Europeans (Gill et al, 2002; Miyashita et al, 2008; Hurren et al, 2011). The experimental 
studies in this thesis are a first step in addressing the acute effects of exercise in South 
Asians.  
 
It is important to note that approximately one third of participants examined in this thesis 
showed a non-beneficial response to exercise i.e. their postprandial TAG was not lowered 
or was even increased. A recent study by Bouchard and colleagues (2012) showed that 
some people get worse with exercise compared to others (adverse responders versus non-
adverse responders). The insulin, TAG, SBP values in their study were higher after 
exercise while the HDL-C values were lower (Bouchard et al, 2012). The prevalence of 
adverse responders appeared to be similar at low and high doses of exercise. However, the 
researchers did not know whether some adverse responders would revert to a more positive 
response pattern if exposed to different exercise doses or exercise modalities. They did not 
find any evidence for differences in the prevalence of adverse responders between Blacks 
and Whites or between men and women. Moreover, the adverse responder traits are not 
explained by prior health status of subjects, age, amount of exercise imposed by the 
program, or lack of improvement in cardiorespiratory fitness. Thus, some individuals 
experience adverse responses when exposed to regular exercise, but the causes of the 
phenomenon are unknown at this time (Bouchard et al, 2012). 
 
In addition to postprandial TAG, the experimental studies described in this thesis also 
suggest that South Asians have lower HDL-C, higher fasting TAG, and a higher ratio of 
total cholesterol/HDL-C than White Europeans which are indicative of an adverse lipid 
profile. This is consistent with previous studies (Anand et al, 2000; Enas et al, 2005; Gupta 
et al, 2006; Tziomalos et al, 2008). Concentrations of HDL-C are inversely related to CHD 
incidence consistent with its role in reverse cholesterol transport (Fielding and Fielding, 
1995). As a result of low HDL-C, South Asians have a higher ratio of total 
cholesterol/HDL-C. Having a low HDL-C is also an indicator of insulin resistance and is 
associated with high fasting TAG values (Tziomalos et al, 2008).  
 
In addition, South Asians exhibited marked elevations in insulin concentrations in the 
fasting and postprandial state in comparison with White Europeans (Chapter five) which is 
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consistent with the findings of Cruz and colleagues (2001). Insulin resistance is thought to 
be a major contributor to the increased risk of type 2 diabetes and CHD experienced by 
those of South Asian descent (Sandeep et al, 2011; Tziomalos et al, 2008). Insulin has 
significant functional effects on the vasculature, including dilation of large and small 
vessels and recruitment of skeletal muscle capillaries to increase nutritive flow (Clark et al, 
2003). Recent data indicate that loss of endothelial-specific insulin signalling reduces 
whole body and skeletal muscle insulin stimulated glucose uptake (Kubota et al, 2011), 
illustrating the broader importance of insulin’s endothelial effects. Furthermore, the 
vasodilatory effects of insulin are attenuated in subjects with impaired endothelial function 
and type 2 diabetes, in that insulin-stimulated nutritive flow to skeletal muscle is largely 
reduced in the insulin resistant state (Laakso et al, 1990; Clark et al, 2008). Thus, 
endothelial cells can effectively become desensitized to insulin, and this endothelial insulin 
resistance occurs in close association with the development of insulin resistance in 
downstream tissues (e.g. skeletal muscle). Exercise is believed to help maintain appropriate 
glucose and insulin metabolism (Holloszy et al, 2005; Kelly et al, 2012; Rogers et al, 1988).   
 
Chronically, elevated levels of IL-6 perturb endothelial function, haemostatic and lipid 
pathways, and may also promote insulin resistance (Yudkin et al, 1999). In the 
experimental chapters IL-6 was examined with varying outcomes. In chapters 4, 5 and 7 
there was no effect of exercise on fasting IL-6 concentrations. Comparing ethnic group 
values in the walking study (Chapter 4) revealed a tendency for fasting IL-6 concentrations 
to be elevated in South Asians compared with the Europeans. This was not supported by 
the findings of the running study (Chapter 5) but was confirmed in the combined cross-
sectional data examined in Chapter 7. Moreover, for postprandial IL-6 concentrations there 
were significant ethnic group differences in Chapters 4 and 7, supporting that South Asians 
have elevated IL-6 concentrations although again this was not observed in the running 
study (Chapter 5). Chapter 5 did reveal a significant exercise induced lowering of IL-6 but 
this was not observed in Chapters 4 and 7.  Thus, these IL-6 findings are somewhat 
ambiguous and require further study with a larger sample of South Asian and European 
participants. If the elevated IL-6 concentrations in South Asians are confirmed this suggests 
another mechanism by which they are at increased risk of CVD.  
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A limitation of the study design in the third study (Chapter 6) is that total physical activity 
outside the lab was not quantified. Breaking up postprandial sedentary time with short 
activity bouts (2 minutes of activity time for every 20 minutes of sitting) is associated with 
changes in the expression of skeletal muscle genes involved in cellular development, 
growth and proliferation and lipid and carbohydrate metabolism (Latouche et al, 2013). 
Activities of daily living also have the potential to alter LPL activity hence altering 
postprandial lipaemia (Hamilton et al 2007). Thus lack of adequate control for activities of 
daily living in the 1-D Ex versus 3-D Ex study may explain the lack of significance in 
postprandial TAG values.  
 
Lastly, according to McKeigue and colleagues (1989) and Eapen and colleagues (2009), 
South Asians are a heterogeneous population. In this respect, most of our participants were 
Indians and there was not equal representation of Pakistanis, Bangladeshis, Sri Lankans 
and Nepalese. Hence the extent to which these findings are applicable to all South Asians is 
uncertain. In addition, the participants included in this thesis are a young and healthy 
population which is not representative of the general South Asian population. 
 
Importantly, the present findings demonstrate that acute bouts of exercise are effective for 
modifying several CVD risk factors in South Asians – at least transiently. Further research 
is required to examine a variety of issues related to the potential of exercise to lower CVD 
risk in South Asians. Below are a few suggestions for research questions which require 
attention in the immediate future.  
 
• To what extent are the differences in postprandial lipaemia between South Asians 
and White Europeans generalizable i.e. can the findings reported in this thesis be 
confirmed with larger sample sizes?  
• Do South Asian females exhibit elevated postprandial lipaemia in response to high 
fat meals in the same way as South Asian males? 
• Does an acute bout of exercise lower postprandial lipaemia in South Asian females? 
• What is the optimal intensity and duration of exercise for lowering postprandial 
lipaemia in South Asian men and women? 
• What is the postprandial lipaemia response to high fat meals in older South Asian 
men and women? 
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• Is exercise effective for lowering postprandial lipaemia in older South Asian men 
and women? 
• What effect does resistance exercise have on postprandial lipaemia in South Asian 
men and women? 
• Do South Asian children and adolescents have elevated postprandial lipaemia in 
response to high fat meals? 
• Is exercise effective for lowering postprandial lipaemia in South Asian children and 
adolescents? 
• How effective is exercise training for lowering postprandial lipaemia in South 
Asian men and women? 
• How does acute and chronic exercise influence lipoprotein lipase activity in South 
Asians? 
• Will exercise induced reductions in postprandial lipaemia lead to a reduction in the 
risk of CVD/CHD in South Asians? 
• How effective will combined diet and exercise intervention be for reducing 
postprandial lipaemia in South Asians?  
• What mechanisms are responsible for the exaggerated postprandial lipaemia in 
South Asians? 
• What exercise intervention strategies are effective for encouraging South Asians to 
be more active? 
 
Although CVD is a fatal disease, it is predictable, preventable and treatable and 
exercise/physical activity is one factor which may help in this regard. Using the findings of 
this thesis as baseline knowledge of acute exercise and its effect on CVD risk markers in 
South Asians, it is important that work now continues to enhance knowledge and 
understanding of the role of exercise in modifying CVD risk factors in South Asians. 
Moreover, it is equally if not more important that this work is publicised among the South 
Asian community and that physical activity promotion and intervention schemes are widely 
implemented in South Asians.  
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10 Appendices 
10.1 Appendix A: Participant information 
 
 
School of Sport, Exercise and Health Sciences 
 
The effect of prior walking on postprandial lipaemia and resting blood pressure in South 
Asian versus European European men 
 
Investigators 
 
Mr Saravana Pillai Arjunan, Miss Alice Rogan Miss Pattida Achakulwisut, Miss Andrea 
Smith, Mr Aled Hills,and Dr David Stensel: School of Sport, Exercise and Health Sciences, 
Loughborough University.  
 
Background 
 
South Asian men living in the UK have a higher than average risk of cardiovascular disease 
(CVD). The reasons for this are uncertain. Physical inactivity is known to increase the risk 
of CVD and it is possible that the prevalence of physical inactivity is higher in South Asian 
men than in men of European descent. Alternatively, physical activity may be less effective 
in preventing CVD in South Asian men than in other men. The proposed study will 
compare the effects of a single bout of exercise on CVD risk markers (blood lipids, 
markers of inflammation) in South Asian men and white men. 
 
Inclusion Criteria 
 
Volunteers will:  
 
(i) be male  
(ii) aged 18-40 y  
(iii) have no personal history of cardiovascular disease, metabolic disease or 
dyslipidaemia, 
(iv) not be dieting or have any extreme dietary habits  
(v) not be taking drugs known to affect digestion or metabolism – medical or illegal 
(for example anabolic steroids, marijuana, amphetamines, thyroid prescription 
drugs).  
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Study Demands 
 
If you volunteer to participate in this study you will be required to attend the Exercise and 
Health laboratory (HE111) in the Clyde Williams building for a screening/familiarisation 
visit lasting approximately two hours and then you will perform two main trials in the 
laboratory at least one week apart. Each main trial will be conducted over two-days and 
you will be in the laboratory from 8.00 am to 5.00 pm on each of these days. You will be 
required to weigh and record all food and drink consumed in the 24 h prior to each main 
trial and to abstain from alcohol, caffeine and structured physical activity during this time.  
 
Preliminary Procedures 
 
During the screening/familiarisation visit we will: 
 
• Explain the objectives of the study and its requirements 
• Ask you to complete a confidential questionnaire regarding your health 
• Familiarise you with the testing procedures and equipment 
• Familiarise you with dietary recording 
• Answer any questions you may have 
 
After this we will collect the physiological/anthropometric measurements listed below: 
 
• Resting blood pressure 
• Height 
• Weight 
• Skinfold thickness at four sites (to estimate body fat percentage)  
• Waist and hip circumferences 
 
You will then complete a submaximal walking test on a treadmill and (once you have 
recovered from this test) a maximum oxygen uptake test. 
 
Main Trials 
 
There will be two main trials each conducted over two days (8.00 am to 5.00 pm on each 
day). These will be assigned in a random order and separated by at least one week. 
 
Exercise trial  
 
On day one of the exercise trial you will report to the laboratory at 8.00 am after a 10 h 
overnight fast. You will rest in the laboratory (reading, working at a computer, watching 
television, listening to music etc) throughout day 1 until 5.00 pm. We will provide you with 
lunch on day 1. At 3.30 pm you will perform a 60 minute walk at 70% of your walking 
maximum oxygen uptake. At 5.00 pm on day 1 you will leave the laboratory. You will 
consume a standardised meal at home in the evening, fast overnight for 10 h and return to 
the laboratory on day 2.  
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On day 2 of the exercise trial you will report to the laboratory just before 8.00 am. A 
cannula will be inserted into a vein in your arm when you arrive at the laboratory. You will 
rest in the laboratory (reading, working at a computer, watching television, listening to 
music etc) throughout day 2 until 5.00 pm. You will be fed standardised meals for breakfast 
(8.00 am) and lunch (12.00 pm). Fourteen, 9 mL venous blood samples will be collected 
from you via the cannula at the following times: 08.00, 08.15, 08.30, 09.00, 10.00, 11.00, 
12.00, 12.15, 12.30, 13.00, 14.00, 15.00, 16.00 and 17.00. In total 126 mL of blood will be 
collected on day 2 and this equates to just over one-quarter of a standard blood donation.  
  
Control trial 
 
The control trial will be identical to the exercise trial with the exception of the 60 minute 
walk on day 1. On the control trial you will perform no exercise on day 1 and remain 
resting in the laboratory. Other than this the trials are identical.  
 
Preparation for the tests 
 
Recording your diet 
 
You will be asked to weigh and record everything you eat and drink for 24 hours prior to 
the first main trial. You will then consume identical amounts of the same food and drink 
prior to your second main trial. Alcohol and caffeine must not be consumed on the days 
when you are recording your diet. These points are very important in order to prevent 
extraneous variables influencing the study findings and we will discuss this with you in 
depth prior to the main trials. 
 
Controlling physical activity  
 
No strenuous physical activity should be performed during the day preceding main trials. 
 
Overnight fast 
 
You will finish eating by 10:00 pm on the evenings before main trials. You may however 
continue to drink water after this time. You will report to the laboratory at 8:00 am the next 
morning without having eaten breakfast. We will provide you with breakfast and lunch on 
both day one and day two of each main trial.  
 
Travelling to the laboratory 
 
If you live within one mile of the laboratory you should walk in slowly on the morning of 
each main trial. Please do not run or cycle. If you live more than one mile from the 
laboratory then you should drive in. If you do not have access to a car please tell us and we 
will arrange for you to be collected.  
 
How much time will it take? 
 
• Screening visit: approximately 2 hours. 
• Two main trials each conducted over two days: nine hours per day, 18 hours per 
trial, 36 hours in total. 
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You will be encouraged to bring work and reading material with you for the main trials. 
Alternatively you may watch television/movies, listen to music or work at a computer 
(internet enabled). 
 
Possible risks and discomforts 
 
High intensity exercise will cause breathlessness. In a tiny minority of individuals, even in 
young adults, the possibility exists that such exercise triggers disturbances to normal 
physiology: these include abnormal blood pressure, fainting or a change in the normal 
rhythm of the heart. There is also a risk of musculoskeletal injury but this is minimal and 
measures will be taken to prevent any occurrences. 
 
Venous cannulation can cause air or plastic embolism (occlusion of a blood vessel) but 
good practice minimises this risk and the personnel conducting the procedure have been 
trained and are highly experienced. Cannulation can also lead to local thrombophlebitis 
(inflammation) in a superficial vein but the absolute level of risk is low. 
 
Benefits of the study 
 
The study should lead to greater understanding about the effects of exercise on the 
cardiovascular disease risk markers in relation to males of South Asian descent and white 
European males. In so doing it will contribute to an expanding body of evidence 
concerning the role of exercise in the prevention of cardiovascular disease. 
 
We will give you feedback on your own results and we will be happy to discuss this with 
you.  
 
Confidentiality  
 
Although information will be stored on computer, each participant will be entered as a 
number rather than by name, in accordance with the Data Protection Act. The information 
linking participant names to their number will be kept for no longer than five years. Data 
will be used for research purposes only and confidentiality will be maintained in any 
publications arising from the study. Participant data will not be kept longer than is 
necessary for the purposes of this investigation. Blood plasma samples collected during this 
investigation will be kept for no longer than three years. Samples will be disposed of via 
bio-hazard waste collection bags.  
 
Right to withdraw 
 
If you volunteer to participate in this study you hold the right to withdraw at any stage 
without having to inform the investigators of your reasons for doing so. 
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Contacts 
 
Please feel free to ask any questions, at any stage. Contact information for the staff 
involved in this study is as follows: 
 
Mr Saravana Pillai Arjunan  
S.P.Arjunan@lboro.ac.uk   
Telephone 01509 226351 
  
Dr David Stensel    
D.J.Stensel@lboro.ac.uk  
Telephone: 01509 226344 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Appendices 
 
 ▏189 
 
 
 
School of Sport, Exercise and Health Sciences 
 
The influence of a one hour treadmill run on coronary heart disease risk markers in South 
Asian and European men 
 
Investigators 
 
Mr Saravana Pillai Arjunan, Mr James King, Miss Lucy Wasse, Miss Taru Irene Saarinen, 
Miss Victoria Rose Paley and Dr David Stensel: School of Sport, Exercise and Health 
Sciences, Loughborough University.  
 
Background 
 
South Asian men living in the UK have a higher than average risk of cardiovascular disease 
(CVD). The reasons for this are uncertain. Physical inactivity is known to increase the risk 
of CVD and it is possible that the prevalence of physical inactivity is higher in South Asian 
men than in men of European descent. Alternatively, physical activity may be less effective 
in preventing CVD in South Asian men than in other men. The proposed study will 
compare the effects of a single bout of exercise on CVD risk markers (blood lipids, 
markers of inflammation) in South Asian men and white men. 
 
Inclusion Criteria 
 
Volunteers will:  
 
(vi) be male  
(vii) aged 18-40 y  
(viii) have no personal history of cardiovascular disease, metabolic disease or 
dyslipidaemia, 
(ix) not be dieting or have any extreme dietary habits  
(x) not be taking drugs known to affect digestion or metabolism – medical or illegal 
(for example anabolic steroids, marijuana, amphetamines, thyroid prescription 
drugs).  
 
 
Study Demands 
 
If you volunteer to participate in this study you will be required to attend the Exercise and 
Health laboratory (HE111) in the Clyde Williams building for a screening/familiarisation 
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visit lasting approximately two hours and then you will perform two main trials in the 
laboratory at least one week apart. Each main trial will be conducted over two-days and 
you will be in the laboratory from 8.00 am to 5.00 pm on each of these days. You will be 
required to weigh and record all food and drink consumed in the 24 h prior to each main 
trial and to abstain from alcohol, caffeine and structured physical activity during this time.  
 
Preliminary Procedures 
 
During the screening/familiarisation visit we will: 
 
• Explain the objectives of the study and its requirements 
• Ask you to complete a confidential questionnaire regarding your health 
• Familiarise you with the testing procedures and equipment 
• Familiarise you with dietary recording 
• Answer any questions you may have 
 
After this we will collect the physiological/anthropometric measurements listed below: 
 
• Resting blood pressure 
• Height 
• Weight 
• Skinfold thickness at four sites (to estimate body fat percentage)  
• Waist and hip circumferences 
 
You will then complete a 16 minute submaximal running test on a treadmill and (once you 
have recovered from this test) a maximum oxygen uptake test. 
 
Main Trials 
 
There will be two main trials each conducted over two days (8.00 am to 5.00 pm on each 
day). These will be assigned in a random order and separated by at least one week. 
 
Exercise trial  
 
On day one of the exercise trial you will report to the laboratory at 8.00 am after a 10 h 
overnight fast. You will rest in the laboratory (reading, working at a computer, watching 
television, listening to music etc) throughout day 1 until 5.00 pm. We will provide you with 
breakfast and lunch on day 1. At 3.30 pm you will perform a 60 minute run at 70% your 
maximum oxygen uptake. At 5.00 pm on day 1 you will leave the laboratory. You will 
consume a standardised meal at home in the evening, fast overnight for 10 h and return to 
the laboratory on day 2.  
 
On day 2 of the exercise trial you will report to the laboratory just before 8.00 am. A 
cannula will be inserted into a forearm or antecubital vein when you arrive at the laboratory. 
You will rest in the laboratory (reading, working at a computer, watching television, 
listening to music etc) throughout day 2 until 5.00 pm. You will be fed standardised meals 
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for breakfast (8.00 am) and lunch (12.00 pm). Fourteen, 9 mL venous blood samples will 
be collected from you via the cannula at the following times: 08.00, 08.15, 08.30, 09.00, 
10.00, 11.00, 12.00, 12.15, 12.30, 13.00, 14.00, 15.00, 16.00 and 17.00. (126 mL of blood 
collected in total on day 2).  
  
Control trial 
 
The control trial will be identical to the exercise trial with the exception of the 60 minute 
run on day 1. On the control trial you will perform no exercise on day 1 and remain resting 
in the laboratory. Other than this the trials are identical.  
 
Preparation for the tests 
 
Recording your diet 
 
You will be asked to weigh and record everything you eat and drink for 24 hours prior to 
the first main trial. You will then consume identical amounts of the same food and drink 
prior to your second main trial. Alcohol and caffeine must not be consumed on the days 
when you are recording your diet. These points are very important in order to prevent 
extraneous variables influencing the study findings and we will discuss this with you in 
depth prior to the main trials. 
 
Controlling physical activity  
 
No strenuous physical activity should be performed during the day preceding main trials. 
 
Overnight fast 
 
You will finish eating by 10:00 pm on the evenings before main trials. You may however 
continue to drink water after this time. You will report to the laboratory at 8:00 am the next 
morning without having eaten breakfast. We will provide you with breakfast and lunch on 
both day one and day two of each main trial.  
 
Travelling to the laboratory 
 
If you live within 400 metres of the laboratory you should walk in slowly on the morning 
of each main trial. Please do not run or cycle. If you live more than 400 metres from the 
laboratory then you should drive in. If you do not have access to a car please tell us and we 
will arrange for you to be collected.  
 
How much time will it take? 
 
• Screening visit: approximately 2 hours. 
• Two main trials each conducted over two days: nine hours per day, 18 hours per 
trial, 36 hours in total. 
 
You will be encouraged to bring work and reading material with you for the main trials. 
Alternatively you may watch television/movies, listen to music or work at a computer 
(internet enabled). 
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Possible risks and discomforts 
 
High intensity exercise will cause breathlessness. In a tiny minority of individuals, even in 
young adults, the possibility exists that such exercise triggers disturbances to normal 
physiology: these include abnormal blood pressure, fainting or a change in the normal 
rhythm of the heart. There is also a risk of musculoskeletal injury but this is minimal and 
measures will be taken to prevent any occurrences. 
 
Venous cannulation can cause air or plastic embolism (occlusion of a blood vessel) but 
good practice minimises this risk and the personnel conducting the procedure have been 
trained and are highly experienced. Cannulation can also lead to local thrombophlebitis 
(inflammation) in a superficial vein but the absolute level of risk is low. 
 
Benefits of the study 
 
The study should lead to greater understanding about the effects of exercise on the 
cardiovascular disease risk markers in relation to males of South Asian descent and white 
European males. In so doing it will contribute to an expanding body of evidence 
concerning the role of exercise in the prevention of cardiovascular disease. 
 
We will give you feedback on your own results and we will be happy to discuss this with 
you.  
 
Confidentiality  
 
Although information will be stored on computer, each participant will be entered as a 
number rather than by name, in accordance with the Data Protection Act. The information 
linking participant names to their number will be kept for no longer than five years. Data 
will be used for research purposes only and confidentiality will be maintained in any 
publications arising from the study. Participant data will not be kept longer than is 
necessary for the purposes of this investigation. Blood plasma samples collected during this 
investigation will be kept for no longer than three years. Samples will be disposed of via 
bio-hazard waste collection bags.  
 
Right to withdraw 
 
If you volunteer to participate in this study you hold the right to withdraw at any stage 
without having to inform the investigators of your reasons for doing so. 
 
Contacts 
 
Please feel free to ask any questions, at any stage. Contact information for the staff 
involved in this study is as follows: 
 
Mr Saravana Pillai Arjunan    Dr David Stensel   
S.P.Arjunan@lboro.ac.uk     D.J.Stensel@lboro.ac.uk 
Telephone 01509 226351    Telephone: 01509 226344 
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School of Sport, Exercise and Health Sciences 
 
The effects of a single bout of running versus three consecutive days of running on 
postprandial lipaemia in men of South Asian descent 
 
Investigators 
 
Mr Saravana Pillai Arjunan, Ms Emma Smith, Mr Daniel Teran, Ms Sara Treacy, Mr 
James Whiting, and Dr David Stensel 
 
Background 
 
South Asian men living in the UK have a higher than average risk of cardiovascular disease 
(CVD). The reasons for this are uncertain but physical inactivity may play a role. 
Alternatively, physical activity may be less effective in lowering the risk of CVD in South 
Asian men than in other men. Previous research from our laboratory has demonstrated that 
a single bout of exercise is effective for lowering blood lipid (triglyceride) concentrations 
after meals. This is important because high triglyceride concentrations are a marker for 
CVD risk. The proposed study will examine whether exercise performed on three 
consecutive days is more effective for lowering blood triglyceride concentrations than a 
single bout of exercise in men of South Asian descent. In addition to assessing the effects 
of exercise on blood triglyceride concentrations this study will also examine the effects of 
exercise on markers of inflammation in the blood because inflammatory markers may also 
be of use in predicting CVD risk.    
 
Inclusion Criteria 
 
Volunteers will:  
 
(xi) be male  
(xii) aged 18-40 y  
(xiii) have no personal history of cardiovascular disease, metabolic disease (e.g. 
diabetes)  or dyslipidaemia (e.g. high blood cholesterol) 
(xiv) not be dieting or have any extreme dietary habits  
(xv) not be taking drugs known to affect digestion or metabolism – medical or illegal 
(for example anabolic steroids, marijuana, amphetamines, thyroid prescription 
drugs).                                                                                                                                                                                                                                  
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Study Demands 
 
If you volunteer to participate in this study you will be required to attend the Exercise and 
Health laboratory (1.11) in the Clyde Williams building for a screening/familiarisation visit 
lasting approximately two hours and then you will perform three main trials in the 
laboratory at least one week apart. These trials are 1) control (resting), 2) one-day exercise, 
3) three-days exercise. The time commitments required for each of these trials are as 
follows:  
 
1) Control (resting): 1 hour in the lab on day 1 and 7 hours in the lab on day 2 (8 hours) 
2) One-day exercise: 1 hour in the lab on day 1 and 7 hours in the lab on day 2 (8 hours) 
3) Three-day exercise: 1 hour in the lab on days 1, 2 and 3 and 7 hours in the lab on day 4 
(10 hours) 
 
In total participants will need to visit the lab on 9 occasions which will require 28 hours of 
their time  
 
Preliminary Procedures 
 
During the screening/familiarisation visit we will: 
 
• Explain the objectives of the study and its requirements 
• Ask you to complete a confidential questionnaire regarding your health 
• Familiarise you with the testing procedures and equipment 
• Familiarise you with dietary recording 
• Ask you about your food tolerances and preferences  
• Answer any questions you may have 
 
After this we will collect the physiological/anthropometric measurements listed below: 
 
• Resting blood pressure 
• Height 
• Weight 
• Skinfold thicknesses at four sites (to estimate body fat percentage) 
• Waist and hip circumferences 
 
You will then complete a submaximal running test on a treadmill and (once you have 
recovered from this test) a maximum oxygen uptake test. 
 
Main Trials 
 
The three main trials will be assigned in a random order and separated by at least one week. 
 
One-day exercise trial 
 
On day one of this trial you will report to the laboratory at 3.00 pm. After a brief warm up 
you will complete a 30 minute treadmill run at 70% of maximum oxygen uptake. After 
completing the run you will warm down and leave the laboratory. You will consume a 
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standardised meal at home in the evening, fast overnight for 10 h and return to the 
laboratory on day 2.  
 
On day 2 of this exercise trial you will report to the laboratory just before 9.00 am. A 
cannula will be inserted into a vein in your arm. You will rest in the laboratory (reading, 
working at a computer, watching movies, listening to music etc) throughout day 2 until 
4.00 pm. You will be fed standardised meals for breakfast (9.00 am) and lunch (12.00 pm). 
Ten, 9 mL venous blood samples will be collected during the day. The timing of these 
collections is as follows: 09.00, 09.30, 10.00, 11.00, 12.00, 12.30, 13.00, 14.00, 15.00, and 
16.00. In total 90 mL of blood will be collected on day 2 and this equates to less than one-
fifth of a standard blood donation.  
  
Three-day exercise trial 
 
For this trial you will visit the lab in the afternoon for 3 consecutive days to complete a 30 
minute treadmill run at 70% of maximum oxygen uptake. The procedures on the fourth day 
will be identical to those outlined for day 2 of the one-day exercise trial.   
 
Control trial 
 
The control trial will be identical to the one-day exercise trial with the exception of the 30 
minute run. On the control trial you will perform no exercise on day 1 and remain resting in 
the laboratory for an hour. Several expired air samples will be collected into Douglas bags 
during this time.  
 
NB It is important that you are free of illness for all lab visits and we will check this with 
you at the start of each visit.   
 
Preparation for the tests 
 
Recording your diet 
 
You will be asked to weigh and record everything you eat and drink for 24 hours prior to 
the first main trial. You will then consume identical amounts of the same food and drink 
prior to the other main trials. Alcohol and caffeine must not be consumed on the days when 
you are recording your diet. These points are very important in order to prevent extraneous 
variables influencing the study findings and we will discuss this with you in depth prior to 
the main trials. For the three-day exercise trial we will ask you to keep a record of your 
food intake over days one to three of the trial.  
 
Controlling physical activity  
 
No strenuous physical activity should be performed during the days preceding main trials. 
 
Overnight fast 
 
You will finish eating by 11:00 pm on the evenings before the final day of each trial. You 
may however continue to drink water after this time. You will report to the laboratory at 
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9:00 am the next morning without having eaten breakfast. We will provide you with 
breakfast and lunch on the final day of each main trial.  
 
Travelling to the laboratory 
 
If you live within one mile of the laboratory you should walk in slowly on the morning of 
each main trial. Please do not run or cycle. If you live more than one mile from the 
laboratory then you should drive in. If you do not have access to a car please tell us and we 
will arrange for you to be collected.  
 
Possible risks and discomforts 
 
High intensity exercise will cause breathlessness. In a tiny minority of individuals, even in 
young adults, the possibility exists that such exercise triggers disturbances to normal 
physiology: these include abnormal blood pressure, fainting or a change in the normal 
rhythm of the heart. There is also a risk of musculoskeletal injury but this is minimal and 
measures will be taken to prevent any occurrences. 
 
Venous cannulation can cause air or plastic embolism (occlusion of a blood vessel) but 
good practice minimises this risk and the personnel conducting the procedure have been 
trained and are highly experienced. Cannulation can also lead to local thrombophlebitis 
(inflammation) in a superficial vein but the absolute level of risk is low. 
 
Benefits of the study 
 
The study should lead to greater understanding about the effects of exercise on the CVD 
risk markers in relation to males of South Asian descent. In so doing it will contribute to an 
expanding body of evidence concerning the role of exercise in the prevention of CVD. We 
will give you feedback on your own results and we will be happy to discuss this with you.  
 
Confidentiality  
 
Although information will be stored on computer, each participant will be entered as a 
number rather than by name, in accordance with the Data Protection Act. The information 
linking participant names to their number will be kept for no longer than five years. Data 
will be used for research purposes only and confidentiality will be maintained in any 
publications arising from the study. Participant data will not be kept longer than is 
necessary for the purposes of this investigation. Blood plasma samples collected during this 
investigation will be kept for no longer than three years. Samples will be disposed of via 
bio-hazard waste collection bags.  
 
Right to withdraw 
 
If you volunteer to participate in this study you hold the right to withdraw at any stage 
without having to inform the investigators of your reasons for doing so. 
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Contacts 
 
Please feel free to ask any questions, at any stage. Contact information for the staff 
involved in this study is as follows: 
 
Mr Saravana Pillai Arjunan  
S.P.Arjunan@lboro.ac.uk   
Telephone 01509 226351 
  
Dr David Stensel    
D.J.Stensel@lboro.ac.uk  
Telephone: 01509 226344 
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10.2 Appendix B: Informed consent form 
INFORMED CONSENT FORM 
(to be completed after the participant information sheet has been read) 
The purpose and details of this study have been explained to me.  I understand that this 
study is designed to further scientific knowledge and that all procedures have been 
approved by the Loughborough University Ethical Advisory Committee. 
 
I have read and understood the information sheet and this consent form. 
 
I have had an opportunity to ask questions about my participation. 
 
I understand that I am under no obligation to take part in the study. 
 
I understand that I have the right to withdraw from this study at any stage for any reason, 
and that I will not be required to explain my reasons for withdrawing. 
 
I understand that all the information I provide will be treated in strict confidence and will 
be kept anonymous and confidential to the researchers unless (under the statutory 
obligations of the agencies which the researchers are working with), it is judged that 
confidentiality will have to be breached for the safety of the participant or others.  
 
I agree to participate in this study. 
 
                    Your name 
 
 
              Your signature 
 
 
Signature of investigator 
 
 
                               Date 
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10.3 Appendix C: Health screen questionnaire 
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10.4 Appendix D: Physical activity questionnaire 
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10.5 Appendix E: Physical activity questionnaire (GPAQ) 
PHYSICAL ACTIVITY QUESTIONNAIRE 
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10.6 Appendix F: South Asian verification form 
 
 
